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Abstract 
ICP27 is an HSV -1 immediate early protein required for the switch from early to late 
gene expression. It is a multifunctional, 63kDa protein that has homologues throughout 
the Herpesviridae, reflecting the importance of this protein to the virus. This may also 
indicate that ICP27's regulatory role is maintained in the identified homologues. 
Deleting ICP27 from the HSV -1 genome severely affects virus production, and, 
although not absolutely required for viral DNA replication, ICP27 enhances the levels 
of replicated DNA by up to 10-fold. Regulatory roles of this protein include effects on 
transcription, RNA stability, splicing, export and translation. ICP27 binds viral and 
cellular RNAs, and recently a yeast three-hybrid (Y3-H) analysis has identified an array 
of viral RNA sequences that interact with ICP27. 
Presented here are analyses of functional assays using a selection of the Y3-H identified 
RNA sequences inserted into the 5' untranslated region (UTR) of a chloramphenicol 
acetyl transferase (CAT) reporter plasmid. A set of plasm ids was transfected into baby 
hamster kidney (BHK) cells and CAT assays carried out to analyse the effects of the 
sequences on gene expression. Results indicated that expression was increased when 
ICP27-binding sequences were present even though no viral proteins were present. 
Comparison of sequences revealed that no common activation code or RNA structure 
was present that could be responsible for the increase in CAT gene expression. The 
levels of expression were further determined in the presence of wild type (wt), ICP27-
null or ICP27 mutant HSV -1 infection to investigate whether ICP27 had any affect on 
CAT expression when ICP27 -binding sequences were present. Interestingly, enhanced 
expression was observed during wt HSV -I-infection when ICP27 -binding sequences 
were present, whereas little to no enhancement was observed during ICP27-null or 
mutant virus infections. However, a higher fold increase in CAT gene expression was 
observed during a HSV -1 infection when ICP27 -binding sequences were not present. 
This indicated that an inhibitory effect on CAT expression observed during wt HSV-I 
infection when ICP27-binding sequences were present was ICP27-dependent. As a 
control, a noncoding, protein binding regulatory HPV RNA sequence was inserted into 
the CAT reporter plasmid, transfected into BHK cells and then infected with wt HSV -1, 
ICP27-null or ICP27 mutant viruses. Surprisingly, CAT expression was increased, 
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albeit to only a limited extent, indicating that the previously observed increase in gene 
expression was not HSV -1 sequence specific. However, upon transfection of plasmids 
with the HPV control sequence inserted in the reverse orientation and a subsequent 
infection of cells no increase in CAT expression was observed. 
Analysis of the control sequence in the reverse orientation identified a shortage in G 
residues, which led to the construction of CAT reporter plasmids containing 
homopolymer sequences inserted into the 5'UTR. A series of transfections and 
subsequent mock, wt HSV -lor ICP27 -null virus infections were carried out using this 
set of constructs. CAT assay analysis revealed an increase in CAT expression, to levels 
similar to those observed when the HSV -1 sequences were present, when poly(G) 
homopolymers were used as inserts during wt HSV -1 infection, whereas poly(A), (C) 
and (T) gave low levels of expression. Little to no enhanced gene expression was 
observed during ICP27 -null virus infection when homopolymer sequences were present 
indicating firstly a preference during an HSV -1 infection for G-rich sequences and 
secondly that enhanced gene expression observed during infection was ICP27-
dependent. This was a significant finding as the HSV -1 genome is 68% GC-rich, 
indicating a preference for ICP27 to enhance expression of viral genes during infection. 
Preliminary experiments were undertaken to identify the role of ICP27 when CAT gene 
expression was enhanced. Reporter plasmids containing HSV -1 sequence inserts were 
transfected into BHK cells and infected with wt HSV -lor ICP27 mutant viruses. Total 
RNA was isolated from these cells and CAT RNA was quantified using quantitative 
reverse transcription and polymerase chain reaction (Q-RT PCR). No significant change 
in levels of CAT RNA was detected, irrespective of whether the RNA had been isolated 
from cells that had been infected with wt HSV-1 or ICP27 mutant viruses, indicating 
that the increase in CAT gene expression was not at the level of transcription. In further 
experiments nuclear and cytoplasmic fractions were isolated after a CAT reporter 
plasmid with an ICP27 -binding sequence insert was transfected into BHK cells that 
were subsequently either mock or wt HSV -1 infected. CAT RNA levels were detected 
using Q-R T PCR and preliminary results identified no significant change in the levels of 
RNA whether the cells were mock or HSV -1 infected, indicating that enhanced CAT 
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expression occurs at the level of translation. These results, alongside recent publications 
linking ICP27 to translation machinery, support the hypothesis that ICP27 enhances the 
expression ofG-rich sequences at the level of translation. 
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Chapter 1: Introduction 
1.1 Herpesviridae family 
Herpesviruses are large double stranded DNA viruses that share common morphological 
features. They constitute a large and diverse family of viruses that have been isolated 
from hosts ranging from fish, amphibians, reptiles, birds and mammals (including pigs, 
cattle and humans) (Roizman, 1993; Roizman, 2001). They vary considerably in their 
size, structure, pathology and biology and are highly host specific. 
1.1.1 Distinctive structural characteristics 
The characteristic morphology of the Herpesviridae family of viruses is shown in 
Figure 1.1. The virions consist of an electron dense core containing a double stranded 
linear DNA genome (124-235kbp), enclosed in an icosahedral capsid (approximately 
100nm diameter) comprised of 162 capsomeres, of which 150 are hexamers (hexons), 
and 12 are pentamers (pentons) of the major capsid protein ULI9. There are also 320 
triplexes, each consisting of two molecules of UL18 and one of UL38, in the 
nUcleocapsid (Schrag et at., 1989; Wildy et at., 1960; Zhou et at., 1994) (Figure 1.2). 
The tegument is an amorphous layer surrounding the capsid (Roizman, 1974), 
surrounded by a lipid bilayer containing virally encoded glycoprotein spikes 
approximately 8nm long (Spear and Roizman, 1972). The tegument layer consists of 
approximately 20 viral proteins and is of varying thickness, thereby affecting the size of 
the virion, resulting in diameters ranging from 150-200nm. Tegument proteins are 
mostly proteins required early in the course of infection including the transcription 
transactivators VP 16 and a protein that induces host mRNA degradation UL41 (also 
known as the virion-induced host shutoff protein, vhs) (Mettenleiter, 2002). 
Furthermore, host cell proteins may be contained in the tegument compartment however 
very little is known of this. For example, cellular filaments have been observed in the 
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Figure 1.1: Schematic representation of the HSV-1 virion. 
Reproduced from Marko Reschke et aI. , 1997. 
Figure 1.2: Reconstruction of HSV -1 B capsid. Produced 
from Zhou et aI. , 1995. 
tegument and the width of these structures suggests they are actin filaments, however, 
this has not been confirmed (Grunewald et aI., 2003). 
1.1.2 Biological properties 
All herpesviruses have similar biological properties including production of enzymes 
involved in nucleic acid metabolism, and DNA synthesis. They replicate in the nucleus 
of the host cell, and budding occurs at the cell membrane where production of virions 
often leads to cell death. A characteristic of these viruses is their ability to enter a latent 
state after primary infection, thus establishing a quiescent infection throughout the 
lifetime of the host. The virus may then reactivate in response to stress, such as UV light 
or the host becoming immunocompromised. Biological variation between members 
occurs at the level of range of host species, speed of multiplication in the host, host cell 
specificity and clinical manifestations. There are eight herpesviruses known to infect 
man that have been identified and they are described in Table 1.1 (Flint., 2003). 
1.1.3 Classification 
Classification of herpesviruses is based on nucleic acid sequence, genomic organisation, 
cell tropism/host range, pathogenicity, duration of reproductive cycle and 
characterisation of latent infection (Roizman, 1982). These DNA viruses are separated 
into three subfamilies, called Alphaherpesvirinae (a), Betaherpesvirinae (~) and 
Gammaherpesvirinae (y). 
1.1.3.1 Alphaherpesvirinae 
Alphaherpesvirinae have two genera identified so far, Simplexvirus (e.g. HSV -1) and 
Varicellovirus (e.g. HHV-3 also known as varicella-zoster virus (VZV)). They have 
variable host range in vivo and in vitro and a relatively short reproductive life cycle. 
Infection causes cell destruction that is quickly spread to other susceptible cells. These 
viruses also have the ability to establish latency in sensory ganglia. HSV -1 is the most 
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Herpesvirus 
Herpes simplex 
virus type-1 
(HSV-1 ) 
Herpes simplex 
virus type-2 
(HSV-2) 
Varicella zoster 
virus 
(VZV) 
Epstein Barr 
virus (EBV) 
Human 
cytomegalovirus 
(HCMV) 
Human 
herpesvirus 6 
(HHV-6) 
Human 
herpesvirus 7 
(HHV-7) 
Kaposi's 
sarcoma 
associated 
herpesvirus 
(KSHV) 
Class 
a 
a 
a 
y 
y 
G+C DNA 
% size 
(kbp) 
68.3 152 
69 152 
46 125 
60 172 
57 229 
42 162 
45 145 
53 140.5 
Associated illness 
Causes 80-95% of oral 
lesions (cold sores) and 30-
50% of genital lesions plus 
other occasional symptoms. 
Causes 5-20% oral lesions 
(cold sores) and 50-70% 
genital lesions plus other 
occasional symptoms 
Primary infection: chicken pox 
(rash) accompanied by fever. 
Reactivation: shingles. 
Primary infection in children is 
often asymptomatic. Infection 
in older children and adults is 
associated with infectious 
mononucleosis (glandular 
fever). Associated with 
Burkitt's lymphoma and 
nasopharyngeal carcinoma. 
Primary infection: 
enlargement and fusion of 
macrophages. Often 
asymptomatic though can be 
fatal in newborns. 
Infant rash, exanthum subitum 
Febrile illness 
Associated with Karposi's 
sarcoma, a vasculated 
nodular skin lesion. 
Table 1.1: Human herpes viruses. Eight human herpesviruses, classification, G+C% 
content, genomic size and disease associated with them. 
extensively studied of the herpesviruses and the prototype virus of the subfamily. The 
most common sites of HSV -1 infection are around the lips and mouth. The virus 
generally remains latent in sensory neurones and causes cold sores upon reactivation. 
HSV -2 is closely related to HSV -1 and is generally associated with genital infections. 
VZV primary infections are classically recognised by the appearance of small pus filled 
vesicles on the skin that are associated with itching (chicken pox) and usually occurs 
during childhood. If reactivated in adulthood the virus can cause a complaint called 
shingles. 
1.1.3.2 Betaherpesvirinae 
Betaherpesvirinae have genera identified as human cytomegalovirus (e.g. HHV-5 also 
known as HCMV) and Roseolovirus (e.g. HHV -6), which are species specific. They 
have relatively long reproductive life cycles, replicate slowly in culture and cause 
enlargement of infected cells, i.e. cytomegalia, in vivo and in vitro. Latency generally 
occurs in lymphocyte precursors. HCMV is the most extensively studied of the 
betaherpesvirinae where infection is usually asymptomatic, however, it can cause 
serious foetal damage if acquired during pregnancy, organ transplant rejection, and 
retinitis in immunocompromised people. 
Two betaherpesviruses, HHV -6 and HHV -7, are members of the Roseolovirus genus 
and have very similar genomes and gene products. HHV -6 can cause exanthema 
subitum, an early childhood disease that is characterised by high fever and rash. This 
disease can also occur in immunocompromised people. 
1.1.3.3 Gammaherpesvirinae 
Gammaherpesvirinae have two genera, Lymphocryptovirus and Rhadinovirus. They are 
a classic lymphoproliferative group where classification is based on their infecting 
characteristics i.e. they replicate and persist in lymphocytes and may cause lytic 
infection in epithelial or fibroblastic cells. They frequently, but not exclusively, infect 
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the same family or order to which the natural host belongs. The genera 
lymphocryptovirus (e.g. HHV-4) are specific for either B or T lymphocytes where lytic 
or latent infection is frequently found. The reproduction cycle and the extent of the 
cytopathology of the gammaherpesvirinae are highly variable. Epstein-Barr virus 
(EBV) can cause infectious mononucleosis in adolescents and young adults. Burkitt's 
lymphoma, nasopharyngeal carcinoma and Hodgkins disease have been associated with 
EBV. 
Kaposi's sarcoma-associated herpesvirus (HHV -8) is a member of the rhadinovirus 
subfamily. This virus is the primary causative factor in all types of Kaposi sarcomas, 
that is, a multiple-pigmented sarcoma of the skin. KSHV has also been linked with other 
diseases such as primary effusion lymphoma and certain cases of multicentric 
Castleman's disease. 
1.1.4 Herpesvirus DNAs 
The majority of herpesvirus DNAs extracted from virions have linear, double stranded 
genomes 124-235kbp in length and contain 70-200 open reading frames (ORFs). Base 
composition varies from 31 % G+C to 75% G+C (Table 1.1). The sequence 
arrangements vary in the copy number of terminal and internal repeat sequences and to 
date, seven genome structures have been identified in herpesviruses (Roizman, 1992) . 
1.2 HSV-1 molecular biology 
1.2.1 Genomic arrangement 
The genome of HSV-1 is 152kbp in length (McGeoch et al., 1988; McGeoch et al., 
1986a; McGeoch et al., 1985; McGeoch et al., 1986b) and encodes over 80 
polypeptides. The genome is composed of long and short unique segments flanked by 
terminal repeat regions. The unique long (ud region is 107.9kbp long and encodes at 
least 59 genes. The unique short (Us) region is 13kbp and encodes approximately 13 
4 
genes. The unique sequences are flanked by inverted repeats, RL (9kbp) and Rs (6.5kbp) 
(McGeoch et at., 1988). The RL and Rs sequences are not related apart from the a 
sequences (400bp) located at the genome termini. One copy of the a sequence is located 
at the S terminus, whereas the L terminus may have more than one copy. The a 
sequence is also present at the L-S junction as an inverted repeat and again can be 
present as more than one copy (Wagner and Summers, 1978). During infection the L 
and S components invert relative to each other so that the progeny viral DNA consists 
of equimolar amounts of four isomers. They differ from each other solely in the relative 
orientation of the two unique components. These isomers are termed h (inversions of 
L), Is (inversion of S) and ISL (inversion of both Sand L) (Figure 1.3) (Delius and 
Clements, 1976; Hayward et at., 1975; Roizman, 1979). 
1.2.2 Lytic cycle and particles 
Figure 1.4 summarises the lytic life cycle of HSV -1 which takes approximately 18-20h 
in fully permissive cells (Roizman, 1996). Infected cells produce three types of HSV-1 
particles; the virion, the L-particle and the PREP particle. The virion contains HSV-1 
DNA and is thus capable of infecting other cells. The L-partic1e lacks the nucleocapsid 
and viral DNA and is therefore non-infectious (Szilagyi and Cunningham, 1991). Pre-
DNA replication, or PREP particles (Dargan et at., 1995), are synthesised when DNA 
replication is blocked; they are similar to L particles but lack the true late proteins or 
only possess them in minute quantities. The lytic cycle consists of virus attachment, 
entry, gene transcription, DNA replication, capsid assembly, virion maturation and 
egress, resulting in the death of the host cell. 
1.2.3 Attachment and adsorption 
The attachment of the HSV -1 Vlnon to the host cell membrane reqUIres the 
simultaneous interaction of the virion envelope glycoproteins with the cell surface 
receptors (Fuller and Lee, 1992). HSV-1 virions usually bind to heparin sulphate (HS) 
(Shukla and Spear, 2001) in most cell mono layers. Fusion of the virion membrane with 
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Figure 1.3: (A) Schematic diagram of the HSV-l genome. The unique 
regions, UL and Us' denoted by single lines are flanked by the RL and Rs 
repeat sequences, respectively (white and blue rectangles). The a 
sequence is represented by a green box and is present at each end of the 
genome in an inverted orientation, separating IRL and IRs (not to scale). 
(B) The four genomic isomers generated by the inversion of UL and Us 
regions are shown: P= prototype, IL = inverted UL' Is = inverted Us' ILS = 
inverted UL and Us ' 
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Figure 1.4: A schematic diagram of the lytic cycle. Adsorption is 
mediated by interactions between the host cell membrane and the 
virion glycoproteins leading to the release of capsid and tegument 
proteins into the cytoplasm. The vhs protein acts to cause 
degradation of mRNAs. The capsid is transported to the NPC and the 
viral DNA is released into the nucleus. Transcription, replication of 
viral DNA and assembly of nucleocapsid takes place in the nucleus. 
Viral gene expression is co-ordinately regulated in a temporal 
fashion starting with Immediate Early (a), Early (~) then Late (y) 
gene expression resulting in the expression of around 80 gene 
products. Viral DNA is replicated initially through a theta replication 
mechanism, followed by the rolling circle mechanism and the virion 
DNA is packaged into the capsid in the nucleus. The virion is 
thought to mature and egress through the secretory pathway and is 
released into the surrounding medium. (From Howley, Fields 
Virology, 2001). 
the cellular membrane is mediated by a number of viral glycoproteins including gB, gH 
(Spear, 1993), however, gD is absolutely required for virus entry. This requires the 
binding of gD to one of a few cell surface receptors including a herpesvirus entry 
mediator, a member of the tumor necrosis factor receptor family; nectin-1 or nectin-2, 
cell adhesion molecules; and specific modifications in HS (Spear et al., 2006). 
1.2.4 Regulation of gene expression 
Viral gene expreSSIOn occurs III a co-ordinately regulated and sequentially ordered 
fashion. Herpesvirus genes can be classified into at least three regulatory classes by the 
kinetics of their expression and their requirement for DNA replication, i.e. immediate 
early (IE), early (E) and late (L). IE gene expression occurs immediately following 
infection and expression peaks at between 3 and 4 h.p.i. Early genes are expressed next 
where the rates of polypeptide synthesis are highest from 5 to 7 h.p.i. Viral DNA 
synthesis begins soon after expression of early proteins and stimulates the expression of 
late genes that are made at increasing rates until at least 12 h.p.i (Zhang and Wagner, 
1987). 
1.2.4.1 Immediate early gene transcription 
The a trans-inducing factor (a-TIP or VP16), a virion structural protein, is responsible 
for trans activating IE genes in the infected cell. Coordinated induction of IE genes 
requires the consensus DNA sequence T AA TGARA T located upstream of all five IE 
gene promoters. The cellular Oct1 DNA-binding protein binds to this cis acting site and 
recruits a-TIP and other cellular proteins, including the RNAP II holoenzyme. They 
assemble into a transcriptional pre-initiation complex (Costanzo et al., 1977; O'Hare 
and Goding, 1988). Four of the five IE gene products, ICP27, ICP4, ICPO and ICP22 
are involved in the regulation of early and late virus genes (Everett, 1987). Regulation 
of IE transcription is by various cis acting elements including TATA and CAAT 
elements, binding sites for the transcription factor Sp 1, and occasionally binding sites 
for ICP4. 
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1.2.4.2 Early gene expression 
E genes are generally involved in nucleotide metabolism and DNA replication and 
depend on the prior synthesis of the IE genes ICPO and ICP4. Promoter regions of E 
genes containing a TATA box, a transcription cap site (McKnight and Tjian, 1986) and 
binding sites for cellular factors such as Sp 1 and a CAA T binding protein, are found 
upstream of the promoter (Jones et al., 1985). No upstream sequences specific for viral 
genes have been detected, though IE proteins (e.g. ICP4) may be involved in the 
stabilization of cellular transcription factor binding or aiding their recruitment. 
1.2.4.3 Late gene expression 
L genes can be subdivided into two classes, the leaky late or y-1 (L-1) genes or the true 
late or y-2 (L-2) genes. Genes from the L-1 class can be expressed at low levels prior to 
DNA replication whereas L-2 gene expression can only be activated during and after 
viral DNA replication has occurred (UL22, UL44, UL47 and US11 are examples ofL-2 
genes) (Honess and Watson, 1977). 
Full expression of L1 genes requires viral DNA replication and some IE and E gene 
products (Honess and Roizman, 1974; Honess and Roizman, 1975). The onset and 
mechanism of L-2 transcription only at times of viral DNA synthesis is not fully 
understood, however this is thought to be due to a number of factors. 
L-2 promoters are weak, compared to IE and E promoters (Guzowski et al., 1994), 
however this weakness alone is not fully responsible for the strict regulation ofL-2 gene 
expression. In vivo transcription assays determined that genome replication was a major 
factor in the activation of L-2 genes, however this is not due to restrictions on regions of 
the viral genome as E and L transcripts were rando mly distributed throughout the 
genome. Nor is it due to the global change in transcription factors as promoters 
controlling both E and L transcripts are active in uninfected cells. It was therefore 
postulated that promoters of each kinetic class require cis-acting sequences for their 
regulation of transcription (Mavromara-Nazos and Roizman, 1987). 
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Generally, sequences required for the efficient expression of all late genes include the 
TATA box and extend into the 5' non-coding regions. (Homa et al., 1988; Johnson and 
Everett, 1986). Unlike IE and E gene promoters, L-2 promoters do not have cis-acting 
elements upstream of the TAT A box regulating transcription. Instead, late gene 
promoters have an initiator element and a downstream cis-acting element called the 
downstream activation signal (DAS). (Hom a et al., 1988; Wagner et al., 1998). It is 
thought that L gene expression is regulated by several factors; for example, ICP4 binds 
to the DAS and may interfere with transcription of the L gene before the onset of viral 
DNA synthesis. Also, the DNA-binding protein ICP8 can down regulate transcription of 
L genes before the onset of viral DNA replication (Rajcani et al., 2004; Weir, 2001). 
1.2.5 HSV -1 DNA replication 
HSV -1 encodes seven genes required for DNA replication and several accessory 
enzymes required for the replication of the viral genome: UL5, UL8, UL9, UL29, 
UL30, UL42 and UL52 (Table 1.2) (Boehmer and Lehman, 1997). It is not known if 
additional host factors are required; however, two functions essential for cellular DNA 
replication, DNA topoisomarase and DNA ligase, are not encoded by HSV -1. 
Viral DNA can undergo circularization within Ih of infection and is thought to serve as 
a template for DNA replication (Strang and Stow, 2005). The circularized DNA then 
enters a rolling circle mode of DNA replication generating branched concatameric DNA 
that is then cleaved and packaged as unit-length molecules. However, the presence of 
the origins of replication and the UL9 protein, that has helicase activity, suggests a theta 
mode of replication and led to the proposed bipartite model of replication where theta 
replication precedes the rolling circle mode of replication (Figure 1.5) (Lehman and 
Boehmer, 1999). 
1.2.6 Latency and reactivation 
The ability to establish a life long latent infection within neurones of the peripheral 
nervous system is the hallmark of HSV -1. The virus is able to exist in a non-replicative 
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Gene Properties and Functions 
UL5 Subunit of the helicase-primase complex in 
association with UL8 and UL52. 
UL8 Subunit of the helicase-primase complex in 
association with UL5 and UL52. 
UL9 Origin binding protein, binds as a homodimer to 
the HSV -1 ori sequences, also has helicase and 
ATPase activities. 
UL29 Single-stranded DNA binding protein (also known 
as Iep8). Stimulates the helicase and ATPase 
activities ofUL9. Recruits UL30 and UL42 
proteins. 
UL30 DNA polymerase with 3' -5' exonuclease and 
RNaseH activities. Forms a heterodimer with 
UL42. 
UL42 Double-stranded DNA binding protein, forms a 
heterodimer with UL30 increasing the processivity 
of the UL30 DNA polymerase. 
UL52 Subunit of the helicase-primase complex in 
association with UL8 and UL5. 
Table 1.2: Summary of HSV-1 DNA replication proteins and their 
functions (adapted from Boehmer and Lehman, 1997). 
Initiation 
UL9 
UL9 
, Theta Replication 
Pol aJprimase , 
Helicaselprimase 
[ 0 ] Rolling Circle Template 
, Rolling Circle Replication 
Pol/UL42 
Figure 1.5: Model for the bipartite replication of the HSV -1 genome in 
which an initial transient phase of theta replication is followed by a 
rolling circle mode, the predominant mode of HSV -1 DNA replication 
(taken from Lehman, et al. 1999). 
state, which is often followed by reactivation and asymptomatic disease (Rock, 1993). 
Lytic viral replication can be dissociated from establishment of latent infection as the 
HSV-1 mutant virus lacking the VP16 protein (the transactivators of IE genes) can 
establish a latent infection even though it fails to replicate during the acute phase of 
infection (Ecob-Prince et al., 1993a; Ecob-Prince et al., 1993b; Steiner et al., 1990). 
Following infection, the virus is transported via retrograde axonal transport (Kristensson 
et al., 1986) to the cell bodies of sensory neurones within the dorsal root ganglia to 
establish latent infection (Figure 1.6). During latent infection the only detecTable viral 
gene expression is that of the major class of transcripts called the latency associated 
transcripts (LATs). Although LATs are not essential for establishment or maintenance 
of latency it appears that both the LAT region of the genome (Block et al., 1993; 
Deshmane et al., 1993; Javier et aI., 1988; Leib et al., 1989) and a functional ICPO 
protein (Chen et al., 1991; Harris et al., 1989) are important for reactivation of latent 
virus. The molecular basis of reactivation is poorly understood but viral protein ICPO as 
well as cellular proteins Oct! and Brn3 have been implicated (Lillycrop et al., 1995; 
Rock, 1993). These cellular proteins are mammalian transcription factors and are 
known to regulate gene expression, particularly in cells of the nervous system by 
binding to the octamer motif ATGCAAA T, which is found in the promoters of several 
cellular genes (e.g. neuronal nitric oxide synthase gene). Two members of the Brn 3 
family, for example, can activate IE promoters (Latchman, 1999). 
Infectious particles are carried back to peripheral tissues by axonal transport (Cook and 
Stevens, 1973). Reactivation takes 3-5 days and is triggered by external stimuli such as 
sunlight and stress (Jones, 2003). The ability ofHSV-1 to reactivate from latency results 
in recurrent disease and virus transmission. 
1.2.7 Host-shutoff 
HSV -1 infection leads to the redirection of cellular factors and metabolism to the task of 
producing infectious virions. Upon infection, HSV -1 down-regulates host cell DNA 
synthesis, translation and splicing, in favour of the production of its own 
macromolecules. Numerous cellular components and pathways are modified during 
HSV -1 infection. 
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Figure 1.6: Establishment, maintenance and reactivation from 
latency. After replication at the peripheral tissue, HSV -1 enters the 
sensory neuron where it is transported to the ganglia that innervate 
the site of infection. Here it resides in a latent state. The virus begins 
to replicate during reactivation and is transported back to the 
peripheral tissues where it replicates to produce infectious virions. 
The processofmodulating host gene expression is initiated by the virion host shut-off 
(vhs) protein, which is delivered in the tegument. Vhs causes the destabilisation and 
degradation ofmRNA (Kwong et aI., 1988). The IE gene product ICP27 causes the 
redistribution of splicing factors (Bryant et aI., 2001; Hardwicke and Sandri -Goldin, 
1994; Phelan et aI., 1996). Most cellular genes contain introns, compared with only five 
genes for HSV -1. The activity of ICP27, therefore, results in the nuclear retention of 
cellular genes. The role ofICP27 in pathways contributing to host shutoff is discussed 
at length in section 1.4. 
Another HSV -1 protein with a role in host shutoff is the true late ICP34. Protein kinase 
R (PKR) is a cellular protein that can be activated by low concentrations of dsRNA and 
its antiviral action results in the global shutoff of translation. This is brought about by 
the ability of the activated PKR to phosphorylate the eukaryotic initiation factor 2 
(eIF2) a subunit. Phosphorylated eIF2a forms a tight complex with the eIF2 guanosine-
exchange factor, eIF2~, and inhibits the exchange of GDP for GTP in the eIF2 complex 
(Ramaiah et aI., 1992; Rowlands et aI., 1988). The recycling of the eIF2 complex to 
form the eIF2-GTP-Met-initiator tRNA ternary complex is therefore inhibited and the 
translation ofmRNA is subject to global shutoff and growth arrest/cell death occurs (see 
section 1.3.5 for mammalian translation initiation). However, this global shutoff at the 
translation step is only observed during HSV -1 infection when ICP34.5 is absent or 
mutated. PKR, however, was activated in cells infected with wt or ICP34.5 virus 
mutants (Chou et aI., 1995). The control of host cell protein synthesis during wt 
infection was later shown to be due to the interaction of ICP34.5 with protein 
phosphatase 1 to dephosphorylate eIF2 thus allowing protein synthesis to proceed (He et 
aI., 1997). 
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1.3 Mammalian pre-mRNA processing 
The HSV -1 IE protein ICP27 is known to play a role in the regulation of gene 
expression by influencing the cellular machinery involved in pre-mRNA processing. 
Cellular pre-mRNA processing will firstly be described and, later, the role of ICP27 
with regard to these processes. 
When a pre-mRNA has been produced by transcription, changes occur before the 
mRNA is ready for transport from the nucleus to the translation machinery. Post-
transcriptional events such as capping, polyadenylation, splicing, nuclear export and 
translation initiation of transcripts all contribute to the final expression levels of the 
gene. 
1.3.1 5' Capping 
The 5' cap structure is essential and is required for efficient pre-mRNA splicing, export, 
stability and translation initiation, is a highly regulated process that occurs in the 
nucleus. The 5' terminal nucleotide of the primary transcript is capped by a 7-methyl 
guanosine linked by a 5'-5' triphosphate bridge (Figure 1.7) (Shatkin, 1976). Three 
enzymatic activities are required for cap formation: the 5' triphosphate end of the 
nascent transcript is hydrolysed to a diphosphate end by RNA triphosphatase; the 
diphosphatase end is capped with GMP by RNA guanylyltransferase; and the 5' guanine 
base is methylated by RNA methyltransferase at the guanine N7 position (Furuichi and 
Shatkin, 2000; Shuman, 2001). There have been no reports on the regulation of 5' 
capping by ICP27. 
1.3.2 Polyadenylation 
The formation of a poly (A) tail at the 3' end of pre-mRNA is also an essential step in 
the maturation of eukaryotic mRNA that contributes to the regulation of mRNA export, 
stability and translation (Edmonds, 2002; Proudfoot and O'Sullivan, 2002). Two 
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Figure 1.7: The 5' cap is found on the 5' end of an RNA molecule 
and consists of a guanosine nucleotide connected to the RNA via 5'-
5' triphosphate linkage (taken from www.Wilkipedia.org). 
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Figure 1.8: The polyadenylation machinery is composed of several 
multimeric proteins. Five factors are involved in the cleavage step: 
Cleavage and Polyadenylation Specificity Factor (CPSF), Cleavage 
stimulation Factor (CstF), Cleavage Factors I and II, and Poly(A) 
Polymerase (PAP), while three factors playa part in the polyadenylation 
step: CPSF, PAP, and poly(A) binding protein 2 (PABP2) (taken from 
www.uvm.edu/microbiology). 
sequence elements that specify pre-mRNA cleavage and poly (A) addition have been 
identified. The highly conserved AAUAAA sequence is located about 10-30 nt 
upstream of the cleavage site, and the GU- or U-rich elements are located about 30 nt 
downstream of the cleavage site (Colgan and Manley, 1997; McLauchlan et at., 1985). 
mRNA 3' end formation occurs in a coupled two step reaction; firstly, the pre mRNA is 
cleaved and then poly (A) addition occurs. Two multi-protein complexes are involved in 
polyadenylation: cleavage and polyadenylation specificity factor (CPSF) binds the 
AAUAAA motif, while the cleavage stimulation factor (CstF) binds the downstream 
GU-rich region (Barabino and Keller, 1999) (Figure 1.8). CPSF and CstF, along with 
cleavage factors (CFI and CFII) and poly (A) polymerase (PAP), cleave the pre-mRNA, 
and CPSF and PAP add the poly (A) tail of between 20-200 (A) nucleotides. Alternative 
polyadenylation sites can also be used. That is, in addition to the AAUAAA and the GU 
rich motifs, some RNAs contain other genetic elements that influence the efficiency of 
polyadenylation, e.g. genomes of viruses and the human C2 complement gene and 
mouse calcitonin, related peptide (Proudfoot, 1996). 
1.3.3 Splicing 
Splicing is the process by which introns (non-coding sequences) are removed from pre-
mRNA and exons (coding-sequences) are joined. The basic mechanism of splicing 
occurs in two steps. Firstly, 5' splice site cleavage and ligation of the intron's 5' end to 
the so-called branch point site (BPS) occurs. Secondly, 3' splice site cleavage occurs 
resulting in the excision of the intron and ligation of the 5' and 3' exons. The lariat is the 
result of a 2'-5' phosphodiester bond between the G at the 5' splice site and 3' end of the 
intron (Figure 1.9). 
The splicing reaction is catalysed by the spliceosome, a macromolecular complex 
consisting of numerous proteins including small nuclear ribonuclear proteins bound 
with uridine-rich RNAs (UsnRNPs) (Will and Luhrmann, 2001). The major 
spliceosomal UsnRNPs Ul, U2, U4, U5 and U6 are responsible for splicing the vast 
majority of pre-mRNA introns (called U2-type introns) (Figure 1.8). Assembly of the 
spliceosome begins with the association of the Ul snRNP with the 5' splice site while 
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the splicing factor U2AF binds to the pyrimidine tract between the BPS and the 3' splice 
site. A stepwise assembly of the spliceosome then occurs around the splice sites. U2 
snRNP is recruited by U2AF and binds to a region encompassing the BPS. A pre-
existing U4!U6!U5 snRNP (Konarska and Sharp, 1987; Konarska and Sharp, 1988) 
joins the complex bringing Ul and U2 snRNPs together (Bindereif and Green, 1987) 
,and immediately prior to splicing a conformational change occurs destabilising the 
association of U4 snRNP, and the spliceosome is activated for catalysis (Staley and 
Guthrie, 1998; Turner et at., 2004). 
Like polyadenylation, the use of alternative splice sites is extremely common. A group 
of proteins most studied and implicated in splice site selection are the SR proteins. The 
SR proteins have a serine/arginine rich domain responsible for protein:protein 
interactions between SR proteins. This domain is thought to aid SR proteins in the 
recruitment and stabilisation of snRNPs with pre-mRNA at multiple and distinct sites 
during the splicing cycle. SR proteins can also interact with RNA via their amino 
terminal RNP domain (Manley and Tacke, 1996). ASF /SF2 is a typical SR protein 
involved in splicing. ASF/SF2 interacts with other proteins, namely SC35 and the small 
unit of the U2AF, forming a link between 3' and 5' splice sites (Huang and Steitz, 2005; 
Wu and Maniatis, 1993). 
1.3.4 Transport of RNA 
Export of mRNA occurs from the nucleus to the cytoplasm via the nuclear pore 
complex (NPC). NPCs are evolutionarily conserved and are composed of around 30 
nucleoporins (nups). FG-nups are essential for translocation as they interact directly 
with transport receptors that are all members of the karyopherin-~ family, e.g. importins 
or exportins, via their FG sequence repeats (Bednenko, et at., 2003: Stewart, et at., 
2001). 
Cellular RNA cargos (except mRNA) that contain signal import/export motifs are 
recognised by the transport receptors and are responsible for most of the exchanges 
between the nucleus and the cytoplasm (reviewed in Gorlich, et at., 1999). These 
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receptors bind to the RNA cargo and the FG repeat on the nup in the NPC and the N-
terminus of the receptor interacts with the receptor cofactor, Ran, in either its GTP or 
GDP-bound state (Moore, et al., 1993). Transition from the GTP-bound to the GDP-
bound state is catalyzed by a GTPase-activating protein (GAP), which induces 
hydrolysis of the bound GTP. The reverse transition is catalyzed by guanine nucleotide 
exchange factor (GEF) that induces exchange between the bound GDP and the cellular 
GTP. Ran-GEF is located predominantly in the nucleus while Ran-GAP is located 
almost exclusively in the cytoplasm. Therefore, in the nucleus Ran will be mainly in 
the GTP-bound state due to the action of Ran-GEF while cytoplasmic Ran will be 
mainly loaded with GDP. This asymmetric distribution has led to idea that Ran-GTP 
enhances binding between an exportin and its cargo but stimulates release of importin's 
cargo; Ran-GDP has the opposite effect (Figure 1.10) (Gorlich and Kutay, 1999; 
Izaurralde et al., 1997b; Mattaj and Englmeier, 1998). 
The specific sequence motifs in proteins for import are called the nuclear localisation 
signal (NLS) and the export motifs are known as the nuclear export signals (NESs). 
Some proteins that have an NLS rely on an interaction with importins although other 
proteins that lack an NLS can be carried 'piggy-back' through the NCP with a NLS-
containing protein. 
Another member of the karypherin-~ family of nUcleoporin receptors is chromosome 
region maintenance 1 (CRM 1). The HIV-1 Rev protein exports viral RNA using the 
CRM 1 pathway via the Rev NBS and this was later shown to be the same route for the 
proteins involved in the export of U snRNAs (with the cap-binding complex) and 5S 
RNA (with TFIIIA) (Fischer et al., 1995; Guddat et al., 1990; Izaurralde et al., 1995; 
Mattaj and Englmeier, 1998). 
The splicing process and the presence of the 5' cap and the 3' poly (A) tail can influence 
the transport of transcripts from the nucleus to the cytoplasm. Pre-mRNA molecules 
bearing splice sites are mostly retained in the nucleus and appear to be due to the early 
stages of splicing where mutations of the 5' splice site or the branchpoint resulted in the 
escape of the unspliced RNA into the cytoplasm (Saguez et al., 2005). The process of 
splicing appears to indirectly increase the rate of export where efficient export of some 
transcripts is dependent on splicing (Collis et al., 1990), however expression of 
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luciferase transcripts with and without an intron did not influence the export of that 
transcript (Nott et a/., 2003). For some transcripts the presence of the 5' cap structure 
can enhance the rate of their export, as a transcript with a non-m 7 G cap is exported more 
slowly than an mRNA synthesised with a m7 G cap (Ramm and Mattaj, 1990). It is 
thought that proteins involved in capping are involved in export. The 3' poly (A) tail and 
a stem loop structure in the 3'UTR can also stimulate the export of mRNA but again is 
not essential (Eckner and Birnstiel, 1992; Saguez et at., 2005). 
The fact that the splicing process and the presence of the 5' and 3' secondary structures 
on the transcript are not absolutely required for export led to the idea that trans-acting 
protein factors, including hnRNPs, were involved. Some hnRNP proteins, including 
hnRNP Al and hnRNP K, are shuttling proteins that are also associated with mRNA. 
This suggests that these proteins are associated with the mRNA from its emergence 
from the transcription machinery, though the nucleoplasm and finally during 
translocation via the NPC (Pinol-Roma and Dreyfuss, 1992). The discovery of a NBS 
within hnRNP Al (Siomi and Dreyfuss, 1995) supported the model that the hnRNP 
proteins mediate the nuclear export of mRNAs via their NBS. TAP is another nuclear 
export factor that, in a complex with p15, binds to the FG-nups and cross-links to 
poly(A)+ RNA (Zenkluses, et at., 2001), however TAP binds only weakly to RNA and 
requires an adaptor protein from the REF family that binds directly to RNA and TAP 
(Strasser, et at., 2000; Stutz, et at., 2000). The RNAiREF/TAP/p15 complex is exported 
as a whole to the cytoplasm through the direct interaction of TAP and the FG-nups 
(Conti, et at., 2001). 
1.3.5 Mammalian translation initiation 
Translation initiation involves the interaction of a wide array of translation factors that 
work in conjunction with the ribosome and tRNA. Translation initiation involves the 
binding of the 40S ribosomal subunit to the 5' end of the mRNA and scanning it in a 5'-
3' direction until the initiation codon is found. The 60S ribosomal subunit joins the 40S 
to form the catalytically competent 80S ribosome, however this process also involves 
many other factors. The small ribosomal subunit (40S) together with eukaryotic 
initiation factors (eIFs) including eIF3 and a ternary complex forms the 43S pre-
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Figure 1.11: (A) Cap-mediated translation initiation. A ternary complex is 
formed between eIF-2, GTP and the methionine loaded initiator tRNA and 
then binds to the 40S ribosomal subunit plus initiation factors (including 
eIF-3) to form the 43S pre-initiation complex. The eIF-3 of the 43S complex 
binds to mRNA via eIF-4G, a scaffolding protein that binds eIF-4E, the 
RNA cap-binding subunit of the eIF-4F complex. The eIF-4G binds PABP 
and consequently circularising the RNA. The eIF-4A unwinds the secondary 
structure and scans the mRNA in a 5'-3' direction allowing the 43S 
ribosomal subunit to migrate to the initiator AUG, thus forming the 48S 
initiation complex. EIF-5B hydrolyses the GTP in the ternary complex 
resulting in the release of initiation factors and the 60S ribosomal subunit 
joins to form the elongation competent 80S ribosome (taken from Gebauer, 
2004). (B) A table describing the characteristics of translation initiation 
factors. 
initiation complex. The ternary complex contains the methionine charged tRNA (that 
will recognise the AUG codon) and initiation factor eIF2 coupled to GTP. The 43S 
complex bridges the mRNA by the interaction of eIF3 with the eIF4 complex. The eIF4 
complex is composed of three initiation factors: eIF4E, which directly binds to the 
m7GpppN cap structure; eIF4A, a RNA helicase thought to unwind secondary 
structures in the 5'UTR; and eIF4G, a scaffold protein thought to interact with eIF3 
(thus aiding the binding of the 43S initiation complex), eIF4E and eIF4A. Furthennore, 
the initiation factor eIF4G also interacts with poly (A) binding protein (P ABP) and the 
simultaneous binding of all these factors brings about the circularisation of the mRNA, 
bringing the 5' and the 3' ends of the mRNA in close proximity to each other (Figure 
1.11). Alterations in the 5' cap or the 3' poly (A) tail do influence the assembly of the 
initiation complex ultimately leading to translational control of that mRNA, or a global 
change in translation could occur when initiation factors are altered (Gray and Wickens, 
1998; Mignone et aI, 2002). 
Efficiency of the initiation of translation is influenced at the 5' and 3'UTR in various 
ways including modifying the cap structure, the presence of secondary structures, RNA-
protein interactions, upstream (u)ORFs, (u)AUGs, internal ribosome entry site (IRES) 
elements, RNA-RNA interactions, cytoplasmic polyadenylation elements, and changes 
in poly (A) tail length (Gray and Wickens, 1998; Mignone et aI, 2002; Jackson and 
Kaminski, 1995). 
1.4 The HSV-l ICP27 protein 
ICP27 is a 512 amino acid multifunctional phosphoprotein that is essential for virus 
replication, as HSV-l ICP27-null viruses are defective for lytic infection (Sacks et ai., 
1985; Smith et ai., 1992). HSV-l mutant viruses that have mutations or deletions in the 
ICP27 gene display a range of phenotypes including a decrease or lack of L-2 gene 
products, a deficiency in viral DNA synthesis due to a decrease in E gene expression, 
and a defect in host-cell shut-off. ICP27 regulates viral gene expression through a 
variety of mechanisms to ensure a lytic infection occurs. 
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1.4.1 Transcriptional control by ICP27 
Transient transfection assays have shown that ICP27 alone can transactivate a HSV-1 
gB promoter fused to a CAT reporter gene (Rice and Knipe, 1988). However, reports on 
transactivation of viral genes have most commonly been observed in conjunction with 
other viral proteins. ICP27 can enhance or repress transcription from viral IE, E and L 
promoters activated by the IE proteins ICPO and ICP4 (Everett, 1986; Rice and Knipe, 
1988; Sekulovich et al., 1988; Su and Knipe, 1989). In these cases, ICP27 works in 
combination with ICPO and ICP4. ICP27 has been reported to interact with ICP4 
(Panagiotidis et al., 1997) and to co-localise with ICP4 in replication compartments in 
infected cells (de Bruyn Kops et aI., 1998). During wt HSV-1 infection, it was found 
that ICP27 acts to down-regulate the expression of certain IE and E genes and to up-
regulate L-1 genes. During a ICP27-null HSV-1 infection some IE and E gene 
expression was increased and L-1 gene expression is decreased. Furthermore, there was 
a dramatic reduction in viral DNA synthesis thus leading to the failure of L-2 gene 
expression (Rice et al., 1989). The effect on viral DNA synthesis during the IC27-null 
virus infection was most likely due to the abnormal sequence of viral gene expression 
rather than a direct effect on DNA synthesis. It is thought that ICP27, therefore, has an 
effect on one or more viral proteins involved in DNA synthesis, or perhaps the over 
expression of the early proteins has an inhibitory effect on DNA synthesis. Mutational 
analysis of the ICP27 gene identified that the transactivator and repressor functions 
were separable and that the C-terminal region is required for both functions (Hardwicke 
et al., 1989; Rice et al., 1989) (Figure 1.12). Furthermore ICP27, and at certain times 
after infection ICP8 (the single stranded DNA-binding protein required for viral DNA 
synthesis), has been reported to associate with RNA polymerase II complexes, and all 
HSV -1 genes are transcribed by RNA polymerase II (Zhou and Knipe, 2002). Thus, 
ICP27 was suggested to playa role in transcription initiation or elongation on the HSV-
1 genome, however a mechanism for this function has not been elucidated. 
1.4.2 ICP27 inhibits splicing of pre-mRNA 
The HSV -1 genome contains only four genes that reqUIre splicing; the rest are 
intronless. There is therefore little requirement for the cellular RNA splicing machinery, 
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a fact that possibly contributes to host-cell shut-off (Bryant et aI., 2001). During early 
times of infection, ICP27 is responsible for the redistribution of splicing snRNPs in the 
nucleus. In uninfected cells, splicing proteins (e.g. SC35) exhibit a widespread 
distribution in the nucleus and as infection proceeds they relocate to a highly punctate 
pattern and co-localise with ICP27. ICP27 was shown to be essential for this effect 
during infection and, furthermore, ICP27 produced by transient transfection was 
sufficient for splicing factor redistribution (Phelan et al., 1993). Further studies showed 
that ICP27 interacts with splicing factors including the SR proteins (involved in the 
assembly of the spliceosome), p32 (an inhibitor of the SF2/ASF SR protein), and the 
spliceosome-associated protein 145 (an essential factor of the splicing complex) (Bryant 
et al., 2000; Bryant et al., 2001; Sciabica et al., 2003). Studies using an HSV-1 ICP27 
null mutant reported that viral mRNAs that contain introns were spliced and located in 
the cytoplasm of the infected cell whereas during wt HSV -1 infection these transcripts 
were usually found to accumulate unspliced in the nucleus (Sandri-Goldin, 1994; 
Sandri-Goldin and Hibbard, 1996). Thus ICP27 was implicated as having an inhibitory 
effect on splicing although a direct role and mechanism have not been delineated. 
1.4.3 ICP27 modulates poly (A) site usage 
Studies using precursor RNA containing 3' processing sequences from different HSV-1 
genes have shown that a viral factor named the late processing factor (LPF) can 
stimulate RNA 3' processing specifically at a late HSV poly (A) site of the UL38 gene. 
This effect was shown to be dependent upon the expression of ICP27 alone 
(McLauchlan et al., 1989). 3' processing of two HSV-1 late genes, UL38 and UL44, 
was increased by an ICP27-induced activity whereas no change was observed for a 
number of IE and E transcripts and it was observed during in vitro polyadenylation 
studies that the late genes had predominantly weak poly (A) sites as compared to the 
relatively strong poly (A) site of the IE and E genes investigated (McGregor et aI., 
1996a). UV cross linking experiments showed that the binding of the polyadenylation 
factor CstF to poly (A) sites of viral RNAs from all temporal classes is enhanced during 
infection and requires the expression of ICP27 (McGregor et al., 1996a). These 
observations suggest the ICP27 property of enhancing the binding of CstF does not 
affect strong sites but increases the efficiency of 3' end formation at inherently weak L 
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poly (A) sites. This mechanism may contribute to ICP27's regulatory role in the switch 
between E and L gene expression. 
1.4.4 ICP27 is an RNA binding protein 
The work by Brown et aI, 1995, led to the analysis of the ICP27 amino acid sequence 
revealing the presence of an RNA recognition domain. This was achieved using an in-
vitro RNA binding assay, i.e. 32P-Iabelled ribopropes were analysed for binding to 
bacterially expressed recombinant ICP27 with a GST tag using a Northwestern blotting 
technique. A cluster of arginines interspersed with glycines at the N-terminus of the 
ICP27 protein was seen in other RNA-binding proteins and termed the RGG box 
(Figure 1.12). UV cross-linking experiments using bacterially expressed protein showed 
ICP27 could bind directly to several RNAs (Ingram et al., 1996), however the RNAs 
used in the Ingram investigation included fragments of an exon, a poly (A) site, a non-
HSV-1 RNA and an ORF of three HSV-1 genes, leading to the supposition that this 
interaction was not specific for HSV -1 RNAs. ICP27 transcribed and translated in a 
eukaryotic expression system bound to poly (G) RNA homopolymers, weakly to poly 
(U) and did not bind to poly (A) or (C). However, ICP27 also bound to negative 
controls, an SV 40 RNA, previously shown not to bind full length ICP27 (Brown et al., 
1995) and the IFN-~ antisense RNA probe. Nevertheless, the fact that ICP27 binds 
efficiently to poly (G) RNA suggests the possibility that G-rich sequences playa role in 
RNA recognition by ICP27 (Mears and Rice, 1996a) which could result in preferential 
binding ofHSV-1 RNA as this is also GC-rich. 
In a study investigating ICP27 RNA binding in vivo, some HSV -1 transcripts that bind 
ICP27 were identified during UV cross-linking experiments, isolating seven HSV-1 
intronless RNAs. Interestingly, ICP27 did not bind two intron-containing RNAs in these 
studies (Sandri-Goldin, 1998a). Investigations to identify further HSV -1 RNAs that 
bind ICP27 were carried out using a yeast 3 hybrid (Y3-H) assay (Sokolowski et al., 
2003). Thirty-one HSV-1 sense transcripts were identified to selectively bind ICP27; 
these ranged in length from 35-225 nucleotides. The identified transcripts mapped to 
regions of HSV -1 genes from 28 ORFs. Even though these isolated RNAs represented 
transcripts from all kinetic classes the corresponding gene, i.e. the gene from which the 
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RNA was isolated, encoded predominantly essential viral proteins with roles in viral 
DNA replication and virion maturation (Table 1.3). Furthennore, the ICP27-RNA 
interaction was abolished or severely reduced when ICP27 lacking an RGG box was 
used, highlighting the importance of the RGG box of ICP27 in the binding of these 
HSV-1 RNAs. In fact, previous work by Mears and Rice (1996a) detennined that not 
only did ICP27 bind directly to RNA but also that ICP27 lacking an RGG box did not 
bind to RNA. 
1.4.5 ICP27 stabilises RNA 
The stability of an mRNA and therefore its lifetime can be crucial in the regulation of 
gene expression. Many mRNAs containing an AU-rich element (ARE), are known to be 
targeted by ARE-binding proteins (ARE-BP) for degradation, however, other ARE-BPs 
have been shown to mediate RNA stabilisation via these sequence motifs (Barreau et 
al., 2005; Zhang et al., 2002). AUF1 is a ARE-BP (also known as hnRNP D) and has 
been associated with both an increase in RNA instability and stability, depending on cell 
type (Loflin et al., 1999). The Hu family of ARE-BPs (e.g. HuR) have been shown to be 
associated with RNA stability (Figueroa et al., 2003) 
Eukaryotically expressed ICP27 has been shown to bind to sequences at the 3' ends of 
RNA. ICP27 alone could increase the half-life and stimulate the steady state 
accumulation of reporter genes containing AU-rich untranslated regions, however, it is 
not known yet whether the binding involves these AU-rich motifs (Brown et al., 1995). 
1.4.6 Nucleocytoplasmic shuttling properties of ICP27 
ICP27 binds to RNA and assists in exporting it from the nucleus to the cytoplasm. In 
situ hybridization assays revealed that during HSV -1 infection intron-containing 
transcripts were retained in the nucleus. Interestingly, immunofluorescence studies 
located these proteins, i.e. ICPO and ICP4, to the punctate regions in the nucleus where 
the splicing factors had relocated (previously discussed in section 1.4.2). ICP27 was 
originally implicated in RNA export when, during an HSV-1 ICP27-null infection, 
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Isolate no Transcript Functional Role 
69,16,17,247, ICP4 Broad-range transcriptional trans-activator, E 
352, 75 
324/16.2 UL4/5 Part of replication complex, NEIE 
309 UL29 ssDNA binding protein, E 
82,5,231 UL30 DNA pol subunit, E 
13.2 UL39/40 Ribonucleotide reductase, NE 
3 UL42 DNA pol subunit, E 
8,300 UL49/49.5 Tegument protein, NE 
4,242 US3 Protein kinase, NE 
212 UL6 DNA cleavage/ packaging, E 
12 UL13 Protein kinase, NE 
21,23 UL15 DNA packaging, E 
274 UL16117 TegumentlDNA packaging, NE/E 
185/85/19, 251 UL19/20 Maj or capsid protein! viral exocytosis, EINE 
55 UL31132 Nuclear phosphoprotein! DNA packaging, E 
281.2 UL36 Tegument protein, E 
334 UL48 Tegument protein, IE trans-activator, E 
258 ICP34.5 N eurovirulence, NE 
- ---~-~.-----~~ -- ---~----------- -~ 
Table 1.3: Transcripts found to bind ICP27 and their functional role in the HSV-l 
life cycle (adapted from Sokolowski et aI, 2003). NE denotes non-essential and E is 
essential in tissue culture. 
intron-containing viral transcripts (ICPO and UL15) were located in the cytoplasm 
(Phelan et at., 1996). Heterokaryon assays visualised the ability of ICP27 to 
continuously shuttle from the nucleus to the cytoplasm, and further ICP27 mutational 
analysis revealed that ICP27 with the dl-2 (deletion of amino acids 12-63) deletion 
significantly reduced shuttling and ICP27 with the M15 (containing mutations of a PG 
at amino acids 465 and 466 to an LE) mutation completely abolished shuttling (Mears 
and Rice, 1998). 
Sequence analysis and ICP27 mutational analysis using the ICP27 deletion mutants d1-
2, dleu (deletion of amino acids 6-19) and d3-4 (deletion of amino acids 110-137) 
revealed that ICP27 contains a nuclear export signal (NBS) and a nuclear localisation 
signal (NLS) within the N-terminal region (Figure 1.12) (Lengyel et at., 2002; Mears et 
at., 1995). The presence of these signals indicated a Crm-1-independent pathway was 
used for export and experiments using the Crm-1 inhibitor, leptomycin B (LMB), on 
HSV -1 infected Vero cells showed a reduced cytoplasmic accumulation of ICP27 
(Soliman and Silverstein, 2000a). However, contradictory to this, it was observed in two 
independent investigations that the localisation of ICP27 was not altered by LMB (Chen 
et at., 2002; Koffa et at., 2001). ICP27 binds directly to REF (the RNA export factor 
previously discussed) possibly functioning as an adaptor protein, and utilises the export 
receptor, TAP, to export viral mRNAs (Chen et at., 2002). The HSV-1 ICP27 mutant 
virus (d3-4) that has a deletion of the REF binding site (and the NLS) exhibited a 40-
fold reduction in titre but remained replication competent (Mears et aI., 1995) 
suggesting that ICP27 may utilise more than one export pathway during the virus life 
cycle. 
1.4.7 ICP27 translational control 
ICP27's role in the regulation of gene expression has been investigated at the level of 
translation initiation. ICP27 is required, post-export, for the expression of various HSV-
1 transcripts. For example, during an HSV-1 ICP27-null infection the short transcript of 
UL24 was located in the cytoplasm yet UL24 protein levels were decreased by at least 
70-fold as compared to wt HSV-1 infection (pearson et at., 2004), leading to the idea 
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that ICP27 is not essential for the export of that transcript but is required for its efficient 
translation. 
ICP27 interacts with translation initiation factors eIF4G and P ABP, contributing to the 
proposal that ICP27 has a function in promoting or inhibiting translation via these 
interactions (Fontaine-Rodriguez et al., 2004). Translation initiation factor eIF4G is a 
scaffolding protein that binds to the cap-binding complex (eIF4F), and interacts with 
PABP and eIF3 (see section 1.3.5). ICP27 stimulated polysomal association ofHSV-1 
VP16 mRNA leading to the control of the levels ofVP16 protein expression, however, 
this was not shown to be due to the direct stimulation by ICP27 (Ellison et aI., 2005). 
Larralde et ai, (2006) however, confirmed the association of ICP27 with polyribosomes 
during infection and demonstrated that this association was abolished when ICP27 
carried the M15 mutation. Using a tethered function assay in Xenopus oocytes, ICP27 
was investigated for its effects on translation independently of any action on 
transcription, polyadenylation and mRNA export. ICP27, in the absence of any other 
viral proteins, directly stimulated the translation ofmRNA by 10-fold and, furthermore, 
ICP27 with the M15 mutation failed to stimulate translation. Thus, the association of 
ICP27 with polyribosomes and its ability to stimulate translation are linked. The 
mechanism of this activity is still unknown. 
1.4.8 Functional domains of ICP27 
1.4.8.1 Essential acidic domain 
ICP27 contains a highly acidic amino terminal region (amino acids 4 to 64) that is 
essential to the virus (Figure 1.12) (Rice et al., 1993). A number of transcription 
transactivators, e.g. HSV-1 VP16, have an acidic region that has been shown to be 
involved in stimulating transcription by interacting with components of the RNA Pol II 
transcription complex, e.g. transcription factor IIA (TFlIA) (Kobayashi et al., 1995; 
Strum, 1991). The HSV-1 ICP27 mutant virus dl-2 has a deletion of amino acids 12-63. 
The dl-2 mutant was shown to be deficient for growth in Vero cells, exhibiting a 
reduced level of DNA replication and a moderate reduction in viral gene expression, 
22 
demonstrating a regulatory function of ICP27's N-terminal region (Rice et al., 1993). 
However, the dl-2 deletion overlaps with the NBS and it is therefore unclear what 
contribution this has to the phenotype of dl-2. 
1.4.8.2 Nuclear export signal 
The NES of ICP27 is located between amino acids 3-17 (Figure 1.12). Sequence 
analysis identified a resemblance to the leucine-rich NESs first identified in HIV -1 Rev 
and PKI (the heat-sTable inhibitor of cAMP-dependent protein kinase) (Fischer et al., 
1995; Wen et al., 1995). ICP27 mutational analysis revealed that ICP27 is still located 
in the cytoplasm when the ICP27 NES is replaced with the NES of Rev or PKI, 
however, a deletion of ICP27 NES resulted in ICP27 nuclear retention (Sandri-Goldin, 
1998a). The heterokaryon assay to determine whether ICP27 shuttles between the 
nucleus and the cytoplasm (discussed in section 1.4.6) revealed the dl-2 ICP27 protein 
had severely impaired import/export abilities, i.e. when the NES is disrupted the 
protein's ability to shuttle is reduced (Rice, et al., 1998). 
A failure or reduction in cytoplasmic accumulation of other shuttling proteins due to the 
disruption of the NBS has been previously been shown e.g. hnRNP Al (Fritz et al., 
1995; Izaurralde et al., 1997a), HIV Rev protein (Fischer et al., 1994), the yeast mRNA 
transport protein Glel (Murphy et al., 1996) and the transcription factor IlIA (Fridell et 
al., 1996). 
Interestingly, in cells infected with the ICP27 mutant virus, dleu, that has a deletion of 
the full NES (amino acid 6-19), ICP27 is highly restricted to the nucleus. This mutant 
virus has, however, only a modest defect in viral gene expression but is deficient in 
virion production (Lengyel et al., 2002) suggesting that the NES of ICP27 is not 
absolutely essential to the replication of the virus. 
1.4.8.3 Nuclear and nucleolar localisation signals 
ICP27 contains multiple NLSs, both strong and weak, that mediate its nuclear 
localisation. The strong bipartite NLS maps to amino acids 110-137 (Figure 1.12). 
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Plasmids expressing ICP27 with a deletion of the NLS, d3-4, expressed ICP27 located 
in the nucleus and the cytoplasm as compared to wild type ICP27 that was almost 
exclusively nuclear. However, nuclear localisation of the ICP27 d3-4 protein indicates 
that the other weak NLS sequences are in use. The recombinant HSV -1 d3-4 virus, that 
expresses ICP27 lacking an NLS, gave a 9-34 fold defect in growth in Vero cells 
indicating the importance of the strong NLS during virus infection (Mears et al., 1995). 
ICP27 also contains a nucleolar localisation signal (NuLS) mapping to amino acids 110-
152. Although ICP27 does not preferentially localise to the nucleolus, ICP27 has been 
isolated in this compartment (Knipe et al., 1987). In cells infected with a recombinant 
HSV-l virus that expresses only amino acids 1-263 of the ICP27 protein (n263R), 
ICP27 is predominantly located in the nucleolus, again indicating the use of another 
NLS(s). Two features, in common with the NuLS of ICP27, have been identified in the 
NuLSs of the HIV -1 Rev and Tat; they are both rich in arginine residues and they 
contain a functional NLS (Cochrane et al., 1990; Dang and Lee, 1989). 
1.4.8.4 RNA-binding domains: ROO box and KH-like domains 
Residues 139-153 encode the RGG box (Figure 1.12); RNA binding domain of ICP27 
and these features are discussed in section 1.4.4. The C-terminal half of ICP27, based on 
limited sequence similarity, contains three RNA binding motifs that have homology to a 
series of hnRNP K homology (KH) domains (Soliman and Silverstein, 2000b). These 
have been mapped to amino acids 288-350, 368-421 and 451-512 and termed domains 
KH1, KH2 and KH3, respectively. KH domains were first identified in hnRNP K and 
later in other cellular proteins including FMRP-l and Nova-I. RNA binding of the 
FMR-1 protein from a severely retarded fragile X patient is abolished due to a single 
point mutation in the KH domain of the protein (Siomi et al., 1994). The precise 
function of FMRP is unknown, however it has been demonstrated to playa role in the 
negative regulation of translation (Laggerbauer et al., 2001; Li et al., 2001). Nova-1 is 
another neuronal RNA-binding protein involved in RNA splicing of two receptor 
proteins. The KH domains of Nova-1 have been shown to be required for RNA binding 
where inhibition of this RNA-binding is postulated to playa role in paraneoplastic 
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opsoclonusmyoclonus, an autoimmune disorder of the nervous system (Buckanovich et 
al., 1993; Laggerbauer et al., 2001). 
The ICP27 mutation F303N is located in the KH-1 domain and was shown to be lethal 
when recombined into the virus. Analysis of protein synthesis revealed a distinct defect 
in a subset of viral late genes. However, the late genes inhibited during F303N infection 
are not essential, suggesting the mutation may also affect the expression of other 
essential HSV -1 genes. 
1.4.8.5 Potential zinc finger 
Metal chelate affinity chromatography has shown that ICP27 binds zinc in vitro through 
the C-terminal amino acids 407-512 (Figure 1.12) (Vaughan et al., 1992). Zinc finger 
domains are associated with protein-nucleic acid and protein-protein interactions. The 
region of ICP27 that spans the zinc finger has been known to be involved and varying 
functions including gene activation and repression (Hardwicke et al., 1989; McMahan 
and Schaffer, 1990). ICP27's self-association has been shown to require amino acids 
from the zinc finger domain and point mutations created in this domain were lethal to 
the virus, suggesting that self recognition is important for function (Zhi et al., 1999). 
1.4.8.6 SM domain 
ICP27's putative SM domain lies at the C-terminus of the protein at amino acids 426-
488 (Figure 1.12). These sequence motifs are known to be utilised by SM proteins that 
are involved in forming the core spliceosome complex (Kambach et al., 1999). The 
identification of the SM motif in ICP27 may contribute to determining the role ICP27 
plays during the inhibition of splicing during wt HSV -1 infection ultimately leading to 
host cell shut off. The HSV -1 ICP27 mutant virus D448L has a mutation within the SM 
domain that results in a defect in host cell shut off during infection thus contributing to 
the above hypothesis (Soliman and Silverstein, 2000a). 
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1.5 ICP27 Partner proteins 
ICP27 interacts with a range of cellular proteins involved in gene expression. Figure 
1.13 summarises ICP27 partner proteins. 
1.5.1 HnRNP K 
Like ICP27, hnRNP K is a multifunctional protein that plays a role in transcription, 
splicing and translation. It was first identified as a component of the hnRNP particle and 
can be found as at least five alternatively spliced isoforms (Dejgaard et al., 1994; 
Matunis et al., 1992). The nucleic acid binding KH domains were first identified in 
hnRNP K, and this protein binds poly (C) RNA or DNA via its three KH domains 
(Siomi et al., 1993a). Between the KH2 and KH3 domains lies a K-protein-interactive 
(KI) region that is responsible for many of the protein interactions (Makeyev and 
Liebhaber, 2002). The hnRNP K protein contains an NLS and a nuclear shuttling 
domain (KNS). The KNS mediated bi-directional transport between the nucleus and the 
cytoplasm can act independently of the NLS (Bomsztyk et al., 1997). 
HnRNP K can transactivate a number of genes when using chimeric constructs with a 
variety of different promoters (Lee et al., 1996). HnRNP K was also shown to be a 
transcription factor as it bound to the CT element of the c-myc gene and activated 
transcription. Affinity chromatography demonstrated that hnRNP K bound specifically 
to components of the RNA polymerase transcription machinery and later an interaction 
was observed with the TATA-binding protein (TBP). Thus, hnRNP K interacts with cis 
acting elements and binds to transcription machinery to activate transcription 
(Michelotti et al., 1996). 
HnRNP K protein has been reported to interact with splicing factors 9G8 and SRp20 
(Shnyreva et al., 2000). This was identified when investigating the chicken ~­
tropomyosin gene where hnRNP K acts as a component of an intronic enhancer 
complex that activates alternative splicing. 
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HnRNP K involvement in translation was first hypothesised when it was found to bind 
to the translation elongation factor-IA (Bomsztyk et a!., 1997). Later it was shown that 
hnRNP K silences translation of a luciferase reporter mRNA that contains a 
differentiation control element (DICE), that is, a CU-rich element normally found in the 
3'UTR of the 15-lipoxygenase (lox) gene (Ostareck et a!., 1997). Lox is an enzyme 
expressed during erythroid cell differentiation and it must be silenced in early erythroid 
cells in the bone marrow and the peripheral blood. The silencing occurs at the level of 
translation initiation as hnRNP K binds to the 3'UTR DICE element effectively 
blocking the recruitment of the 60S ribosomal subunit (Ostareck et al., 2001). HnRNP 
KlDICE binding is mediated by the tyrosine kinase c-Src, as phosphorylation of hnRNP 
K by this kinase, due to extracellular signals, removes hnRNP K from the DICE element 
and translation initiation can occur (Ostareck-Lederer et al., 2002). Alternatively, during 
an investigation of the c-myc IRES, hnRNP K protein together with hnRNPE112 was 
shown to stimulate translation (Evans et al., 2003). 
HnRNP K binds HSV-l ICP27, as determined by a yeast-two (Y2-H) hybrid system and 
immunoprecipitation assays. Interestingly, when hnRNP K was co-precipitated with 
ICP27 by anti-ICP27 serum, hnRNP K was phosphorylated by CK2 (another ICP27 
partner protein, see later) (Wadd et al., 1999). Phosphorylation ofhnRNP K resulted in 
a number of actions including a decrease of its binding to RNA, and release from the 
DICE thus leading to hypotheses of its role in binding to ICP27 during infection. That 
is, the similarities between ICP27 and hnRNP K suggest similar functions and therefore 
possible common cellular pathways. During infection, the ICP27-mediated 
phosphorylation of hnRNP K could prevent RNA binding thus promoting ICP27 RNA 
binding and ultimately inhibiting any competition by hnRNP K. Alternatively; perhaps 
hnRNP K is recruited, by ICP27, leading to the speculation that the host of functions 
accredited to ICP27 are due, at least in part, to the interaction with hnRNP K. 
1.5.2 REF and TAP 
TAP in association with pIS is the nuclear export receptor for metazoans, and the yeast 
homologue, Mex67p, also functions as an export receptor (Braun et al., 2001; Gruter et 
27 
ai., 1998). Both of these proteins have the ability to shuttle in and out of the nucleus, 
cross-link to poly (At RNA, and associate with nucleoporins (Fribourg et ai., 2001; 
Katahira et ai., 2002). TAP was first identified as the cellular factor that interacts with 
the constitutive transport element (CTE) present in RNAs from type D retroviruses and 
aiding in the export of those RNAs (Bear et ai., 1999). Over expression of TAP was 
shown to stimulate mRNA export and inactivation of TAP by RNA interference resulted 
in the nuclear accumulation of poly (At mRNA, indicating a role for TAP in mRNA 
export (Herold et ai., 2003; Tan et ai., 2000). 
REF is a component of the ex on junction complex (ECJ) shown to function in splicing, 
nuclear export and RNA localisation. REF is recruited to the spliceosome complex by 
interacting with UAP56, a DEAD box helicase involved in spliceosome assembly 
(Gatfield et ai., 2001). REFs can associate with intronless RNAs independent of 
splicing, with variable efficiency depending on the sequence and length of sequence, to 
enhance the export of un spliced mRNAs (Rodrigues et al., 2001). 
REF was found to bind to ICP27 during a Y2-H assay (Wadd, 2000) and later from 
HSV -1 infected cells (Chen et al., 2002). During Xenopus oocyte microinjection assays, 
ICP27 was shown to bind directly to REF where the interaction dramatically stimulated 
export of certain viral RNAs. ICP27 that fails to bind REF such as the ICP27 d3-4 
(discussed previously as having a deletion in the NLS), failed to stimulate viral mRNA 
export (Koffa et ai., 2001). ICP27 is present in a complex with TAP and REF during 
infection, indicating a role for both cellular proteins for viral RNA export. Viral mRNA 
export was indeed stimulated in oocytes by REF and TAP and it was proposed that 
ICP27 recruits REF to intronless viral RNAs that are then transported via the T AP-
mediated export pathway (Koffa et ai., 2001). 
1.5.3 Casein Kinase II (CK2) 
CK2 phosphorylates serine/threonine residues that are N-terminal to acidic amino acids. 
The protein kinase consists of two catalytic subunits (a or a') and two regulatory ~ 
subunits, and can exist in three forms: a2~2, aa'~2 or a'2~2 (Allende and Allende, 1995). 
CK2 is a regulator of cell growth, cell division, signal transduction and apoptosis 
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(Dobrowolska et al., 1999; Guerra et al., 1997). CK2 has been implicated in the cell-
cycle dependent phosphorylation of the C-terminal domain of RNA polymerase II, 
altering transcription efficiencies (Bregman et al., 2000). It plays an important role in 
positive and negative transcriptional regulation by phosphorylating transcription factors 
including Sp 1 (Pugh and Tjian, 1990), Ap 1 (Lin et al., 1992) and serum response factor 
(Marais et al., 1992). 
Using Y2-H and immunoprecipitation assays ICP27 has been shown to interact with 
CK2 ~ subunit. Two regions of ICP27 were shown to involved in the interaction, the C-
terminus containing the zinc finger and a portion of ICP27 containing the arginine rich 
region (Wadd et al., 1999). ICP27 was shown to be required for the activation of CK2 
and also the redistribution of CK2 relocating from the nucleus to the cytoplasm. 
Furthermore, phosphorylation of ICP27 by CK2 was required for the cytoplasmic 
localisation of ICP27 (Koffa et a!., 2003). 
1.5.4 Splicing-associated protein 145 (SAP 145) 
SAP145 is an essential component of the spliceosome. It can bind pre-mRNA and is 
implicated in the tethering of U2 snRNA to the BPS (Champion-Arnaud and Reed, 
1994; Staknis and Reed, 1994). 
ICP27 interacts with SAP145 and during infection ICP27 and SAP145 colocalise in the 
nucleus of Vero cells. During HSV -1 ICP27 mutant virus infection this interaction is 
severely reduced or abolished. In vitro splicing reactions revealed that, in the presence 
of ICP27, splicing was inhibited prior to the first catalytic step (Bryant et al., 2001). 
This data strongly indicated that ICP27 recruited SAP145 to inhibit splicing. 
1.5.5 P32 
P32 was originally isolated from a complex with the splicing factor ASF/SF2 (Krainer 
et al., 1990). ASF/SF2 is a member of a family of splicing factors known to have a role 
in enhancing splicing and regulating alternative splicing (Fu, 1995). P32 regulates RNA 
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splicing by inhibiting ASF/SF2 RNA binding and phosphorylation (petersen-Mahrt et 
at., 1999). Immunofluorescence studies observed p32 to be located in the mitochondria 
and also in the nucleus as granule and tubules (Matthews and Russell, 1998). Previously 
it was shown that this pattern of localisation was altered upon adenovirus infection 
where p32 redistributes to the nucleus to co-localise with the viral core protein 
(Matthews and Russell, 1998). Many other proteins that interact with p32 have been 
reported including the HSV -1 ORF P protein (Bruni and Roizman, 1996), EBV EBNA 
1 protein (Chen et at., 1998) and HIV proteins Rev and Tat (Luo et at., 1994; Yu et at., 
1995). 
A Y2-H assay and immunoprecipitation assays have revealed an interaction with p32 
and HSV-1 ICP27. The p32 that co-immunoprecipitated with ICP27 is phosphorylated 
by CK2, which is also precipitated with ICP27. During an HSV-1 infection ICP27 co-
localises with p32 and alters its distribution to form a speckled pattern in the nucleus 
(Bryant et at., 2000). These data led to the speculation that ICP27 recruits p32 to aid in 
the inhibition of splicing. 
1.5.6 Cellular RNA polymerase II and ICP8 
The transcription of all viral genes is dependent on cellular RNA polymerase II; 
furthermore several viral proteins stimulate viral gene transcription, e.g. ICP4, ICPO and 
ICP8. ICP8 is a single stranded DNA binding protein that negatively affects 
transcription from the parental viral genome (Godowski and Knipe, 1985; Godowski 
and Knipe, 1986). ICP27, ICP8 and RNA polymerase II has been reported to form a 
complex at early time of infection, as determined by immunoprecipitation assays and 
western blot techniques, and formation of the complex was dependent on viral DNA 
synthesis (Zhou and Knipe, 2002). These data suggest a role for ICP27 in stimulating E 
and L gene expression and or a role in inhibiting cellular transcription. The association 
with ICP8 suggests a role in stimulating L gene expression, as the association with 
ICP27 was not detected until 5 h.p.i. (Zhou and Knipe, 2002). 
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1.6 ICP27 Homologues 
ICP27 is a regulatory protein homologous to proteins identified in all classes of 
herpesviruses, implicating a regulatory function that is conserved throughout the 
Herpeseviridae family. However, although sequence similarities have been identified, 
the ICP27 homologues exhibit functional diversity. Comparing the structural and 
functional properties of these conserved genes with ICP27 aids in the understanding of 
each homologue and ultimately of their evolution during the emergence of the different 
herpesviruses. 
The gammaherpesvirus homologues contain an N-terminal region from an additional 
exon that the alpha and betaherpesviruses do not have. The N-terminal region is not 
conserved throughout the herpesviruses, however the central region is conserved within 
the herpesvirus family. 
l.6.1 BHV-1 BICP27 
BICP27 is an alphaherpesvirus ICP27 homologue of bovine herpesvirus l. The BICP27 
protein is expressed early during infection, in contrast to ICP27 that is IE, and localises 
to the nucleus of the infected cell. This protein has a role in processing efficiencies of 
mRNAs that contain weak poly (A) sites (Singh et ai., 1996), like ICP27. 
1.6.2 HCMV UL69 
The betaherpesvirus HCMV gene UL69, is a positional homologue of the HSV-1 ICP27 
and, unlike ICP27, is expressed at early to late times during infection and ultimately 
becomes a phosphorylated tegument protein of the virion (Winkler and Stamminger, 
1996). A function of the HCMV protein, similar to that of ICP27, is its ability to 
transactivate particular viral promoters (Winkler et ai., 1994). 
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1.6.3 Herpesvirus saimiri (HVS) ORF57 
ORF57 from the gammaherpesvirus HVS, is a multifunctional regulatory protein that 
shares limited homology with HSV -1 ICP27. ORF57 is involved in the activation and 
repression of early and late gene expression at the level of transcription. The repressor 
function was determined by the different spliced forms of ORF57 (Whitehouse et ai., 
1998). Like ICP27, ORF57 protein structure contains a transactivation and repressor 
domain at the C terminus. 
During HVS infection, ORF57, like ICP27, is responsible for the redistribution of the 
splicing factor SC35 and was found to relocate with this factor at distinct nuclear 
aggregates (Cooper et ai., 1999). Further similarities of ORF57 to ICP27 include viral 
RNA binding, shuttling between nucleus and cytoplasm, and the export of viral RNA 
(Goodwin and Whitehouse, 2001). Taken together, these data suggest that ORF57 
regulates gene expression using similar pathways to HSV-1 ICP27. 
1.6.4 HHV -8 ORF57 
The gamma herpesvirus HHV -8 ORF57 is a spliced gene that is expressed very early in 
lytic cycle (Lukac et ai., 1999). Like HSV-1 ICP27, ORF57 localises to the nucleus, co-
localises with SC35 and can shuttle between the nucleus and the cytoplasm (Bello et aI., 
1999; Gupta et ai., 2000; Kirshner et ai., 2000). 
A range ofHSV-1 ICP27 identified partner proteins that are also found to associate with 
ORF57 include hnRNP K, CK2 and REF (Malik et ai., 2004a; Malik et ai., 2004b; 
Malik and Clements, 2004). ORF57 has a role in viral RNA export via the same 
pathway as HSV-1 ICP27, by forming a complex with the cellular export factors REF 
and TAP (Malik et ai., 2004b). 
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1.7 AIMS 
The HSV -1 protein ICP27 has an essential role in viral gene expression at the level of 
transcription and post-transcription. It is an RNA-binding protein, however, little is 
known about the RNA ligands of this signature herpesvirus protein that has a 
counterpart in all sequenced herpesviruses that infect mammals and birds. HSV -1 RNAs 
that interacted specifically with ICP27 were identified using a genomic DNA library 
yeast three-hybrid screen and were found to belong to transcripts that encode 
predominantly essential proteins with roles In viral DNA replication and virion 
maturation: use of ICP27 mutant protein largely abolished the interactions, indicating 
their biological relevance (Sokolowski et al., 2003). HSV-1 sense RNAs identified were 
35 to 225 nucleotides in length and located to the 5'UTR and ORF's ofHSV-1 IE, E and 
L genes. With the knowledge of the RNA sequences that bind ICP27 my project aimed 
to investigate any activational or inhibitory properties of these sequences in the presence 
of ICP27. To this end, plasmids were constructed with a selection of these sequences 
inserted into the 5'UTR of a reporter construct, and the functional properties of the 
sequences in the presence or absence of ICP27 were studied. This was achieved by 
measuring the levels of CAT activity after transfecting the plasmid into BHK cells and 
subsequently infecting with wt HSV-1, ICP27-null or ICP27 mutant viruses. CAT RNA 
levels were also measured during these experiments, using Q-R T -PCR, to identify the 
level at which ICP27 acts. 
ICP27 is known to affect viral late gene expression. During an ICP27-null HSV-1 
infection the expression of certain late genes are severely reduced or not detected. To 
analyse late gene expression when a function of ICP27 was altered, my initial 
experiments utilised a panel ofICP27 mutant viruses. After infecting BHK cells with 
these viruses, celllysates were obtained and used to analyse expression levels of three 
true late genes and two leaky late genes using western blotting techniques. Furthermore, 
an immunofluorescence study was carried out to confirm or identify the localisation of 
ICP27 during each mutant virus infection. Unfortunately, as these experiments 
proceeded it became obvious that this was an extremely complicated system with 
regards to the affect ICP27 has on viral DNA replication, which in turn would influence 
late gene expression. True late gene expression is dependent on the onset of viral DNA 
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replication thus ICP27's effect on late gene expression and viral DNA replication must 
be separated. Furthermore, ICP27s effect on viral DNA replication when an ICP27 
mutant virus is infected into different cell types is extremely variable making results 
difficult to interpret. Due to these difficulties, current literature regarding the affect on 
late gene expression is conflicting. It was decided, therefore, to discontinue this 
approach and with the new knowledge and identification of viral RNAs that bound to 
ICP27 it was decided that an investigation into the properties of these RNAs would be 
more informative. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Enzymes 
All restriction enzymes were purchased from Roche. BamHI, EeoR!, 10U/J.!1 and calf 
intestinal phosphatase, 10U/J.!1 
T4 DNA ligase, Invitrogen; 1 U/J.!l 
RNase A, Promega; 10U/J.!1 
Acetyl coenzyme A; Sigma 
DNase I, Promega RQ1 RNase-Free DNase; 1 U/J.!l 
Alkaline Phosphatase; Biolabs, 10U/J.!1. 
PFU Turbo DNA Polymerase; Stratagene, 2.5U/J.!1 
2.1.2 Radiochemicals 
Radiochemicals were purchased from PerkinElmer Life Sciences Inc. 
[14C]-Chloramphenicol (CAM); Specific activity of60Ci/mmol (0.05 I-lCi/l-ll) 
2.1.3 PlasmidsN ectors 
pcmvlO 
pcmv63 
A eukaryotic expreSSIOn vector containing the immediate-early (IE) 
promoter of human cytomegalovirus (HCMV) and RNA processing 
signals ofSV40 (Stow et al., 1993). 
The pcmv63 plasmid consists of the complete open reading frame of 
ICP27 downstream of an IE HCMV promoter. This fragment was ligated 
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into the EcoRIlBamHI digested pcmv10 plasmid (Donated by :\. 
Reuthmeir, Institute of Virology, Glasgow). 
pcmv-~gal The plasmid pcmv-~galactosidase (~-gal) contains the ~-gal coding 
sequence downstream of a CMV promoter. Provided by Nigel Stow, 
MRC Virology Unit, Glasgow. 
psvCAT This plasmid has a SV 40 promoter upstream of a CAT ORF (Figure 4.1) 
(a kind gift from Dr R. Everett, MRC Virology Unit, Glasgow). 
2.1.4 Antibodies 
Monoclonal antibodies (MAb) used during this investigation and their sources are listed 
in Table 2.1 
2.1.5 Viruses 
HSV-1 wild type (wt) strain 17+ was used in this study. HSV-1 ICP27 mutation/deletion 
viruses including phenotypes and references are listed in Table 2.2. 
2.1.6 Bacterial strain 
The A. coli strain DH5a was used for maintenance and propagation of plasmid DNA. 
2.1.7 Bacterial culture media 
Bacterial culture media were supplied by the Institute of Virology, Glasgow. 
LB-Broth: 
LB-Agar: 
YT broth 
109 NaCl, 109 Bacto-tryptone, 5g yeast extract per litre. 
LB-Broth with 1.5% (w/v) agar. 
5g NaCl, 16g Bactopeptone, 109 yeast extract per litre. 
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PRIMARY 
ANTIBODY 
ICP27 (1113) 
ICP27 (1119) 
ICP4 (10176) 
ICP4 (58s) 
ICPO (11060) 
VP22A (LP 13) 
VP19 (CB2068) 
UL9 (13924) 
VP5 
UL44 (4916) 
US11 
WESTERN BLOT 
DILUTION 
1:3000 (1:500 for IF) 
1:3000 
1:5,000 
1:100 
1: 10,000 
1 :2,000 
1:10 
1:4,000 
1:100 
1:5,000 
1:2,500 
SOURCE AND REFERENCE 
Goodwin Institute for Cancer Research, Florida. Ackennan, 1984. 
Goodwin Institute for Cancer Research, Florida. Ackennan, 1984. 
R.Everett, 1993. 
Showalter, 1981. 
R.Everett, 1993. 
Serotech, Oxford, UK. 
C.Boutel, Institute of Virology 
N.Stow, Institute of Virology 
D.McClelland, J.Virol 199 
H.Marsden, Institute of Virology 
Roller and Roizman, 1992 
Table 2.1: Monoclonal antibodies used during this investigation 
HSV-IICP27 Mutation Functional domain(s) Amino acid(s) Growth in BHK-21 Reference 
mutant/deletion virus ty~e affected affected cells 
27LacZ Deletion All 1-512 Defective I Rice, 2000 
dl-2 Deletion Acidic 12-63 Deficient2 Rice, 1993 
d3-4 Deletion NLS 109-138 Deficient Rice, 1995 
d4-5 Deletion RGG 139-153 Defective Rice, 1996 
M15 Point, PG to LE Zn finger, KH3 465,466 Defective Rice, 1994 
-- - --- ----
Table 2.2: HSV-l ICP27 mutant/deletion viruses used during this study. The following abbreviations were used: 1 HSV-l mutant virus that 
cannot grow in BHK-21 cells, 2HSV-1 mutant viruses that have reduced titres when grown on BHK-21 cells. 
Where necessary, media and LB-agar were supplemented with antibiotic: 100jJ.g! ml 
kanamycin (for pEGFP transformed cells) or 100jJ.g! ml ampicillin (for psv or pcmv 
transformed cells). 
2.1.8 Cells and tissue culture media 
BHK-21 C13 cells 
The fibroblast line derived from baby hamster kidney cells (Macpherson, 1962) was 
grown in Glasgow Modified Eagles Medium (GMEM) supplemented with 10% new 
born calf serum, 10mM L-glutamine and 10% (v/v) tryptose-phosphate broth (the 
medium already contained sodium bicarbonate), 100 units/ ml penicillin and 100jJ.g! ml 
streptomycin. 
M49 cells 
M49 was a BHK derived ICP27-complementing cell line (Lilley et aI., 2001). M49 cells 
were cultured in DMEM supplemented with 10% FCS and 5% TPB. Continual selection 
was achieved by maintaining cells in 800jJ.g of G418/ ml and 750jJ.g of zeocinl mI. 
Provided by R.S.Coffin, Department of Molecular Pathology, University College, 
London. 
2.1.9 Synthetic oligonucleotides 
Oligonucleotides were synthesised by Sigma-Genosys. 
The sequences, names and uses of the oligonucleotides are described in Table 2.3 
2.1.10 Solutions 
5x Agarose gel loading buffer 
Blocking buffer: 
Ix TAE, 1% SDS (w/v) , 50% (v/v) glycerol, 1 
mg! ml bromophenol blue. 
PBS-Tween with 5% MARVEL skimmed milk 
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A: PCR nrimers fl 
------ --- . ----- -------
Insert 5'primer 3'primer 
ICP27 mutant gene, from pAlter plasmids (dl-2, d3- CCGGAATTCCATGGCGACTGACATTGATATGC CGCGGATCCAAACAGGGAGGTGCA 
4, d4-5 and MI5), cloned into pEGFP-Cl. 
NRE ACGGATCCGCTAAACGCAAAA ACGGATCCACATACAAACATA 
B: Annealin~ primers for full vector inserts with BamID overhangs 
Insert I 5'primer 
#212 I GATC~GGCCTCGGCCCTCCCTGGAACGGCTGGTCGGT 
#247 
#300 
#82 
#334 
#212,1-30 
#212,15-35 
#212,31-63 
#212,15-24 
#212 
6Gs 
6As 
CCCCGGGTTGCTGAAGGTGCGGCGGGT 
GATCACCCGCGGTGTCGCGGCAGCACGCCTACCTGGCGTGCG 
AGCTGCTGCCCGCCGTGCAGTGCGCCGTGCGCTGT 
GATCAACTCCGCCCCCGCGAGTAGCGACGGCCGTGTGCCAGT 
CGCCATCGTT 
GATCACCCCGAGTTCGCGACCGGGTACAACATCATCAACTTC 
GACTGGCCCTTCTTGCTGGCCAAGT 
GATCACCCCCCCGCTGTACGCAACGGGGCGCCTGAGCCAGGT 
GATCAAAAAAGGCCTCGGCCCTCCCTGGAACGGCTT 
GATCACCTCCCTGGAACGGCTGGTCGT 
GATCAGGTCGGTCCCCGGGTTGCTGAAGGTGCGGCGGGT 
GATCACCTCCCTGGAT 
GATCAACGGCTGGTCGT 
GATCAGGGGGGT 
GATCAAAAAAAT 
C: Primers for Quantitative RT-PCR 
Gene amplified 5' 
CAT AATCACTGGATATACCACCGTTGA 
-- - --
3'primer 
GATCACCCGCCGCACCTTCAGCAACCCGGGGACCGACCAGC( 
GTTCCAGGGAGGGCCGAGGCCTTnITT 
GATCACAGCGCACGGCGCACTGCACGGCGGGCAGCAGCTCG 
ACGCCAGGTAGGCGTGCTGCCGCGACACCGCGGGT 
GATCAACGATGGCGACTGGCACACGGCCGTCGCTACTCGCG( 
GGGCGGAGTT 
GATCACTTGGCCAGCAAGAAGGGCCAGTCGAAGTTGATGAT( 
TTGTACCCGGTCGCGAACTCGGGGT 
GATCACCTGGCTCAGGCGCCCCGTTGCGTACAGCGGGGGGGl 
GATCAAGCCGTTCAGGGAGGGCCGAGGCCTTnITT 
GATCACGACCAGCCGTTCCAGGGAGGT 
GATCACCCGCCGCACCTTCAGCAACCCGGGGACCGACCT 
GATCATCCAGGGAGGT 
GATCACGACCAGCCGTT 
GATCACCCCCCT 
GATCATrnnlT 
3' 
TGAACGGTCTGGTTATAGGTACATTG 
Table 2.3: (A) Primers used in the PCR of fragments for cloning. (B) The primers that were annealed and cloned into the BamHI site of psvCAT vector. (C) 
Primers used in quantitative RT-PCR. 
Diethyl pyrocarbonate (DEPC) 
treated dH20 
6x DNA loading buffer 
HEPES extract buffer 
PBS 
PBS-Tween 
7x Protease Inhibitor Cocktail 
Protein Loading Buffer: 
Protein gel running buffer 
RNA loading buffer 
powder. 
300~1 DEPC added to SOO ml dH20, Incubated 
overnight at room temperature and baked at 80°C 
for 20 mins to inactivate the DEPC. 
0.2S% bromophenol blue, 0.2S% xylene cyanol, 
40% (w/v) sucrose made up in ciH20. 
SOmM HEPES, SOmM NaCI, 0.1% (v/v) NP40, 
complete protease inhibitor Tablet (Roche), pH 
7.S. 
170mM NaCI, 3.4mM KCI, 10mM Na2HP04, 
1.8mM KH2P04, pH 7.2 
PBS plus O.OS% (v/v) Tween 20. 
One Tablet of protein inhibitor (without EDTA) 
(Roche) was dissolved in 1.S ml distilled water. 
100mM Tris-HCI (PH 6.8), 4% (w/v) SDS, 200 
mM ~-mercaptoethanol, 20% (v/v) glycerol, 
0.2% (w/v) bromophenol blue. 
SOmM Tris base, SOmM glycine, 0.1 % (w/v) 
SDS. 
lS% (w/v) ficoll, 10mM sodium phosphate (PH 
7.0), 0.2S% (w/v) bromophenol blue, 1mM 
EDTA 
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STET solution 
lOx Tris-Borate-EDTA (TBE): 
TAE buffer 
TE buffer 
TEN buffer 
Towbin's Blotting buffer 
Trypsin 
Versene 
1 % (v/v) Triton-Xl 00, 40mM EDTA, SOmM 
Tris-HCI, 8% (w/v) sucrose, pH 8. 
890mM Tris, 890mM boric acid, 10mM EDT A. 
40mM Tris-acetate 1mM EDTA 
10mM Tris-HCI, 1mM EDTA, pH 8. 
SOmM Tris pH 7.2, 1mM EDTA, O.lSmM NaCI. 
2SmM Tris base, 192mM glycine, 20% (v/v) 
methanol. 
0.2S% (v/w) trypsin, III Tris-saline, containing 
phenol red, adjusted to pH 7.S with NaHC03. 
0.6mM EDTA in PBS, 0.002% phenol red. 
Sterile dH20 obtained from a "Milli-Ro 60 plus" 
deioniser (Millipore, USA) and sterilised by 
autoc1aving. 
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2.1.11 Chemicals and reagents 
All chemicals and reagents were purchased from BDH Chemicals UK or from Sigma 
Chemicals Co. unless otherwise stated in this section or in the methods. 
30% Acrylamide solution, acrylamide:bis-acrylamide, 37.5:1 
40% Acrylamide solution, acrylamide/bis solution 19: 1 (Bio-Rad) 
3MM paper (Whatmann) 
Ampicillin (Penbritin) 
Amp1iscribe T7 Transcription Kit (Cambio) 
Bradford's reagent (Bio-Rad) 
Diethyl Pyrocarbonate (DEPC) 
ECL Western Blotting Detection Reagents (Amersham) 
Ethidium bromide 
Ethyl acetate (Fisher Bioreagents) 
High Pure PCR Purification kit (Roche) 
Lipofectamine 2000 (Invitrogen) 
Mini Quick Spin RNA Columns (Roche) 
Nitrocellulose Membrane (Hybond-ECL, Amersham) 
Nonidet P-40 (NP40) 
Nuclear Extract Kit (Active Motif) 
Omniscript RT Kit (QIAGEN) 
Penicillin/Streptomycin (Gibco) 
Precision Broad Range Prestained Protein Marker (BioRad) 
QIAfilter Midi Prep Kit (QIAGEN) 
QIAquick Gel Extraction Kit (QIAGEN) 
Rapid DNA LigationKit (Roche) 
RNeasy Mini Kit (QIAGEN) 
SYBR Green PCR Mastermix (Applied Biosystems) 
TEMED (N,N,N',N' Tetramethylethelenediamine) 
TLC plastic sheets (Merk) 
TRIzol reagent (Invitrogen) 
40 
2.2 Methods 
2.2.1 DNA manipulation 
2.2.1.1 Polymerase chain reaction (peR) amplification of DNA 
PCR reactions were carried out in a Hybaid PCR Express machine in thin walled 0.5 ml 
tubes. Typical PCR reactions were performed in a final concentration of 50~1 containing 
IV Pfu turbo (DNA polymerase), Ix Pfu PCR buffer (supplied with Pfu turbo), 0.5mM 
dNTPs and 10-50pmoll~1 primer. The DNA templates were used at a final concentration 
of 0.2ng/~1 (plasmid Fll) or 2ng/~1 (pAlter plasmid). Prior to PCR cycles, reactions 
were heated at 94°C for 3 min to allow complete denaturation of the nucleic acids. PCR 
reactions were carried out under the following conditions: i) strand-separation at 94°C 
for 30 sec, ii) primer annealing at 54°C or 65°C for 30 secs (temperature varied 
depending on the primer), iii) strand elongation at 72°C for 30 sec for 30 cycles, iv) a 
final elongation step at 72°C for 5 min. 
2.2.1.2 Oligonucleotide annealing 
All sequences to be inserted into the psvCAT (except the control sequence) were 
ordered as full-length oligonucleotides (see Table 2.3 B) and annealed as follows: 
5' oligonucleotide 7~1 
3' oligonucleotide 7~1 
Buffer B (Roche) 5 ~l 
dH20 31~1 
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Each reagent was pipetted into 1.5 ml reaction vials, placed in a beaker of boiling water 
and allowed to cool. The annealed primers were purified, as below, to allow a change of 
buffer during ligation. 
2.2.1.3 Purification of DNA after annealing or digesting 
Annealed or digested DNA was cleaned before further manipulation by using High Pure 
PCR Product Purification Kit (Roche) in which DNA binds to glass-fibres in spin-
columns in the presence of guanidine isothiocyanate. The protocol was performed 
according to the manufacturer's instructions. Briefly, 500J.ll of binding buffer was added 
to the PCR reaction and vortexed briefly. This mixture was applied to a spin column and 
centrifuged at 15,700 xg for 1 min in a bench top centrifuge at room temperature. The 
flow through was discarded and 500J.ll of wash buffer was applied to the upper chamber 
of the column, which was centrifuged again for 1 min. Again the flow through was 
discarded, 200J.ll of wash buffer was added and the column centrifuged for 1 min once 
more. The column was centrifuged for 1 min to remove residual buffer, the column 
attached to a fresh 1.5 ml centrifuge tube and 50J.ll of elution buffer added to the centre 
of the column. The column was left for 1 min and then centrifuged for 1 min at 15,700 
xg, leaving the eluted DNA. The DNA was analysed by agarose gel electrophoresis 
prior to its use, to determine the amount and quality of DNA. 
2.2.1.4 Agarose gel electrophoresis of DNA 
Gel electrophoresis of DNA samples was carried out using 1 % solution ofagarose (w/v) 
in TBE containing, OAJ.lgl ml ethidium bromide, on a horizontal slab gel apparatus. 
Ix TBE was used as a running buffer. Samples were loaded in 5x DNA loading buffer. 
Between 75 and 150 V was applied to the apparatus for 30-50 min. Gels were analysed 
on a ultra-violet transilluminator and images recorded. 
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2.2.1.5 Purification a/DNA/rom agarose gels 
PCR DNA fragments or digested plasmids were electrophoretically separated on an 
agarose gel as described above. The gel was visualised on a long-wave UV 
transilluminator and the band corresponding to the DNA fragment of interest was 
excised from the gel with a scalpel. Care was taken to avoid contamination with other 
bands in the lane. The DNA was purified using the QIAquick Gel Extraction Kit. 
Briefly, 300!-l1 buffer QC was added to the gel slice and incubated at 50°C for 10 min, 
vortexing every 2-3 min. lOO!-l1 isopropanol was added and the sample was placed into 
QIAquick column and centrifuged at 15,700 xg for 1 min. 750!-l1 wash buffer PE was 
added to wash the column and centrifuged for 1 min. The QIAquick column was placed 
into a fresh tube and the DNA was eluted from the column by adding 50!-l1 elution 
buffer. Samples were analysed on an agarose gel. 
2.2.1.6 Restriction enzyme digestion a/DNA 
Small-scale restriction enzyme digestion of DNA was used to digest plasmids, peR 
fragments or identify recombinant plasmids. Digests were generally carried out in 20j.l1 
reaction volumes using IOU of restriction enzyme per !-lg of DNA and Ix enzyme 
specific buffer. Reactions were incubated at 37°C for 3 h before further treatment or 
analysis. 
2.2.1.7 Alkaline phosphatase treatment a/plasmid DNA 
Removal of 5' phosphates from vector fragments with complementary ends, produced 
by digestion with a single restriction enzyme, was performed by incubating the DNA 
with 1 U of alkaline phosphatase in the provided buffer, for 30 min at 37°C. The alkaline 
phosphatase was heat-inactivated at 65°C and the treated DNA was later re-purified 
using the purification method above. 
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2.2.1.8 Ligation of DNA using T4 DNA ligase 
Samples of the purified fragments were run on an agarose gel to determine the 
concentrations of each to be used in the ligation reactions, and molar ratios of vector to 
insert DNA between 1: 1 and 1:5 were used. The standard reaction carried out was as 
below: 
vector DNA 1 J.ll (100ng) 
insert DNA 19J.ll 
T4 DNA ligase 3 J.ll (1 U/J.ll) 
10 x ligase buffer (Sigma) 3 J.ll 
dH20 4J.ll 
Reactions were left for 16 h at room temperature and transformed into bacterial cells 
immediately as described below. 
2.2.1.9 Ligation using Rapid DNA Ligation Kit 
Purified annealed oligonucleotides were ligated into the psvCAT using this method. The 
plasmid and oligonucleotide DNAs were diluted in DNA dilution buffer (as supplied) to 
a total volume of 10J.l1. The molar ratio of vector to insert used was 1 :5. 10J.llligation 
buffer and IJ.ll T4 DNA ligase was added to the reaction mixture, left at room 
temperature for 15 min and transformed immediately, as described below. 
2.2.1.10 Making competent E.coli 
A single colony of DH5a bacteria was inoculated into 10 ml of L-broth and grown at 
37°C for 16 h. 2 ml of the overnight culture was used to inoculate 200 ml L-broth and 
incubated at 37°C with shaking until an OD6oo of 0.4 was reached. The culture was 
centrifuged at 2100 xg for 10 min at 4°C, the pellet resuspended in 20 ml ice-cold O.1M 
CaCh and incubated on ice for 30 min. Cells were centrifuged at 2100 xg and the 
resulting pellet resuspended in 10 ml ice-cold O.IM CaCh and incubated in ice for a 
further 15 min. The suspension was centrifuged once more and the pellet was 
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resuspended in 4 ml ice-cold O.lM CaCh with the addition of 15% glycerol, dispensed, 
snap frozen and stored at -70°C. 
2.2.1.11 Transformation 
Transformation of plasmids into competent cells used approximately 0.2~g of DNA, 
which was mixed with 75~1 of competent bacteria and the mixture was chilled on ice for 
30 min. The cells were then heat-shocked at 42°C for 2 min and immediately placed 
back on ice for 2 min. 200~1 of YT broth was added and tubes were placed in a 370C 
water bath for 1 h. 100~1 of this suspension was spread onto an LB-agar plate 
containing 1 OO~g/ ml ampicillin or, in the case of EGFP plasmids, 1 00~g! ml 
kanamycin. 
2.2.1.12 Miniprep and midiprep plasmid DNA preparations 
(i) Quick analysis of plasm ids during cloning. 
Single colonies of transformed bacteria were picked and inoculated into 3 ml aliquots of 
L-broth containing the appropriate antibiotic. Cultures were grown for 6 h at 37°C in a 
shaking incubator. 1.5 ml of each culture was centrifuged at 15700 xg for 1 min. The 
bacterial pellets were resuspended in 200 ~l STET solution and 20~l of lysozyme (10 
mg! ml) was added before placing into a boiling waterbath for 40 sec. Cell debris was 
removed by centrifugation at 15700 xg for 10min. The supernatant was removed to a 
fresh tube, 0.9 volumes of isopropanol with 0.1 volumes of 3M sodium acetate were 
added to precipitate the DNA, and the tube was centrifuged at 15700 xg for 10 min. The 
DNA pellet was allowed to dry before resuspending in 20~l dH20. 1~1 of RNase A was 
added and placed in a 37°C water bath for 1 h before digesting and analysing on an 
agarose gel. 
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(ii) Small scale plasmid preparation: Qiagen 'QIAprep spin' miniprep kit 
This method was used to prepare high quality DNA for sequencing. The kit is based on 
an alkaline lysis method followed by selective adsorption of plasmid DNA onto a silica-
gel column and subsequent elution from the silica gel by water. 
The use of this kit was according to the manufacturer's instructions. 1.5 ml of bacterial 
culture was centrifuged for 1 min 15700 xg. The bacterial pellet was resuspended in 
250/J-l of chilled Buffer Pl. To lyse the cells, 250/J-I Buffer P2 was added and the tube 
inverted 6 times. 350/J-I Buffer N3 was added to neutralise the solution, and the tube 
once more inverted 6 times. After centrifugation for 10 min at 15700 xg the supernatant 
was transferred to a QIAprep column and centrifuged for 1 min at 15700 xg. 0.75 ml of 
wash buffer Buffer PE was added to the column, which was again centrifuged at 15700 
xg for 1 min. The column was centrifuged for 1 min again, to remove any residual 
buffer, transferred to a clean 1.5 ml tube and 50/J-I dH20 added to the centre of the silica 
gel. After 1 min, to allow the water to filter throughout the silica gel, the column and 
tube were centrifuged for 1 min at 15700 xg, after which the DNA had eluted in the 
water. 
(iii) Large scale preparation of DNA 
Midi prep DNA preparation was carried out on all EGFP plasmids. 
Qiagen midi preps were used to prepare large-scale preparations of plasmid DNA for 
transformation or expression in mammalian cells. 
0.2 ml of an overnight 10 ml culture from a single colony of the relevant bacterial strain 
was inoculated into 50 ml L-Broth (Plus antibiotic) and incubated at 37°C for 12-16 h 
(overnight) with shaking. The culture was centrifuged at 6000 xg for 15 min at 4°C and 
the bacterial pellet was resuspended in 4 ml of buffer Pl. The suspension was lysed with 
4 ml buffer P2 for 5 min and 4 ml of chilled buffer P3 was added to neutralise the 
suspension, which was immediately poured into a QIAfilter cartridge and allowed to 
settle for 10 min. The lysed bacterial suspension was pushed through the QIAfilter 
46 
cartridge to clear any precipitated bacterial debris by a syringe method. Passing the 
filtrate through an equilibrated QIAGEN-tip 100 purified the DNA. This was then 
washed twice with buffer QC. The DNA was eluted by adding 5 ml buffer QF and 
allowing the eluant to drip through by gravity flow. The DNA was precipitated by 
adding 3.5 ml isopropanol and immediately centrifuged at 15000 xg for 30 min. The 
DNA pellet was washed with 70% ethanol and centrifuged at 15000 xg for a further 10 
min. The pellet was air dried and re-dissolved in 50J..tl dH20. The DNA content was 
measured with a spectrophotometer and the concentration calculated was roughly 
confirmed by running the sample o.n an agarose gel in comparison with known 
standards. 
(iv) Large scale preparation of high quality DNA. 
Caesium chloride banded plasmid DNA was used for analysis of CAT expression. 
500 ml of overnight bacterial culture was pelleted by centrifugation at 9200 xg for 10 
min at 4°C. The pellet was resuspended in 10 ml solution 1 (50mM glucose, 25mM 
Tris-HCl pH 8.0, 10mM EDTA). The cells were lysed by adding 10 ml of freshly 
prepared solution 2 (0.2M NaOH, 1 % SDS), mixed by inversion and incubated at room 
temperature for 10 min. The sample was neutralised by adding 15 ml ice-cold solution 
3 (3M potassium acetate, 11.5% acetic acid), inverted 5 times and incubated on ice for 
10 min to precipitate the protein complexes. Cell debris was pelleted by centrifugation 
at 9200 xg for 15 min at room temperature. The supernatant was filtered through muslin 
and the plasmid DNA was precipitated from the filtrate by adding 26 ml isopropanol, 
incubating at room temperature for 10 min and pelleted by centrifuging at 9200 xg for 
15 min at room temperature. The DNA pellet was allowed to air dry and was 
resuspended in 5.5 ml TE buffer with 5.5g CsCl and 400J..tl ethidium bromide (10 mg! 
ml). This solution was centrifuged at 12100 xg for 10 min at room temperature to 
remove any undissolved material. The supernatant was transferred to an ultracentrifuge 
tube and centrifuged at 197400 xg for 16 h at room temperature. The plasmid DNA 
band was removed by side-puncturing the tube using a syringe and needle and 
transferred to a 15 ml tube. Ethidium bromide was removed from the plasmid DNA by 
repeated extraction with TE-saturated butanol. The DNA was precipitated with chilled 
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ethanol, incubated on ice for 30 min and pelleted by centrifuging at 12100 xg for 10 
min. The DNA pellet was washed with 70% ethanol and finally resuspended in 500~1 
TE buffer. The DNA content was measured with a spectrophotometer and the 
concentration calculated was roughly confirmed by running the sample on an agarose 
gel in comparison with known standards. 
2.2.1.13 Sequencing of DNA fragments 
DNA sequencing was performed by the University of Glasgow MBSU using an ABI 
377 DNA sequencer. The procedure used was the Sanger method based on chain 
termination. DNA was denatured to give single stranded DNA by heating to 96°C. A 
site-specific primer was annealed to one of the DNA strands and the sequencing 
reaction continued in the presence of nucleotides (dNTPs) and dideoxynucleotideds 
(ddNTPs) labelled with a fluorescent dye. The ddNTPs are identical to the NTPs except 
they contain a hydrogen group on the 3' carbon instead of a hydroxyl group. This 
modification prevents the addition of further nucleotides and thus the DNA chain is 
terminated with a fluorescent ddNTP. As the reaction starts at the same nucleotide, the 
continually synthesised DNA chain will terminate at all possible positions, creating 
DNA stretches of different lengths. The DNA is denatured again and the contents of 
each tube are run on a polyacrylamide gel to separate each band. As each dye has a 
different wavelength, a laser can read the gel to determine the identity of each band (G, 
A, T or C). The results are given as a chromatograph where each coloured peak 
represents a nucleotide in that location of the sequence i.e. blue is C, green is A, black is 
G and red is T. 
48 
2.2.2 RNA extraction and manipulation procedures 
2.2.2.1 Extraction of total RNA from BHK cells 
Extraction of RNA from transfected and/or infected cells was carried out using TRIzol 
reagent, a mono-phasic solution of phenol and guanidine isothiocyanate. Whole cell 
extracts were disrupted by the solution, following which the addition of chlorofonn 
separated the lysate into protein, DNA and RNA phases. Use of this reagent was 
according to the manufacturer's instructions. 
Initially, 1 ml of TRIzol reagent was added to a 35mm cell culture dish, transferred to a 
1.5 ml sample tube and vortexed to give an even suspension. This was incubated at 
room temperature for 5 min and 0.2 ml chlorofonn was added, the tubes vigorously 
shaken for 20 sec and then incubated at room temperature for 5 min. The suspension 
was centrifuged at 15700 xg for 15 min, at 4°C, which allowed a clear separation into a 
lower organic phase (proteins and cell debris), an interphase (DNA) and an upper 
aqueous phase of approximately 600 ~l containing the RNA. 500~1 of the aqueous 
phase was transferred to a new 1.5 ml tube. 500~1 of isopropanol was added and the 
tubes mixed vigorously for 20 sec. The solution was incubated for 10 min at room 
temperature and centrifuged at 15700 xg for 10 min at 4°C. The pellet was washed with 
1 ml 70% ethanol in DEPC-treated dH20. Pellets were air-dried and resuspended in 50~1 
of DE PC-treated dH20 and stored at -20°C. 
2.2.2.2 Isolation of cytoplasmic RNA 
All solutions were supplied from the Nuclear Extract kit (Active Motif). A 35mm dish 
of confluent cells was washed with 2.5 ml of the supplied PBSlPhosphatase Inhibitor 
solution and the cells harvested by scraping in 1.5 ml PBSlPhosphatase Inhibitor 
solution. Cells were centrifuged for 5 min at 4000 xg at 4°C and the cell pellet 
resuspended in 0.25 ml Ix hypotonic buffer solution and incubated for 15 min on ice. 
12.5~1 of the detergent solution was added, the suspension vortexed for 10 sec and 
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centrifuged for 30 sec at 15700 xg at 4°C. The supernatant contained the cytoplasmic 
fraction and RNA was extracted using the TRIzol method above. Extracted RNA was 
analysed on an agarose gel and quantified and standardised using a NanoDrop 
spectrophotometer. 
2.2.2.3 DNase treatment of RNA 
19J.!1 TRIzol extracted RNA was incubated with 2J.!1 lOx DNAse buffer and 1J.!1 DNase 
for 30 min at 37°C. The solution was extracted twice by phenol/chloroform extraction, 
once with chloroform and then the RNA was ethanol precipitated. 
2.2.2.4 Phenollchloroform extraction and ethanol precipitation of RNA 
Precipitated RNA was resuspended In 200J.!1 water and 200J.!1 
phenol:chloroform:isoamyl alcohol (25 :24: 1) was added. The mixture was vortexed for 
30 sec and centrifuged at 15700 xg for 5 min. The upper phase was carefully removed 
and transferred to a clean microfuge tube. The RNA was precipitated with the addition 
of 0.5 volumes of 7.5M ammonium acetate and 2.5 volumes of ice-cold ethanol and 
incubated at -20°C for 1 h. The RNA was pelleted by centrifuging at 15700 xg for 10 
min, washed once with 70% ethanol and resuspended in dH20. 
2.2.2.5 Generation of eDNA from chloramphenicol acetyltransferase (CAT) RNA by RT-
PCR 
Using TRIzol extracted, DNAse treated RNA, generation of cDNA was performed 
using the Omniscript Reverse Transcription kit (QIAGEN). 3J.!1 (120ng) standardised 
RNA was added to 9.7J.!1 dH20 and 20J.!1 mineral oil was placed on top. To denature any 
secondary structures, the RNA was incubated at 65°C for 5 min and cooled to 4°C. A 
mastermix was prepared consisting of the following quantities per sample: 
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lOx buffer RT 2.0J.lI 
dNTP (5mM of each dNTP) 2.0J.lI 
Primer (40 pmoVJ.lI) 1.0J.lI 
RNasin (40U/J.lI) 0.3J.lI 
Omniscript 1. 0 J.lI 
dH20 1.0J.lI 
The mastermix was added to the denatured RNA, ensuring that pipetting was below the 
mineral oil. Each sample was placed on a BIOMETRA PCR machine and incubated at 
37°C for 1 h, 93°C for 5 min and 4°C for up to 24 h. 
2.2.2.6 Quantification of extracted RNA by Quantitative PCR (Q-PCR) 
The resulting CAT cDNA from the above RT-PCR procedure was subjected to 
quantitative PCR (Q-PCR) using the SYBR Green I mastermix (Applied Biosystems) 
which contains SYBR Green I dye, Amplitaq ® Gold, DNA polymerase, dNTPs and 
PCR buffer. SYBR Green I is a fluorescent dye that binds to the minor groove of 
double-stranded DNA upon which fluorescence increases greatly. 
Highly purified salt-free primers for the target within the CAT gene were designed 
using the Primer Express package (Table 2.3 C). These primers were designed to 
produce a product of 104bp and optimised to an annealing temperature of 60°C. A 
mastermix (SYBR Green I mastermix and primers) was made up in bulk to allow for 
each RNA sample to be tested in triplicate i.e. l2J.l1 SYBR Green I mastermix and 
0.75J.lI of each primer (lOpmol/J.ll) and 10J.lI of dH20. This mix was vortexed for 1 sec 
before 24J.lI of mastermix was dispensed into each well of a 96 well plate and 1 J.lI of 
cDNA was added, ensuring that no air bubbles were present. The plate was placed on a 
TaqMan PCR machine linked to ABI Prism software. 
The cycling program used was as follows: 
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initial stage 
initial denaturation 
then 40 cycles of: 
denaturation 
annealing! elongation 
50°C 2 min 
95°C 10 min 
95°C 15 sec 
60°C 1 min 
Analysis was carried out using the ABI Prism package, which calculates the relative 
amount of RNA in each sample on a scale of 0 to 40, with 40 indicating no detectable 
RNA and 0 being the maximum detectable RNA. 
2.2.3 Tissue culture techniques 
2.2.3.1 Maintenance of cell lines: 
Mammalian cells were grown in 175 cm2 flasks for 3-4 days until confluent. Cells were 
washed twice with 20 ml versene and the versene was discarded. 4 ml of a 1:4 solution 
of trypsin:versene was added to the cells, followed by incubation at 37°C for 2 min. 
When the cells started to detach from the flask, they were harvested by adding 10 ml of 
medium. This cell suspension was passaged by splitting in a 1: 10 ratio into a new flask. 
Cells and were grown at 37°C in a humidified incubator supplied with 5% (v/v) C02. 
2.2.3.2 Liposome-mediated transfection ofBHK cells: 
Transfections were carried out in 24 well plates when BHK cells were 80% confluent. 
The medium was changed to penicillin/streptomycin free medium 30 min before 
transfection. 50~1 Opti-MEM was mixed with 1~1 Lipofectamine 2000 and incubated 
for 10 min at room temperature. 300ng of plasmid DNA was added to the 
Lipofectamine/Opti-MEM mix and incubated for 15 min at room temperature. The 
DNA! liposome solution was added gently to the cells and left for 16 h. 
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2.2.3.3 Infection of cells 
80% confluent BHK mono layers were infected with wt HSV-1 or HSV-1 lCP27 mutant 
viruses at a multiplicity of 1 or 10, or no virus (mock). Adsorption was for 1 h at 370C 
, 
after which the medium was changed and infection was allowed to proceed at 37°C in a 
humidified incubator supplied with 5% (v/v) CO2. 
2.2.4 Virus propagation techniques 
2.2.4.1 Preparation of virus stocks 
BHK21 C13 (for wt HSV-1 virus) and M49 cells (for HSV-1 lCP27 mutant viruses) 
were grown in roller bottles to a confluency of 80% and infected at an MOl of 1 plaque 
forming units (Pfu) in 300 cells in 40 ml of medium at 31°C for 3-5 days until a 
cytopathic effect (CPE) was observed. Cells were detached by shaking the roller and 
harvested by centrifugation at 950 xg for 30 min at 4°C. To isolate the cell-release virus, 
the supernatant was removed and centrifuged at 22100 xg for 2 h. The pellet was 
resuspended in 1 ml/roller bottle of culture medium, sonicated briefly, dispensed, and 
frozen on dry ice and stored at -70°C. The cell-associated virus was harvested by 
resuspending the cell pellet in 5 ml medium and sonicated for 10 min in a sonibath. The 
cell debris was pelleted by centrifugation at 950 xg for 10 min and the supernatant 
removed. The pellet was again resuspended in 5 ml fresh medium, sonicated and 
pelleted. The supernatant was added to that gained in the first round, dispensed, frozen 
on dry ice and stored at -70°C. Serial dilutions (10-1-10-8) of the virus stock were titrated 
on BHK cells (for wt HSV-1 virus) or M49 cells (for HSV-1 lCP27 mutant viruses). 
Cells were grown on 60mm dishes to 90% confluency and infected for 1 h at 37°C. 
Cells were overlaid with BHK or M49 media containing 1 % methylcellulose. After 2-3 
days the medium was removed and the cells were overlayed with Giemsa stain for 2 h 
and gently washed with water to remove excess stain. The Giemasa stain stained the 
fibroblastic cells and allowed detection and counting of plaques (cleared areas due to 
cell cell death) under a microscope. The titre was calculated as pfu/ ml. Virus stocks 
were checked for bacterial contamination by streaking a loopfull of virus stock onto 
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blood agar plates, containing 10% (v/v) horse blood (blood agar) and incubating at 370C 
for 7 days; if colonies appear the virus stock should be discarded. 
2.2.5 Protein manipulation techniques 
2.2.5.1 Preparation of celllysates for western blot analysis 
The culture medium was removed from mono layers of BHK cells grown in 35mm 
dishes, the cells were washed with PBS and the solution discarded. Cells were scraped 
into 1 ml fresh PBS and centrifuged at 4000 xg for 10 min. Cell pellets were 
resuspended in 200J.ll HEPES buffer, sonicated and centrifuged at 15700 xg at 4°C for 
10 min. The supernatant was removed to a fresh tube and stored at -20°C. 
2.2.5.2 Preparation of celllysates for CAT assays 
BHK cells grown in a 24 well dish were washed twice with PBS and the solution was 
discarded. 400 J.lI TEN buffer was added to each well and left until cells detached from 
the well. Cells were collected into a 1.5 ml vial, centrifuged at 15700 xg for 10 min and 
the supernatant discarded. Pelleted cells were resuspended in 30J.ll 0.25M Tris.HCI pH 
7.5 and lysed by three rounds of freeze/thawing. Centrifuging at 15700 xg for 10 min 
pelleted cell debris, and supernatants were removed to a fresh tube and stored at -20°C. 
2.2.5.3 f3-Galactosidase(f3-gal) Enzyme Assay system 
BHK cells were co-transfected with psvCAT constructs and ~-gal plasmids. Cell 
extracts were assayed for ~-gal activity. Samples obtained were treated using the ~-gal 
Enzyme Assay System (Promega) on a 96 well plate format and activity was measured 
by absorbance of the samples at 405nm in a plate reader (Anthos htII plate reader). 
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2.2.5.4 SDS polyacrylamide gel electrophoresis (SDS-PAGEj of proteins 
35/-l1 protein loading buffer was added to standardise celllysates and boiled at 1000 e for 
2-3 min prior to separation by SDS-P AGE. Denatured proteins were resolved by 
electrophoresis through polyacrylamide minigels containing SDS. Gel mixes were as 
follows 
For 10 ml 10% resolving gel For 2 ml stacking gel 
dH20 4ml 1.4 ml 
30% acrylamide mix 3.3 ml 0.33 ml 
1.5M Tris (PH 8.8) 2.5 ml 0.25 ml (PH 6.8) 
10% SDS 0.1 ml 0.02 ml 
10% APS 0.1 ml 0.02 ml 
TEMED 0.004ml 0.004 ml 
After the resolving gel mixes were poured between the glass plates of the mini gel kits, 
dH20-saturated butanol was overlaid to produce a smooth interface. Once set, the 
butanol was removed and the gel rinsed with dH20 prior to overlaying the stacking gel. 
Samples were loaded onto the gel and electrophoresed at 150V in Ix running buffer 
until the dye front reached the bottom of the gel. 
2.2.5.5 Western blot analysis of denatured proteins 
Denatured proteins resolved on a SDS-PAGE were transferred to nitrocellulose 
membranes by the method of Towbin et al (Towbin et at., 1992) using a BioRad 
transblot cell. The western blot gel sandwich components, pre-soaked in Towbin's 
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buffer, were assembled as follows. The gel was placed onto an appropriate sized piece 
of Whatman 3MM paper. A piece of nitrocellulose membrane was placed onto the gel 
and air bubbles removed with a pipette. Another piece of Whatman paper was placed on 
top of the membrane and the sandwich was put between two sponges provided by 
BioRad and inserted into the blotting cassette. Transfer was carried out at 100mA for 1 
h. Following transfer, the membrane was incubated in 50 ml blocking buffer overnight 
at 4°C. The membrane was washed twice for 10 min with PBS before the primary 
antibody was added (at the appropriate dilution in 1 % blocking buffer). Incubation was 
continued for 1 h at room temperature. The nitrocellulose membrane was washed three 
times for 10 min in PBST before being left for 1 h in horseradish peroxidase (HRP) 
conjugated antibody (at appropriate dilution in 1 % blocking buffer). The membrane was 
finally washed three times in PBST for 10 min each and proteins detected by ECL 
western blot detection reagents. The membrane was placed between two sheets of 
transparent plastic and exposed to Kodak X-Omat S film for varying lengths of time. 
2.2.5.6 CAT assays 
Chloramphenicol acatyltransferase (CAT) is a popular reporter gene and protein. CAT 
catalyses the transfer of the acetyl group from acetyl coenzyme A (acetyl CoA) to 
chloramphenicol resulting in the formation of mono- and di-acetylated chloramphenicol. 
The amount of acetylation is directly proportional to the amount of CAT enzyme 
present, thus the amount of acetylated chloamphenicol in different protein extracts can 
be measured. In this protocol, [14C]-chloramphenicol (CAM) was used and the products 
were analysed by thin layer chromatography (TLC). This involves extraction with 
organic solvents, resuspension and spotting of the sample onto the origin of a TLC 
plate. The TLC plate was lowered into a chamber containing a solvent 2cm from the 
bottom and the sample was allowed to migrate up the TLC plate thus separating the 
different acetylated forms of [14C]_CAM (Figure 2.1). The TLC plate was then dried 
and exposed to a phosphoscreen for analysis.The protocol used in this investigation was 
as follows: 
2, 10 OR 20).!1 BHK cell lysate obtained for CAT assays was incubated with l).!l 50mM 
acetyl CoA, 1).!1 [14C]_CAM and 18).!1 O.25M Tris.HCI pH 7.5 at 37°C for 1 h. The 
reaction was stopped by adding 200).!1 ethyl acetate, mixed by vortexing and centrifuged 
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at 15700 xg for 5 min. The upper organic phase was retained and placed in a Speediyac 
to be lyophilised for 30 min. Each sample was resuspended in 25~1 ethyl acetate and 
vigorously vortexed for 20 sec. Samples were spotted onto a TLC plate, which was 
placed into a shallow pool of solvent consisting of 95 ml chloroform, and 5 ml methanol 
allowing separation of acetylated and unacetylated forms of [14C]_CAM as the solvent 
rose through the sample. When the solvent reached near to the top of the plate, the TLC 
plate was removed and dried in a fume hood. The plate was exposed to a previously 
erased phosphor screen for approximately 2 h and scanned to give an image of each 
sample on the TLC plate. Each band was analysed and quantified using Bio-Rads' 
Quantity One software. The amount of acetylated [14C]_CAM was quantified in cmp, 
which was then divided by the total amount of [14C]_CAM, in cpm, and multiplied by 
100 to give % CAT activity. Each plasmid was transfected in BHK cells on at least 
three separate occasions and CAT assays carried out on the lysates obtained. 
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Figure 2.1: This diagram represents a phosphoscreen exposed to a TLC plate 
after TLC demonstrating the separation of acetylated and unacetylated forms 
of [14C]-CAM. Lane 1: psvCAT construct 1; Lane 2: negative control; Lane 3: 
positive control. 
CHAPTER 3: The use of a CAT • expressIon 
vector to investigate the properties of ICP27-
binding sequences in BHK cells. 
3.1 Introduction 
The RNA binding properties of ICP27 are crucial to virus viability (Lengyel et ai., 
2002; Mears and Rice, 1996b; Sandri-Go1din, 1998a). Functional properties of ICP27 in 
connection with the RNA binding domains of ICP27 have been studied using various 
viruses containing deletions or mutations of the RGG box, or of the putative KH 
domain(s) of the ICP27 protein (Rice and Lam, 1994; Soliman and Silverstein, 2000b) 
both of which are RNA binding domains. Although these mutant forms of the ICP27 
protein are produced during infection, the disruptions of these respective RNA binding 
domains have detrimental effects on virus survival producing no, or severely reduced 
numbers of, infectious progeny. Furthermore, the mutations greatly reduce the 
nucleocytoplasmic shuttling capabilities of ICP27 and ultimately inhibit the expression 
of some late genes, e.g. gC (Jean et aI., 2001). The shuttling capability is possibly an 
RNA export function of ICP27 that diminishes when ICP27 cannot bind RNA (Sandri-
Goldin, 1998a; Soliman et ai., 1997; Soliman and Silverstein, 2000b). 
Previously, a few HSV -1 RNAs were found to bind ICP27 by performing UV cross-
linking experiments, covalently binding protein to RNA. Seven po1y(At HSV-1 RNAs, 
those encoding ICP4, TK, ICP8 gD, gC, UL41 and ICP27, were found to bind ICP27. 
This result also confirmed the association ofICP27 with intron1ess RNAs, as two RNAs 
containing introns, ICPO and UL15, did not bind to ICP27 (Sandri-Goldin, 1998a). 
A more wide-ranging investigation to identify HSV-1 RNAs that bind ICP27 was 
carried out (Sokolowski et ai., 2003). This involved an extensive yeast 3-hybrid (Y3-H) 
study isolating from a genomic library HSV -1 RNAs that interact with ICP27 protein. 
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Figure 3.1: Schelnatic drawing of the c0111plex fom1ed during the yeast-3 hybrid systel11 
The Y3-H system relies upon a physical RNA-protein interaction resulting in the 
assembly of two protein hybrids and a fusion RNA. This forms a complex capable of 
trans-activating promoters of LacZ and HIS3 reporter genes. Briefly, a yeast strain that 
stably expresses the bacteriophage MS2 coat protein was transformed with a plasmid 
expressing an ICP27/GAL4-binding domain fusion protein. These cells were also 
transformed with an RNA expression vector containing a range of small HSV -1 inserts, 
from an HSV -1 genomic library, cloned upstream of an MS2 binding site. When ICP2 7-
RNA binding occurs a complex is formed with their respective fusion proteins and the 
reporter genes on each plasmid are transactivated (Figure 3.1). Isolation of 
transformants containing this complex was achieved by using selective media. These 
isolates were subjected to further rounds of selection and eventually 68 single 
transformants showed activation of the LacZ gene with the ICP27 fusion protein and did 
not activate when the negative control protein (iron regulatory protein 1) was present. 
Sequence analysis of these selected HSV -1 library plasmids revealed that 31 of the 68 
isolated transformants contained plasmid inserts encoding RNA corresponding to HSV-
1 transcripts in the correct orientation (Table 3.1). The remaining 37 RNAs were found 
to have no biological significance as they were located in the reverse orientation as 
compared to the HSV -1 sequence or were found to contain more than one insert. ~­
galactosidase liquid assays were carried out on the 31 selected transfomants and the 
results confirmed that the ICP27-RNA interaction was specific (and was also a possible 
measure of binding affinity). Further analysis was undertaken using ICP27 protein with 
a deletion of the RGG-box (d4-5) or a mutation in the KH3 domain (MI5). Both 
domains are thought to be involved in RNA binding (Mears and Rice, I996b; Sandri-
Goldin, 1998b; Soliman and Silverstein, 2000b). Separate assays carried out with these 
mutant ICP27 proteins either abolished or gave an extremely weak interaction with the 
31 isolates. Thus, these results indicate not only a relationship between ICP27 functions 
and these binding domains but also that the function of ICP27 and its ability to bind 
RNA are connected. 
Although these viral transcripts were recognised and their sequences analysed in the 
Y3-H investigation, little was known of their roles in gene expression or the 
significance of ICP27 binding during infection in vivo. Extension of the Y3-H results 
discussed above is essential to identify a possible functional relationship between ICP27 
and the isolated ICP27-binding HSV-1 sequences. To enable the function of these 
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Gene ,kinetic Isolate no. Length (nt) Genomic position° 
classa 
ICP4 a 69 95 130251c 
ICP4 a 16 50 128982c 
ICP4 a 17 36 128003c 
ICP4 a 247 71 128005c 
ICP4 a 352 196 127879c 
ICP4 a 75 148 127879c 
UL5u ~ 324/ 16.2 66 15333c 
UL29 ~ 309 108 59581 
UL30 ~ 82 61 64180 
UL30 ~ 5 72 66092 
UL30 ~ 231 100 66092 
UL39 ~ 13.2 104 88443 
UL42 ~ 3 62 93504 
UL49 ~ 8 40 106100c 
US3 ~ 4 72 135702 
US3 ~ 242 87 135702 
UL6u y 212 63 15022 
UL13 Y 12 160 27101c 
UL15i y 23 35 32178 
UL15u y 21 209 28826 
UL16 Y 274 41 30757c 
UL19 y 19/85/185 122 38856c 
UL19 y 251 159 38902c 
UL32u y 55 225 69322c 
UL36 y 28l.2 47 77686c 
UL48 y 334 36 104979c 
UL49Au y 300 40 106100c 
ICP34.5 y 258 139 1306 
Table 3.1: HSV-l RNAs interacting specifically with the ICP27 protein 
The following abbreviations were used: u, partially or completely in the untranslated 
region of the corresponding gene; i, located in intron;aimmediate-ear1y; ~, early; y, 
late; c, complementary genomic strand; a HSV -1 transcribed genes in which the 
identified RNAs are encoded, with expression kinetics for the genes as described 
previously (55, 58). b Position of the 5'-end of each RNA isolate in the HSV-l 17+ 
genome. For ICP34.5 and ICP4, nucleotide numbers refer to one of the inverted repeats 
(adapted from Sokolowski et aI, 2003). 
sequences to be measured in a system that responds to endogenous regulatory proteins 
(i.e. host cell factors) or input regulatory proteins (e.g. ICP27), it was decided to study 
these HSV -1 RNA sequences in a mammalian cell system. A series of recombinant 
plasmids containing the reporter gene, CAT, was used to measure the impact of these 
sequences and ICP27 protein on CAT expression, under varying conditions. 
3.2 Criteria for choosing Y3-H identified sequences for 
investigation 
HSV -1 RNAs found to bind ICP27 were examined for sequence homology and 
secondary structures, however, the resulting identified sequences showed no obvious 
similarities. Due to the plethora of isolated RNAs, the choice of sequences for further 
analysis was based on various criteria to allow a full range of ICP27 -binding sequences 
to be studied. Criteria were as follows: 
1. Each sequence chosen should originally be from a different gene. Analysis 
should cover a range of genes to prevent results being confined to one gene. 
Experiments should be carried out on sequences from different genes to 
determine whether any change in gene expression when ICP27 is present is 
specific to a particular gene. 
2. Sequences should be chosen that are found in genes belonging to different 
classes i.e. IE, E or L genes. This would provide a sequence from a gene from 
each of the temporal classes. 
3. Isolated RNAs were found from different areas of the gene, for example, isolate 
#212 is located to the 5'UTR of the UL6 gene whereas isolated sequence #82 is 
located within the ORF of the UL30 gene. The ICP27 binding location within 
each gene may be an important factor. 
4. Sequences chosen should direct a range of p-gal activities in the Y3-H assay. p-
gal activity values may be indicators of the affinities of these RNAs for ICP27. 
RNA-protein binding affinities may significantly affect gene expression. 
After applying the above criteria, 5 sequences were selected for further investigation 
(Table 3.2). A schematic diagram of the HSV-1 genome is shown in Figure 3.2, which 
indicates the position of all the transcripts identified by the Y3-H assay. The isolates 
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Figure 3.2: Schematic diagram of the HSV -1 genome highlights the transcripts 
identified using the Y3 -H (indicated by #). Dark shaded thick arrow show ORFs that 
encode the 3 ' co-terminal transcripts. Indicated in red are the transcripts chosen for 
further investigation in this study, all of which do not overlap with any other gen. 
ISOLATE MATCH TO : NT POSITION INSERT GENE KINETIC GROUP : 
NO . LENGTH POSITION DESCRIPTION 
212 46 nt 15022-15084, 63 5 'UTR y : a v irion procein 
upstream of sense 
UL6 start 
required for DNA 
247 
cleavage / packaging 
RS1 (Vmw175, 127934-128 005, 71 5' ORF a: transcription 
ICP4 ) antisense and 
transactivator . 
150228-150298 
82 UL30 (DNA 66092-66163, 61 ORF ~: essential for DNA 
polymerase ) sense 
replication 
300 75 nt 10 7 068-1071l3 , 46 5'UTR Y2 : putative membrane 
upstream of antisense 
associated protein 
UL49.5 ATG 
334 
UL48 (VP16) 104944-1049 7 9, 36 3 'ORF y: induces alpha genes 
antisense 
Table 3.2: ICP27-binding HSV-l RNAs selected for investigation. ORF 
denotes open reading frame. 
212F AAAAAGGCCTCGGCCCTCCCTGGAACGGCTGGTCGGTCCCCGGGTTGCTG 
AAGGTGCGGCGGG 
212R CCCGCCGCACCTTCAGCAACCCGGGGACCGACCAGCCGTTCCAGGGAGGG 
CCGAGGCCTTTTT 
247F CCCGCGGTGTCGCGGCAGCACGCCTACCTGGCGTGCGAGCTGCTGCCCGC 
CGTGCAGTGCGCCGTGCGCTG 
247R CAGCGCACGGCGCACTGCACGGCGGGCAGCAGCTCGCACGCCAGGTAGGC 
GTGCTGCCGCGACACCGCGGG 
82F CCCCGAGTTCGCGACCGGGTACAACATCATCAACTTCGACTGGCCCTTCT 
TGCTGGCCAAG 
82R CTTGGCCAGCAAGAAGGGCCAGTCGAAGTTGATGATGTTGTACCCGGTCG 
CGAACTCGGGGATG 
300F ACTCCGCCCCCGCGAGTAGCGACGGCCGTGTGCCAGTCGCCATCGT 
300R ACGATGGCGACTGGCACACGGCCGTCGCTACTCGCGGGGGCGGAGTATG 
334F CCCCCCCGCTGTACGCAACGGGGCGCCTGAGCCAGG 
334R CCTGGCTCAGGCGCCCCGTTGCGTACAGCGGGGGGG 
Table 3.3: A list of chosen sequences shown in both forward and reverse 
orientation. The red characters in sequence 300R and 82R show the start codon 
found only in this orientation. Refer to Table 3.2 for data on each sequence. 
The italicized ATG at the end of sequence 82R and 300R was not incorporated 
into the oligo, instead it represent the start codon of the CAT gene to identi fy 
whether the ATGs within 82R and 300R are in-frame. 
coloured in red highlight the transcripts chosen for investigation in this study and are 
-, 
found not to overlap with any other HSV -1 genes. Sandri-Goldin (l998a) previously 
identified an interaction with the HSV -1 RNA transcript ICP4, and ICP27 protein, 
otherwise, there has been no previously published data showing interactions of the 
selected HSV -1 transcripts with ICP27. 
3.3 Introduction to CAT reporter assays 
The CAT gene was originally used as a reporter to assay indirectly the transcriptional 
activity of mammalian promoters and enhancers in transiently transfected cells (Gorman 
et al., 1982). The BamHI site within the 5'UTR of the plasmid was used, as the majority 
of the isolated RNAs from the Y3-H investigation were located to the 5'UTR of the 
corresponding gene. The effect of sequences inserted into the BamHI site at the 3' end 
of the 5'UTR was quantified by measuring the amount of CAT enzymatic activity. A 
CAT enzyme assay determines the amount of CAT protein being expressed from each 
construct as CAT converts [14C]-labelled chloramphenicol (C4C]-CAM) into mono- and 
diacetylated forms. In this assay, the labelled products were separated by thin layer 
chromatography, allowing the modified forms to be separated and measured as units of 
[ 14C]_CAM converted per J.lI cell lysate. This assay was sensitive, reproducible and 
devoid of enzymatic activities of the host cell. In this section I report the effects the 
ICP27-binding sequences have on CAT activity in the presence or absence of ICP27 
and also the effects on CAT activity when sequences are inserted in the reverse 
orientation. 
3.4 Cloning isolated HSV-l sequences into the CAT 
reporter vectors 
In this study, a reporter plasmid (psvCAT) that contains a CAT gene under the control 
of an SV40 promoter, 95bp of 5' untranslated sequence and an HSV-2 IE4/5 polyA site 
(Gaffney et al., 1985) was used (Figure 3.3). psvCAT is an intronless vector and was 
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95bp 
5'UTR 
Figure 3.3 : psvCA T plasn1id. This plasmid was originally derived fron1 a pUC8 plaslnid and reconstructed 
into the CAT reporter plasmid pL WI by Gaffney et al 1985, which contained a HSV -2 IE4/5 pr01110ter and 
poly A site. R.Everett altered this vector further and the IE4/5 pr01110ter was replaced with an SV 40 pronloter. 
A single BamHI site was available for cloning into the 5 'UTR of this vector. 
chosen as ICP27 is known to affect the expression and binds preferentially to intronless 
viral transcripts (Phelan et ai., 1996' Sandri-Goldin 1998a) Th b , ,. e sequences to e 
inserted into the reporter plasmids were short (only 36 to 71 bp in Ie gth) th ~ n , erelore, 
oligonucleotides encompassing these sequences with introduced BamHI sites at both 5 
and 3' ends were synthesised. The oligonucleotides were annealed and ligated into the 
single BamHI site within the 5'UTR of the plasmid as described. The BamHI sequence 
on each annealed oligonucleotide contained a mutation from GATCC to GATCA on its 
5' end and a T on the 3' end (see Table 2.3 for list of primers). This allowed the ligation 
mixture to be digested with the BamHI restriction enzyme, eliminating re-circularised 
plasmids and preserving plasmids containing inserts. Several clones from each ligation 
were sequenced to enable each HSV -1 sequence to be identified in both forward and 
'reverse orientations (Table 3.3). Caesium chloride banded plasmid DNA prepared 
(using the large-scale preparation of DNA method) allowed the isolation of the closed 
circular DNA only. 
3.5 Quantifying expression of CAT enzyme from a 
psvCAT construct 
Each plasmid was transfected at 200, 300, 400 and 500ng per well, into BHK cells, 
using the liposome-mediated transfection method. Expression of the CAT enzyme was 
allowed to proceed for 16 h before cell lysates were harvested and the CAT assays 
performed. A transfection time of 16 h was chosen as future experiments aimed to 
include the co-transfection of a plasmid expressing ICP27, where expression of this 
plasmid for times longer than 16 h was known to be detrimental to the cells. 
Transfection of varying psvCAT plasmid DNA concentrations gave an increasing 
response of CAT activation and [14C]_CAM conversion units were calculated using the 
volume analysis function in Bio-Rad's Quantity One software. The titration assay was 
carried out for each psv plasmid discussed in the following chapters. Despite the 
observation that CAM conversion units for each transfected CAT plasmid differed, the 
structure of the curve was similar for each plasmid, giving a steady increase in activity 
as the amount of DNA transfected was increased. I have therefore included one graph as 
an example of the profile obtained for the transfected plasmids (Figure 3.4). The CAT 
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Figure 3.4 : Quantifying CATgene expression after transfection of a 
psvCAT construct. No error bars are present on this graph as thi s is a 
typical example of a CAT assay carried out after a plasmid transfectio n 
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Figure3.5: TLC plate showing the products of CAT assays carried 
out with reducing concentrations ofBHK celllysates 
60 ~----------------------------------------~ 
50 ~----------------------------------------~ 
40 ~-------1~b~----------~ 
~ 30 
.. 
e 
I-
~ 20 -1---------
1I 
10 -1----------1 
pavCAT pav212t pav2471 pav821 pav3001 
pav3341 
-10 L ________________________________________ ---' 
plasmid 
Figure 3.6: CAT activation when ICP27-binding sequences are present m 
the absence of any viral proteins (n=3)_ 
production at 400ng DNA gave a high [14C]_CAM conversion level therefore there was 
a risk of failing to detect a response to additional factors due to saturation of the assay. 
Conversion levels at 100 and 200ng DNA were low which may not have allowed the 
clear detection of a possible inhibitory affect when other factors were present during 
transfection. Transfections of all plasmids at 300ng DNA/well were chosen as a good 
response allowing the possible detection of an activation or inhibitory affect of CAT 
gene expression to be observed. The psvCAT plasmid without insert gave a consistently 
low level of CAT activity and was consequently used as a control for each transfection 
carried out. CAT assays were further carried out on 20, 10 and 2J.lI cell lysates after 
BHK cells were transfected with 300ng plasmid DNA. Figure 3.5 demonstrates a typical 
TLC plate showing the products of a CAT assay using these volumes. From these data 
2J.lI cell lysates were used in each CAT assay unless otherwise stated. To ensure 
transfection efficiencies were similar between wells a ~-gal plasmid was co-transfected 
with a psvCAT construct into BHK cells and CAT and ~-gal assays were carried out. 
These results are presented in chapter 4 and demonstrate transfection efficiencies were 
similar between wells. 
3.6 CAT gene expression increases when HSV-l 
isolated sequences are present in the reporter plasmid. 
The effect does not require HSV-l proteins and is not 
orientation dependent 
After inserting the five chosen, isolated sequences into psvCAT all plasmids plus 
psvCAT control were transfected into BHK cells as described above. CAT assays were 
performed on cell lysates and volume analysis, using BioRad software, of each 
converted [14C]_CAM band on each TLC plate was quantified and values plotted on an 
excel graph. 
CAM conversion units were considerably higher for all plasmids containing inserts 
compared to the control vector with increases ranging from 40-80 fold, depending on 
the sequence inserted (Figure 3.6). This indicates that, after transfection of the plasmid 
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into the cell, the inserted sequences enhanced CAT gene production. Interestingly, this 
effect did not involve any HSV-1 proteins, suggesting that a cellular component(s) 
possibly in association with these small inserts, located 5' to the CAT gene, aids in 
synthesis of CAT. 
Sequence analysis of the clones inserted in the forward orientation did not detect any 
obvious homologies, however, small RNA sequence or structure specificity may still be 
a factor in the 5'UTR's ability to increase CAT gene expression. To test for sequence 
orientation requirements, CAT assays were performed on extracts prepared from BHK 
cells transfected with psvCAT constructs containing the above sequences in reverse 
orientation. An increase in CAT synthesis was observed from all reverse constructs 
(Figure 3.7), except psv300R. The psv300R construct was found to have a start codon in 
its reverse inserted sequence and this gave no CAT activity after transfection. The 
results imply that properties of the viral sequences, other than orientation, were 
important, such as RNA structures or very small HSV -1 sequence motifs, for 
enhancement of CAT expression. Alternatively, the effect could be due to a non-specific 
RNA spacer with no sequence specificity at all. Furthermore, the presence of an intron 
within the 5'UTR of some CAT reporter plasmids can increase the expression of CAT. 
It was therefore postulated that by inserting these HSV -1 sequences into the 5'UTR of 
the psvCAT plasmid an intron might be created. Sequence analysis of isolates #212F, 
#212R, 247F, #247R, #82F and #82R including the 5'UTR sequence of the psvCAT 
plasmid (found 5' and 3' to the insert), was performed using software from two 
independent Internet sites that allowed splice site predictions i.e. NetGene2.com and 
Biogen.com. Results identified only a single 5' splice site in sequence #247, therefore 
by the insertion of sequences #212, #247 and #82 in both orientation, no conventional 
introns were likely to be formed. 
Later, in Chapter 4, I discuss the length of the inserted sequence and the G or C base 
content of each insert. A control sequence that was inserted into the psvCAT plasmid to 
detect any specificity for HSV -1 sequences is also discussed later. 
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Figure 3.7: CAT activation is independent of orientation of sequence. 
Sequences inserted in both forward and reverse orientations, within the 
psvCAT plasmid, activate CAT gene expression in the absence of viral 
proteins (n=3). 
63kDa ... 
... ICP27 
Figure 3.8A : Western blot analysis showing a prominent band at 63KDa 
identified as Iep27 was present when 50ng of plasmid pcmv63 was 
transfected into BHK cells for 16 h. The control plasmid, pcmv 1 0, does 
not contain the Iep27 gene. 
Figure 3.8B: Immunofluorescence data of a BHK cell transfected with 
pcmv63 and probed with an anti-IeP27 antibody (1113). 
3.7 Transiently transfected ICP27 has no effect on 
HSV-l sequence induced CAT activation 
To investigate the effect of ICP27 on CAT production when inserts were present, a 
plasmid containing the ICP27 gene under the control of a HCMV promoter (pcmv63) 
was co-transfected with the psvCAT clones. The plasmid pcmv10, which did not 
contain the ICP27 gene insert, was used as a control to ensure any affect is not due to 
the amount of DNA transfected or due to the plasmid alone. To detect any effect of the 
pcmv plasmids on CAT activity, both pcmv10 and pcmv63 were co-transfected at DNA 
concentrations ranging from 50-500ng/well. This DNA titration revealed that with both 
pcmv10 and pcmv63, CAT activity levels were reduced at concentrations greater than 
50ng/well due to a detrimental effect on the cells resulting in cell death. ICP27 was 
undetecTable by western blot using lysates from transfections of less than 50ng/well 
pcmv plasmid DNA in this assay. A value of 50ng/well pcmv plasmid DNA was 
therefore the chosen amount for transfection. This allowed the introduction of ICP27 
into the cells without any obvious cytopathic effects. Western blots were carried out on 
lysates obtained from each transfection and probed with anti-ICP27 antibody (1113) to 
confirm that ICP27 was expressed (Figure 3.8A). The transfection of pcmv63 plasmid 
DNA into BHK cells followed by immunofluorescence using an anti-ICP27 antibody 
(1113) identified the location of ICP27 as predominantly nuclear with some staining in 
the cytoplasm, using confocal microscopy (Figure 3.8B). The transfection of pcmv63 
plasmid DNA into BHK cells resulted in approximately 1: 100 cells being transfected 
with that plasmid DNA. Transfection of the pcmv63 was previously shown not to affect 
the expression of another reporter gene by co-transfecting with pcmvp-gal (Leiper, 
2004). p-gal assays and western blotting assays (probing with anti-ICP27) were 
performed and results indicated that, during the expression of ICP27, p-gal expression 
levels remained similar to levels seen when no ICP27 was present (refer forward to 
chapter 4, Table 4.1). 
Plasmids pcmv10 or pcmv63 (50ng/well) were co-transfected with psvCAT, psv212F, 
psv247F or psv82F for 16 h and CAT assays carried out on celllysates. There was no 
significant difference in the amount of CAT produced when pcmv63 or pcmv10 was co-
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transfected with the psvCAT constructs containing psv212, psv247 and psv82 (Figure 
3.9). There was also little to no difference when pcmv63 or pcmv10 was co-transfected 
with the psvCAT control plasmid. 
3.8 Analysis of RNA secondary structures using the 
Rfam database 
It was of interest to examine the RNA structures of each HSV -1 sequence found to bind 
ICP27 during the Y3-H study as compared to a database of structures of known small 
RNAs. 
Rfam is a database of structure-annotated multiple sequence alignments, covariance 
models and family annotations for a number of non-coding RNA families 
(http://www.sanger.ac.uk/Software/Rfamlindex.sht ml). Rfam contains 503 such 
families. The alignments are hand curated and aligned using available data, and 
covariance models are built from these alignments using the INFERNAL software suite 
(http://infemal.wustl.edu/). The full alignments are created by searching the Rfamseq 
database using the covariance model, and then aligning the hits above a family specific 
threshold to the model. Important sequence similarities can be analysed on the bases of 
their biological importance as information regarding the known RNA within each 
database is cited. The aim here was to enter all HSV -1 sequences previously identified 
by the Y3-H assay to bind ICP27 protein, to identify structural similarities with any of 
the small RNA structures within the Rfam library and further to note any biological 
relevance or relation to the input sequence, if similarities were encountered. 
All sequences of interest were 'trimmed' for any duplicate sequences per HSV -1 gene 
and entered into the INFERNAL program to align any possible homologues. After 
entering all 24 sequences, the INFERNAL program identified only 4 hits with 10 input 
sequences. These hits were identified as: 
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ICP27 coding region (pcmv63) or no insert (pcmvlO) (n=3). 
1) Histone 3'UTR stem loop, known to be involved in nucleocytoplasmic transport of 
the mRNA, and in stability regulation and translation efficiency in the cytoplasm (Wang 
et al., 1999). The #212 sequence gave a hit to the histone 3' RNA in Rfam. #212 is a 
63nt sequence found within the 5'UTR of the HSV -1 UL6 gene; a protein known to be 
required for the fonnation of full virion capsids and for the processing and packaging of 
replicated viral DNA. 
2) Cardiovirus CIS-acting replication element (CRE), a sequence coding for the VP2 
protein of Theiler's virus containing this element required for replication of the genome 
(Lobert et al., 1999). The #82 sequence, contained within the HSV-1 UL30 gene 
encoding the catalytic subunit of the DNA polymerase; and the #13_2 sequence found 
within the HSV-1 UL39 gene, i.e. the large subunit of the ribonucleotide reductase, 
gave a hit with the CRE RNA in Rfam. 
3) Iron response element (IRE), a sequence found in the 5'UTR of mRNAs involved 
in iron metabolism (Hentze and Kuhn, 1996). This IRE hit with six input sequences; 
#247, a sequence found within the HSV-1 RS1 gene encoding the immediate early 
transactivational protein ICP4; #16_2 sequence found within the 5'UTR of the UL4 
gene, where the non-essential function of the encoded protein is not known; #352, a 
sequence found within the RS 1 gene; #4, found within the UL34 gene; #55, found 
within the 5'UTR of the UL32 gene which encodes protein involved in viral DNA 
packaging; #12 from the UL13 gene encoding the VP57 protein involved in the post-
translational processing. 
4) Hepatitis C virus stem loop IV, found to be important in replication but not 
essential for colony fonnation by the HCV sub genomic replicon (exact function in the 
virus is not known) (Lee et al., 2004). This aligned with one input sequences, #258, 
found within the 3'UTR of the HSV-1 RL1 gene, encoding a neurovirulence factor 
involved in promoting host-cell shut-off. 
The secondary RNA structures and the score, in bits, of each sequence with a hit in 
Rfam was analysed and can be seen in figure 3.10 A, B and C. These structures were 
compared here with the secondary RNA structures obtained when analysing 
thennodynamic folding of each sequence entered into the Rfam program using the 
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from the Rfam hit and RNA structures predicted as a comparison with these 
hits. Arrows point to areas of sequence homology to indicate small regions of 
structural similarity. 
RNAfold program. The sequences in bold above that were analysed previously in this 
study (#212, #247 and #82) were further analysed for secondary RNA structures, i.e. 
these sequences were 'trimmed' to encompass only the region of sequence that was 
similar to the hit identified by Rfam. A comparison of the hit sequence structure with 
the full and trimmed input sequence is shown in fig 3.10 and reveals that there are very 
small similarities. For example, the CRE RNA structure contains a P-loop structure 
composed of bases ACAA that is also seen in the trimmed #82 RNA structure. Such 
small similarities were also observed for #212 and #82. 
The scores for hits with each input sequence ranged from 0.06 to 4.65 bits (as shown in 
fig 3.10 A, B and C) was analysed to determine the significance of each hit. According 
to the INFERNAL manual the scores greater than the log (base two) of the input 
sequence length are significant i.e 4.65 bits. That is, after analysis of each input 
sequence length and their scores, it was concluded that these hits were not significant. 
These score values remained the same for the 'trimmed' sequences shown in figure 3.11. 
In conclusion the RNA structures identified by Y3-H analysis were not similar to each 
other or significantly similar to the Rfam hits identified here, as based on the above 
criteria. That is, there were only ten sequences identified to be homologous to known 
small RNA structures from 24 input sequences and comparisons of all ten gave very low 
scores, rating them not significant. Also, the data from each Rfam hit was analysed and 
compared to the input sequence data revealing that there did not seem to be any 
biological similarities. And finally, the analysis of the RNA secondary structures of the 
Rfam hits, compared to the optimally thermodynamic RNA structures of the input 
sequence, had only very small similarities. 
3.9 Discussion 
HSV -1 sequences that bind ICP27 were found to activate gene expression when inserted 
into the 5'UTR of a CAT reporter plasmid. The increase in expression occurred for all 
plasmids (except psv300R) containing HSV -1 sequences inserted in both forward and 
reverse orientations. 
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An increase in gene expreSSIOn when cis-acting sequences are present in either 
orientation has been observed at the levels of transcription, stability and translation. 
With regards to transcription, these sequences are called enhancers and are 
transcriptional controlling elements. They are composed of sequence motifs and can act 
independently of enhancer sequence orientation and can activate transcription over long 
distances either up- or down-stream of the transcription initiation site, i.e. a remote 
control effect (White, 2001) . The best example is that of the enhancer element of the 
immunoglobulin (Ig) heavy-chain gene that increases transcription from within the 
gene, showing the potential for enhancers to be located anywhere. Increased 
transcription rates occur when a specific interaction between enhancer-binding proteins 
and components of the transcription machinery are formed by DNA looping (Ptashne 
and Gann, 1997; Wang and Giaever, 1988). Such enhancer sequences have been found 
in viruses. The long terminal repeat (LTR) of the lymphoproliferative disease (LPD) 
virus of turkeys (LPDV) contains two direct repeats (DR). Enhancer elements were 
identified within each of the DR regions and were found to be involved in positively 
regulating transcription from the viral promoter (Sarid et a/., 1995). Similar 
observations have been reported with DRs found within LTRs of RSV (Laimins et a/., 
1984a; Laimins et al., 1984b) and sequence analysis revealed an homologous binding 
site for a transcription factor, enhancer factor III (EFIII). Regulation of HIV-1 
transcription is also, in part, by enhancer elements located in the LTR. The enhancer 
elements identified in the L TR were cloned into a CAT vector and were shown to 
stimulate transcription independent of position and orientation to the promoter (Verdin 
et al., 1990). In the study presented here, an increase in CAT activity by HSV-1 
sequences in either orientation could in principle occur at the level of transcription. To 
confirm whether these sequences act as enhancers, further experiments would include 
inserting the sequences of interest upstream of the promoter or in the 3 'UTR of the 
psvCAT vector. If these HSV-1 sequences were acting as enhancers, CAT activation 
would be observed in cells transfected with plasmids with inserts at all locations. A 
search to identify any possible transcription factor binding sites was carried out using all 
sequences investigated here at the TFSEARCH website 
(http://www.cbrc.jp/researchldb/TFSEARCH.ht ml) holding a database of 1.+83 
sequences of known transcription factors binding sites. No relevant transcription factor 
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binding sites were identified using this database however thl'S s h' b 
, earc IS y no means 
exhaustive and further searches should be undertaken. 
Another level of activity of the HSV -1 sequences could be in regulating RNA stability 
ultimately resulting in an increase in expression. Sequences found in the 3'UTR of a 
luciferase gene were found to stabilise RNA, in a sequence orientation-independent 
manner. The length of the 3'UTR was the regulating factor resulting in an increase in 
translation as the sequence length increased (Tanguay and Gallie, 1996). However, the 
HSV -1 sequences under investigation in this study are all located in the 5'UTR. 
Sequences within the 5'UTR of ornithine decarboxylase have been reported to have a 
position-dependent but orientation-independent effect on translation. However, this 
effect is to suppress translation and is thought to be due to the sequence forming a very 
sTable hairpin structure thus inhibiting translation initiation (Grens and Scheffler, 
1990). The presence of HSV -1 sequences, investigated in the study presented here, 
result in an increase of gene expression making it improbable that these sTable 
structures are formed. 
Activation of gene expression by ICP27-binding sequences occurred when no other 
viral proteins were present, indicating the possible recruitment of a cellular factor(s). 
Cellular multifunctional proteins that have comparable functions to ICP27 should be 
investigated to further this proposal. Candidates for investigation might be shuttling 
proteins with a regulatory role that are involved in RNA binding. The Y -box proteins 
are one such group of multifunctional regulatory proteins. Y -box proteins are RNA-
binding proteins involved in translational silencing of several maternal RNAs by 
exporting the transcripts to the cytoplasm and destabilising RNA secondary structures 
(Jiang et aI., 1997). They also bind DNA via a consensus sequence (ATTGG) (the Y-
box) and regulate transcription of many cellular genes (Sommerville, 1999). The 
coupling of the regulation of transcription and translation is a conserved feature of these 
proteins (Sommerville, 1999). The Y -box proteins function to silence gene expression 
whereas the possible involvement of a cellular protein, in this study, increases CAT 
gene expression suggesting that these Y -box proteins may not playa role in CAT gene 
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expression when HSV -1 sequences are present. The multifunctional protein hnRNP K 
has roles in the regulation of gene expression that includes transcription splicina 
, b' 
translation and mRNA stability, comparable to HSV-1 ICP27. Generally, hnRNP K is 
involved in both transcriptional and translational repression, however a few reports have 
revealed that this multifunctional protein can also activate transcription and translation. 
Evans et aI, (2003) described hnRNP K as a transcription factor and demonstrated its 
ability to increase specific RNA synthesis by interaction with an element found 
upstream of the c-myc gene. Furthermore, hnRNP K was shown to interact with the 
TATA-binding protein indicating hnRNP K binds a specific cis-acting element and 
interacts with the RNA polymerase II machinery to stimulate transcription (Evans et aI., 
2003; Michelotti et aI., 1996). HnRNP K also increases translation of the c-myc protein 
in an IRES-independent manner (Evans et aI., 2003). A further similarity of hnRNP K 
to ICP27 is their protein structure, both containing an RNA binding domain, three KH 
domains, an acidic domain and an NLS (Bomsztyk et aI., 1997). This protein is a prime 
candidate for further research here as, not only does hnRNP K have similar functions 
and protein structure, it is known to bind ICP27 (Wadd et aI., 1999). As wt HSV-l 
infection proceeds it is not known if ICP27 recruits the functions of hnRNP K thus 
facilitating it through the cellular pathways. Alternatively ICP27 may be hijacking 
hnRNP K's role and subsequently inactivating it. 
The activation of gene expression was not altered when ICP27 was introduced by 
expression from a transfected plasmid, indicating that other viral proteins may have 
been required to work in conjunction with ICP27 to give a possible effect, or perhaps 
ICP27 did not function in this assay. However, complementation assays identified that 
ICP27 expressed from the pcmv63 plasmid, used in this study, was functional resulting 
in wt HSV-1 titres when expressed during an ICP27-null HSV-1 infection (Leiper, 
2004). 
ICP27 has been known to require other viral proteins to function efficiently. ICP27 can 
function independently or in combination with other viral proteins. ICP27 can trans-
activate the HSV-1 gB promoter to induce expression of CAT, however this level of 
expression is significantly increased in the presence of ICPO and ICP4 (two HSV -1 IE 
proteins) (Rice and Knipe, 1988). However, ICP27 absolutely requires both ICPO and 
ICP4 to trans-activate the HSV -1 TK promoter possibly forming a complex to give this 
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synergistic effect (Everett, 1986). The trans-repressor function of ICP27 was also 
observed when activation of expression by ICPO was reduced in the presence ofICP27, 
depending on the HSV-l promoter used (Hardwicke et al. 1989· Sekulovich t I 
" ea., 
1988; Su and Knipe, 1989). Therefore, in the investigation presented here, the inability 
of ICP27 alone to alter gene expression was not altogether unexpected given the 
requirements for other viral proteins in the regulation of other genes. Furthermore, the 
simultaneous reduction of host cell factors that would normally occur during HSV-1 
infection may also be necessary for an effect of ICP27 to be seen. In this assay, the host 
cell factors involved in gene expression were almost certainly still being expressed, as 
the cells continued to grow, when ICP27 was introduced thus possibly masking the 
effect of ICP27. This may have a diminishing affect on the ability of ICP27 to bind 
these sequences possibly through competition with cellular RNA binding proteins, 
and/or the ability to activate gene expression due to the presence of cellular proteins that 
would normally be reduced during a wt HSV-l infection. Moreover, perhaps ICP27 
requires to be modified (e.g. phosphorylated) by another HSV -I-specified protein, thus 
transiently transfected ICP27 would be rendered inactive for this activating function 
The sequences identified to bind ICP27 using the Y3-H system show little similarity to 
each other leading to the idea that perhaps there was a similarity in RNA structures. 
Comparisons of HSV -1 RNA structures with small RNA structures with known biology 
did not significantly detect any similarity with any small RNAs in the Rfam library. 
However, it should be noted that this search is not exhaustive as the Rfam database is 
relatively new and the input data are constantly being updated. Continual screens should 
be carried out to compare the HSV -1 sequences isolated and identified from the Y3-H 
study with new input sequences of the Rfam database. 
Bioinformatic studies on these HSV -1 RNA secondary structure formations can be 
furthered by the application of several other computational methods. Programs for 
thermodynamic predictions and free energy calculations are continuously being 
developed. A further prediction method that includes sequence scanning for covariant 
sites alongside associated secondary structures has recently been developed. This 
method can produce extensive information on the formation of RNA secondary 
structures thus linking the identified RNA structure (e.g. a small stem loop) to an 
essential function of the virus (e.g. replication) (Tuplin et aI., 2002; Turner et ai., 2004). 
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Chapter 4: During HSV-l infection, ICP27 
regulates transfected CAT gene expression via 
short HSV-l RNA sequences 
4.1 Introduction 
ICP27 acts to enhance viral gene expression and in some cases works in conjunction 
with ICPO and ICP4. ICP27 can transactivate the expression of gC and gB without the 
presence of other IE proteins, however, some viral promoters require the presence of 
ICP4, ICPO or both for the regulation of certain (early and late) genes, e.g. TK and 
VP5, HSV-1 early and late gene, respectively (Everett, 1986; Knipe, 1989; Rice and 
Knipe, 1988; Sekulovich et ai., 1988). 
The inability of transfected ICP27 to activate CAT gene expression via the Y3-H 
identified binding sequences in vivo (Chapter 3) was not altogether unexpected. 
ICP27 has such a range of functions and partner proteins during an HSV -1 infection 
that transiently transfected ICP27 alone may not be sufficient to elicit an effect on the 
expression of CAT. The observation that transiently transfected ICP27 does not 
significantly affect CAT gene expression, along with previous work revealing that 
ICP27 associates with ICPO and ICP4, suggests that perhaps other viral proteins are 
required to affect CAT gene expression in conjunction with ICP27. For this reason it 
was decided to study the effect of ICP27 on CAT activation during productive 
infection. This approach would introduce all viral proteins required for ICP27 
interactions and furthermore lead to a productive infection, with consequent host-cell 
shut-off. This would allow ICP27 to carry out its functions in the presence of its 
partner proteins and in reduced levels of cellular factors. 
The identified ICP27-RNA binding sequences did not bind to ICP27 (or binding was 
severely reduced) when the protein was present in mutant form (M15 and d4-5) in the 
Y3-H assay, confirming the ICP27 interaction with this range of HSV -1 RNAs 
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(Sokolowski et al., 2003). Three rCP27 mutant viruses, 27LacZ, d4-5 and M15, were 
used in the studies presented here. Mutant 27LacZ lacks the rCP27 coding sequences, 
and d4-5 rCP27 lacks an RGG box RNA binding domain. The M15 ICP27 is unable 
to shuttle and the protein's transactivation function is inactivated. The effects of 
infection with these viruses were investigated in the CAT expression system described 
in chapter 3. 
4.2 CAT gene expression during HSV-l infection 
BHK cells were transfected with each of the psvCAT constructs independently and 
incubated for 6 h to allow expression of CAT protein to commence. Subsequently, the 
cells were infected with wt HSV -1 to introduce all viral factors including ICP27. To 
optimise plasmid CAT directed gene expression during infection, transfected BHK 
cells were infected with wt HSV-1 for 16 h at a range of Mor from 0.1-10. The 
maximum level of CAT gene expression was observed at an MOr of 1, which was 
used throughout these experiments unless otherwise stated (fFigure 4.1A). Infections 
with wt HSV-1 at MOrs of 5 and 10 also elicited an increase in CAT expression 
levels, however, this proved to be detrimental to the BHK monolayer and led to cell 
death leaving very few cells for protein extraction. 
To ensure transfection efficiencies were similar, constructs psv212F and 212R were 
co-transfected with 200ng of a ~-gal plasmid (pcmv~-gal) into BHK cells for 6h, in 
duplicate. Each well of transfected cells was subsequently mock or wt HSV-1 
infected, harvested after a further 16h and celllysates obtained. ~-gal and CAT assays 
were performed using the cell lysates obtained and results identified a significant 
increase in CAT expression when comparing cells that were mock and wt HSV-1 
infected, while ~-gal values remained very similar (Figure 4.1B and Table 4.1). This 
preliminary data indicates transfection efficiencies between cells in each well were 
similar. 
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PlasmidlInfection 
psv212F 
psv212R 
Mock infection 
0.361 
0.337 
Wt HSV-l infection 
0.3 16 
0.341 
Table 4.1: ~-gal values obtained after co-transfection of psv212 and p~ -gal 
plasmid DNA followed by mock and wt HSV -1 infection. 
500 ~--------------------------~~--~----~ CI mock Inf.ctlon 
• wt HSV· 1 Infection 450 +------------+-------T------~~~~--~~ 
.c t ' of insert-containing Figure 4.2: CAT activity following tranSlec IOn 
plasmid DNA and infection with wt HSV -1 (n=3). 
4.3 During wt HSV-l infection, CAT gene expression 
is enhanced. 
Plasmids psv212, psv247, psv82, psv334 with HSV-1 DNA inserts and control 
plasmid, psvCAT, were transfected into BHK cells and after 6 h cells were then 
infected with wt HSV -1 and incubated for a further 16 h. Assays carried out on the 
resulting celllysates revealed an enhancement of CAT activity when HSV-1 proteins 
were present as compared to levels observed during mock infection (Figure 4.2). As 
HSV -1 infection proceeds different viral factors could possibly influence the increase 
in CAT expression. However, as the inserts at the 5'UTR of these psvCAT plasmids 
were identified as ICP27 RNA binding sequences, it would appear likely that the 
presence of ICP27 during HSV-1 infection might playa role in the altered CAT 
activation levels. For example, after mock infection of psv247 transfected cells a 
value of 22 ± 3 CAM units was obtained. In contrast, infection with wt HSV-1 
resulted in a value of 387 ± 87 CAM units (Figure 4.2). This is a dramatic response to 
infection with the reporter plasmid carrying ICP27 binding sequences, for when the 
sequences are absent, i.e. psvCAT, and virus infection proceeds, the CAT activity 
only reached 30 ± 19 CAM units .. However, even though this level of activity for 
psvCAT is considerably lower than the levels seen with the insert-containing 
plasmids, the fold increase calculated from CAT activity levels reached during mock 
infection to those reached during wt HSV -1 infected levels is much higher when there 
is no insert present. That is, a 56 fold increase in CAT activity was calculated for cells 
transfected with psvCAT as compared to only a 8-17 fold increase for cells 
transfected with insert-containing plasmids, when comparing mock to wt HSV-1 
infections (Table 4.2). However, it should be noted that the background levels of 
activity reached when no viral proteins and no insert sequences are present (i.e.mock 
infected cells with a psvCAT DNA transfection) are extremely low thus making it 
difficult to calculate an accurate fold increase in CAT activity upon HSV-1 infection. 
These results suggest ICP27 is having a negative effect on CAT gene expression due 
to the presences of the insert sequences. 
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Transfected Plasmid psvCAT psv212 psv247 psv82 psv334 
F old increase in C AT activity 56 .74 8.7 17.35 8. 8 12.22 
Table 4.2: Fold increase in eAT t· · fr 
k 
. . ac IVlty om levels reached d . 
moc mfectIOn to those reached during wt HSV 1 ..c . un ng 
- mlectlOn. 
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Figure 4.3: Western blot analysis of BHK cell lysates infected wi th wt 
and Iep27 null HSV -1 viruses [AJ and Iep27 mutant viruses [BJ to 
indicate the absence or presence of the immediate early protein ICP27 
during these infections. The presence of immediate early protein ICPO is 
also shown [AJ. The Iep 27 band seen during the d4-5 infection is sli ghtl y 
smaller than wt Iep 27 due to the RGG box deletion. 
4.4 Enhanced CAT gene expression during wt HSV-l 
infection is not dependent on the orientation of the 
inserted sequences. 
In the absence of virus, there was no detectable difference in CAT activation when 
forward or reverse orientations of the HSV-I sequences were compared (Figure 3.4). 
However, when all viral proteins are present during infection, it was anticipated that 
the effect of ICP27 in regulating CAT gene expression, via these ICP27-binding 
sequences, would be an orientation specific effect because sequences in reverse 
orientation might not be recognised and would not be expected to affect CAT gene 
expression. Sequences #212, #247, #82 and #334 were inserted into the 5'UTR of the 
psvCAT plasmid in the reverse orientation and plasmids containing these sequences in 
both forward and reverse orientations were transfected into BHK cells separately for 6 
h. Cells were subsequently infected with wt HSV -1 for 16 h and lysates were obtained 
for analysis. Western blot analysis confirmed that ICP27 was expressed during 
infection (Figure 4.3A). Unexpectedly, little difference in CAT activity was observed 
between cells transfected with plasmid containing the sequences in the forward or the 
reverse orientation (Figure 4.4). Only psv82 sequence in the reverse orientation gave a 
drop in value from 375 ± 91 to 79 ± 18 CAM units which was probably due to the 
presence of two consecutive ATGs not in-frame with the CAT ORF. One ATG codon 
before the initiation codon for CAT; this upstream ATG was not in frame with the 
CAT initiation codon. Therefore, translation initiation at the upstream ATG would not 
generate a protein encoding CAT. Hence, CAT enzyme activity would not be detected 
for plasmid psv300R. All sequences presented here contain the Kozak consensus 
sequence of a G at position +4 (Kozak, 1997). Again, these results suggest that the 
sequences in reverse orientation were also recognised by ICP27 during wt HSV-1 
infection giving a reduced fold increase in CAT activity when compared to activity 
when no ICP27-binding sequences were present. There may be a small motif present 
in the sequences, in both orientations, that may be responsible for the decrease in 
CAT activity. To detect possible motifs present in both orientations of each insert, 
each sequence insert was analysed for palindromes of 7 -10 nucleotides in length. Only 
one insert (#247) contained a palandromic sequence, leading to the conclusion that a 
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sequence motif of 7-10 nucleotides in length is not responsible for the decreased 
enhancement in of CAT gene expression when these sequences were present in both 
orientations. This result could also imply the recognition of very small HSV-l 
sequences or structures. These issues are investigated further and discussed later in 
this chapter. 
4.5 Characteristics ofHSV-l lCP27 mutant viruses 
To identify the role lCP27 plays in the expression of CAT when lCP27 binding 
sequences were present, a range of HSV -1 lCP27 mutants were used. Experiments 
were carried out to gain a profile of each mutant virus as compared to wt HSV-l 
infections. Here, three lCP27 mutant/deletion viruses are described and a protein 
expreSSIOn profile of each VIruS was gained by immunoblotting and 
immunofluorescence analysis. 
BHK cells were infected with a particular virus at an MOl of 1 for 7 h. Extraction of 
total cell protein was carried out (Chapter 2.2.6.1) and protein concentration was 
determined using a Bradford assay. SDS-PAGE was performed using 10~g of each 
extracted protein sample per lane and proteins were later subjected to western 
blotting. Each blot was probed with antibodies raised against six HSV -1 proteins (see 
Materials and Methods Table 2.1). Basic properties of these six HSV-l proteins are as 
follows: 
1. lCP27: previously described 
2. US 11: a L-2 gene that encodes a 21kDa protein with DNA binding properties 
and is located within the nucleolus. The US 11 gene product is not essential for 
viral growth. 
3. UL44: is an unspliced L-2 gene that encodes glycoprotein C (gC). gC is a 
130kDa non-essential membrane protein possibly involved in membrane 
attachment that is processed before incorporation into the virion and plasma 
membrane. 
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4. UL38: a L-2 gene that encodes VP19C a minor component fth . 
, 0 e outer capsId 
shell that is involved in scaffold formation It has a I I .gh 
. mo ecu ar WelD" t of 
53kDa. 
5. UL19: encodes the essential viral protein VP5 (L-l), a major component of the 
viral capsid shell with a molecular weight of 150kDa. VP5 is not only required 
for capsid formation but also for the cleavage of viral DNA into unit-length 
genomes. 
6. UL26.5: encodes a 45kDa L-l capsid protein found in a complex with UL38 
and ULI9. Though not essential for viral growth, the virus progeny from a 
UL26.5 null mutant is severely reduced. 
4.5.1 Characteristics of the HSV-l ICP27 deletion mutant 27LacZ 
The replication-defective mutant virus, 27LacZ, is a virus in which the ICP27 gene 
has been interrupted by the insertion of the LacZ gene thus no ICP27 protein is 
translated. The 27LacZ virus was originally used to investigate the post-
transcriptional regulatory functions of ICP27 and it was found that although some late 
genes were transcribed, their translation was severely reduced, as also observed 
during other ICP27 mutant virus infections (Sandri-Goldin and Mendoza, 1992). Viral 
DNA synthesis does not occur during 27LacZ virus infection, which is reflected in the 
severely reduced expression levels of certain L-2 genes. Furthermore, after 27LacZ 
infection, host shutoff does not progress (Ellison et aI., 2005; Hardy and Sandri-
Goldin, 1994). 
BHK cells were infected with 27LacZ virus, celllysate~ obtained and western blotting 
analysis was performed. Figure 4.5 confirms that ICP27 is not present at a detectable 
level during infection. Analysis of RNA levels during 27LacZ virus infection using an 
ICP27 probe revealed no detectable levels of ICP27 RNA (data not shown) 
confirming that no ICP27 was present during these infections. With respect to L-2 
gene expression, levels of US 11 were severely reduced and expression of gC and 
UL38 were undetectable. Analysis of L-l gene products revealed that the level of 
UL19 expression was reduced and the level of UL26.5 protein was severely reduced 
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(Figure 4.5). The above results reveal an overall detrimental effect on all late aenes 
b 
analysed here. 
4.5.2 Characteristics of HSV -1 VIruS infection when ICP27 shuttling is inhibited 
(MIS) 
The HSV-1 ICP27 mutant virus, M15, has a two amino acid substitution at amino 
acids 465 and 466, in a region of the protein that is very closely conserved throughout 
the herpesviruses, changing amino acids 465 and 466 from PG to LE (Figure 4.6A). 
Infection with this virus was found to abrogate the transactivational properties of 
ICP27 yet leaves the transrepressor activity intact (Rice and Lam, 1994). Analysis of 
virus kinetics revealed that the MIS virus infection exhibited an inability to fonn 
plaques, indicating the MI5 mutation is lethal to the virus and reveals that this 
mutation inactivated an essential function of ICP27. Furthermore, viral yield assays 
revealed MI5 virus infection to be severely restricted for growth. Viral gene 
expression analysis showed enhanced immediate early gene expression (ICP4 and 
ICP27) and a slight enhancement of early gene expression (ICP8), as seen with the 
ICP27 null virus d27-1. M15 virus infection exhibits a slight reduction in the 
expression of L-1 genes (ICP5 and ICP25), whereas L-2 gene expression was not 
detected (ICPl-2 and gC). Northern blot analysis demonstrated that the MIS virus 
was unable to induce the expression of gC mRNA giving an almost 30-fold reduction 
as compared to wt HSV-I virus(Rice and Knipe, 1990). Overall, MIS failed to repress 
IE and E gene expression while also failing to induce L-2 gene expression, a loss of 
both transactivation and transrepression functions. 
Although this MI5 mutation alters these important functions of ICP27 another 
striking effect of this mutation is that it renders the protein completely unable to 
shuttle, as determined by heterokaryon assays. 
While the MI5 defects are lethal to the virus and to the function of ICP27 it was 
interesting to note that this mutation does not affect viral DNA replication, which is 
comparable to wt levels (Rice and Lam, 1994). Again, infection with the MIS mutant 
virus resulted in cells that did not progress into host shutoff. 
79 
[A] 
[8] 
1 
ICP27 
2 
UL38 
1 2 3 
[C] [i] 
3 
63KDa 
46KDa 
1 
US11 
2 
Mutation 
465,466 
PG to LE 
288 J i D 45J 512 
IKH1 IKH2 1 I KH3 / 
368 421 
3 
21KDa 
1 
UL44 
2 
UL26.5 
3 
UL19 
123 1 2 3 
150 
KDa 
[ii] 
Figure 4.6: Analysis of the HSV-I ICP27 mutant virus, MIS. 
A cartoon of ICP27 protein [A] indicating the point mutations PG-LE at 
a.a.465 and 466 to affect the carboxy domain of the protein. Western blots 
[B] for a range of HSV -1 proteins expressed during mock (lane 1), wt HSV-
1 (lane 2) and MIS (lane 3) infections. Immunofluorescence [C) carried out 
on BHK cells infected with MIS virus (i) or wt HSV -1 (ii) revealing the 
localisation of ICP27. 
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During the investigation presented here, viral late gene expression during M 15 virus 
infection was analysed for L-2 gene expression and revealed that UL44 was not 
detectably expressed and levels of US 11 protein were severely reduced (Figure 4.6B). 
The UL38 and UL19 protein expression were also reduced and UL26.5 protein was 
not detectably expressed. 
IF data revealed that the M15 ICP27 protein localised to the nucleus in a punctate 
pattern and furthermore, no ICP27 protein was detected in the cytoplasm (Figure 4.6 
[C][iJ). This data confirms previous reports on the location of virally expressed M15 
ICP27 and indicates a defect in ICP27's ability to shuttle (Mears and Rice, 1998). 
4.5.3 Characteristics ofHSV-l when the RGG-box of ICP27 is deleted (d4-5) 
ICP27 has a nuclear import and export signal allowing nuclear shuttling of the ICP27 
protein (Soliman et aI., 1997). As ICP27 also affects the export of lEllO and UL15 
viral transcripts (Phelan et aI., 1996) it was speculated that ICP27 was involved in 
RNA binding. It contains an arginine/glycine-rich (RIG) domain, and such domains 
have been previously reported to playa role in RNA binding. This RlG- rich domain, 
termed the RGG box, is composed of 15 RIG residues spanning amino acids 138-152 
and a direct interaction of this domain alone with RNA transcripts has been 
demonstrated (Mears and Rice, 1996a) (Figure 4.7 A). 
A recombinant HSV -1 VIruS containing ICP27 with the RGG box deleted was 
constructed (d4-5) which was shown to have a 58-84 fold defect in growth. This 
reflected the severely reduced viral DNA levels seen during this mutant virus 
infection. Interestingly, d4-5 virus infection in cells results in host shutoff (Mears et 
aI., 1995). 
BHK cells infected with d4-5 virus were analysed for viral late gene expreSSIOn. 
Levels of ICP27 protein are higher in the d4-5 infection as compared to wt levels. 
Interestingly, levels of two true late proteins (gC and US 11) were significantly 
reduced however another true late protein, UL38, gave levels slightly higher than 
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Figure 4.7: Analysis of the HSV-1 ICP27 mutant virus, d4-S . 
A cartoon of ICP27 protein [A] indicating the deletion at the amino dom ain 
of the protein i.e. the RGG region a.a.139-1S3. Immunoblot analysis [B] for 
a range of HSV -1 proteins expressed during mock (lane 1), wt HSV -1 (lane 
2) and d4-5 virus (lane 3) infections. Immunofluorescence [C] carried out 
on BHK cells infected wi th d4-S virus (i) or wt HSV -1 (ii) revealing the 
localisation of ICP2 7. 
45KDa 
those seen in wt infection. Both leaky-late protein levels "'1 . 
remam SImI ar to wt (FIgure 
4.7B). 
Immunofluorescence showed that d4-5 ICP27 10calI'sed t th 1 
o e nuc eus and the 
cytoplasm (figure 4.7 [C][i]). This pattern is similar to wt ICP27 1 l' . 
oca IsatlOn, 
however, there was no ICP27 detected within the nucleolus in the d4-5 infected cells. 
This was not unexpected as the RGG domain overlaps the nucleolar localisation 
signal (NuLS). The NuLS has been mapped to amino acid 110-152 (Figure 1.12). The 
loss of the NuLS may also playa vital role in the viability of the virus and should not 
be disregarded. Conversely, the disruption of the NuLS may have an affect on the 
phenotype of this virus. 
4.6 Infection with an HSV-l ICP27 deletion mutant 
virus does not enhance CAT gene expression when 
ICP27 binding sequences are present • In either 
forward or reverse orientations. 
The 27LacZ virus is an ideal candidate to confirm ICP27's role in the expression of 
CAT in the transfectionlinfection assay. During infection, 27LacZ successfully enters 
the cell and releases a full set of tegument proteins and continues with the synthesis of 
all immediate early proteins with the exception of ICP27. This includes the 
transcription transactivator ICP4 and the activator of gene expression, ICPO, two 
major regulatory proteins of the virus known to work in conjunction with ICP27. As 
these viral transcriptional and translational activators are present during 27LacZ 
infection, any change in CAT activity, as compared to wt HSV -1 infection, would 
give an indication of the magnitude of ICP27's role in this assay. 
BHK cells were transfected with plasmids psv212, psv247, psv82 and psv334, having 
inserts in both forward and reverse orientations, for 6 h and subsequently infected 
with 27LacZ for a further 16 h. Virus infection was verified by Western blot analysis 
using anti-ICP27 antibody and an anti-ICPO antibody. As all immediate early proteins 
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except ICP27 are expressed during 27LacZ infection, ICPO (an immediate early 
protein) should be present during this infection. Western blot analysis confirmed that 
ICP27 was not detected during the 27LacZ infections whereas ICPO was present at 
normal levels (Figure 4.3A). 
Celllysates were also assayed for CAT activity. During 27LacZ virus infection CAT 
activation was limited for all insert-containing plasmids and the enhancement of CAT 
activity as seen during wt HSV -1 infection was almost lost (Figure 4.8). For example, 
CAT activity for lysates of psv247 transfections reached 387 ± 87 CAM units when 
cells were infected with wt HSV-l and only reached 42 ± 36 CAM units when 
infected with 27LacZ. The activity levels obtained with the virus lacking the ICP27 
gene were very near to mock-infected levels, that is, all insert-containing plasmids 
gave a slight increase but remained within the experimental error (except psv212r) 
when compared to mock-infected cells. A certain level of increase in CAT levels was 
predicted upon 27LacZ infection as this virus expresses all other IE proteins including 
the transcription transactivators protein ICP4. 
The data strongly indicate at least an indirect role for ICP27 when CAT expression is 
altered during wt HSV -1 infection, possibly in conjunction with cell factors. The 
inability to increase CAT gene expression, during 27LacZ infection, was not 
orientation dependent as again both forward and reverse orientations of the inserts 
showed little enhancement of CAT activity. It is also important to note that during the 
27LacZ infection the cell does not progress into host-cell shut-off, as seen during wt 
HSV-I infection, and this may suggest that the ICP27-dependent difference in CAT 
activation between wt HSV -1 and 27LacZ could be greater than the values discussed 
here. Furthermore, perhaps a cellular protein that destabilises RNA is being down 
regulated during wt HSV -1 infection thus leading to CAT mRNA stability. 
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Figure 4.8: CAT levels obtained when psvCAT constructs were transfected and 
cells subsequently infected with a mutant HSV -1 virus that does not express 
ICP27, 27LacZ (n=3). 
4.7 Infection with an expressing HSV-I ICP27 mutant 
containing a 2 amino acid mutation that abolishes 
shuttling of the protein (MIS) fails to enhance CAT 
• gene expressIon. 
During the Y3-H analysis (Sokolowski et al., 2003), the MI5 mutation severely 
reduced or abolished binding to RNA transcripts originally found to bind wt ICP27. 
MI5 has been shown not to shuttle and this mutation affects late gene expression. 
Furthermore, an MI5 infection does not enter into host-cell shut-off. Therefore, to 
determine whether these functions affect the production of CAT enzyme from a 
vector with ICP27 binding sequences, infections with the MI5 mutant virus were 
carried out. 
Plasmids psvCAT, psv2I2f, psv247f, psv82f and psv334fwere transfected into BHK 
cells, which after 6 h cells were infected with the MI5 virus and left for a further 16 h. 
Western blot analysis confirmed expression of ICP27 during this infection (Figure 
4.3B). Figure 4.9 shows the CAT levels obtained when the insert sequences are 
present and following MI5 mutant virus infection. The levels of CAT activity were 
comparable to those seen in mock-infected cells. As with 27LacZ, cells infected with 
MI5 are defective in host-cell shut-off. To investigate the contribution of virion host 
shut off in this investigation, a virus was used that expressed a defective ICP27 
protein yet retained the ability to enter the cell into host-cell shut-off and produce 
almost normal levels of progeny virus. 
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4.8 The ICP27 mutant virus d4-5, that lacks the RGG 
box RNA binding domain, does not upregulate CAT 
gene expression when ICP27-binding sequences are 
present 
Binding of HSV -1 transcripts to ICP27 protein was abolished or severely reduced 
when the mutant d4-S ICP27 protein was used during the Y3-H assay (Sokolowski et 
ai., 2003), highlighting the importance of the RGG box at binding the viral transcripts 
identified. Notably, cells infected with this virus display host-cell shut-off. Thus it 
was decided that the d4-S virus was an important control virus to use in these 
experiments. 
BHK cells were transfected with psvCAT, psv212, psv247, psv82 and psv334 for 6 h 
and subsequently infected with d4-S virus for a further 16 h. Western blot analysis 
was carried out on celllysates using anti-ICP27 antibodies. ICP27 was present during 
the d4-S infection giving a band slightly smaller than that of wt ICP27 (Figure 4.3B). 
The CAT assays carried out on the celllysates are shown in Figure 4.10. All insert-
containing plasmids gave only low levels of CAT with the d4-S virus. These levels 
were 0.8-1.S fold higher than mock infected levels and are comparable to the 1-3 fold 
increase obtained following 27LacZ infection. This indicates that enhanced CAT 
expression, as seen during wt HSV -1 infection, requires the RGG box RNA binding 
domain of ICP27. Furthermore, host-cell shut-off does not seem to be a major factor 
in CAT gene expression as ICP27 mutant viruses that do and do not progress into 
host-cell shut-offboth give limited CAT expression levels. 
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4.9 Effects of truncations of insert #212 on CAT gene 
• expressIon 
RNA isolate #212 is a 63-nucleotide sequence found 46 nucleotides upstream of the 
UL6 (y1) start codon. This RNA sequence is sufficient to activate CAT gene 
expression in the absence of any viral proteins. Also, during HSV -1 infection a 
dramatic increase in CAT activity, from 41 to 365 CAT units, was observed when this 
sequence was present in the 5'UTR of the CAT reporter plasmid. All sequences 
inserted into the CAT vector behaved similarly in terms of effect on CAT activity 
(except #82r). Plasmid psv212 plasmid transfections and consequent CAT activity 
analysis was repeated with this plasmid more than any other (at least 20 times), 
revealing a relatively consistent level of activity. Isolate #212 was therefore 
considered to be a suitable candidate to manipulate in order to establish the minimum 
sequence requirements for CAT activation. 
The #212 sequence was divided into three sections; bases 1-30, 31-63 and 15-35 
(Figure 4.11). Oligonucleotides were synthesised, annealed and ligated into the CAT 
plasmid as previously described. Sequencing verified that each oligonucleotide was 
inserted in the sense orientation. The psv212 truncated constructs, psv212 full length 
and psvCAT alone were transfected into BHK cells and after 16 h cell lysates were 
isolated and used to determine CAT activity levels. 
When the truncated #212 inserts were present in the CAT plasmid, expression levels 
increased significantly as compared to psvCAT alone. CAT expression levels 
obtained with 1-30 and 15-35 were very similar to values obtained with the full-length 
sequence present (Figure 4.12). The truncation 31-63 gave a lower level of CAT 
conversion units (15 ± 5 units) when compared to the full-length sequence (35 ± 10 
units). However, this reduced value was still significantly higher than psvCAT alone, 
showing that this short sequence stimulates CAT gene expression. 
As transfection with truncation 15-35 elicited a good response this truncation \vas 
further cropped and inserted into psvCAT as15-24 and 25-35. The transfected 
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Figure 4.12: CAT actlvlty levels obtained when truncations of the 
#212 isolate were inserted into the psvCAT vector and transfected into 
BHK cells. The numbers refer to the nucleotides present from sequence 
#212 (n=3). 
psvCAT reporter plasmids containing these small sequences gave elevated levels of 
CAT activity (Figure 4.12), however, the values were severely reduced and variable 
when compared to full length #212. The reduction observed dun' tr c:' . 
ng anslectlOn wIth 
both plasmids indicates that there is a possible loss of interaction between host cell 
factors and the inserted sequence, or perhaps the actual size of the sequence itself had 
an effect on expression. 
4.10 Control sequences inserted into the 5'UTR of the 
CAT reporter plasmid identifies possible 
requirements for stimulation of CAT expression 
When ICP27 binding sequences are present in the 5'UTR of a CAT expression vector 
the regulation of CAT gene expression is altered by vir ally expressed ICP27. To 
investigate the specificity of the sequences involved in these effects, a non-HSV-1 
sequence, the negative regulatory element (NRE) of human papillomavirus type 16 
(HPV-16), was used as a control. 
HPV -16 is a member of the papovaviridae family of double stranded DNA viruses. 
The HPV -16 late gene (L 1 ORF) 3'UTR contains the NRE and during an investigation 
using the L1 3'UTR in a CAT expression vector, expression was reduced 100 fold 
when the NRE was present in the plasmid, as compared to the control plasmid with 
the NRE deleted precisely (Kennedy et al., 1991). The NRE is 79 nucleotides in 
length, and the 3' portion contains a GU rich domain. This domain binds to RNA 
processing factors such as U2AF65 (Dietrich-Goetz et ai., 1997), HuR (Koffa et ai., 
2000) and SF21 ASF (McPhillips et al., 2004). The GU-rich sequence exerts a negative 
regulatory effect when expressed in the 3'UTR of the late gene and additionally in the 
3'UTR of the CAT reporter gene originally used to detect the element. The NRE 
simultaneously forms a complex with several proteins and functions through diverse 
mechanisms (Cumming et aI., 2003; McPhillips et ai., 2004). The complex has a 
function in RNA stability (Kennedy et al., 1991; Tan et ai., 1995), and causes nuclear 
retention of transcripts (Koffa et ai., 2000). Preliminary experiments carried out by 
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Jim Scott (Institute of Virology, University of Glasgow) identified that R;.~A 
transcribed from the NRE sequence did not bind to ICP27 in gel shift assays. For this 
reason the NRE sequence was used as a non-HSV-l, non-ICP27 binding control. 
The NRE sequence was synthesised by PCR using primers (Table 2.3), that allowed 
the introduction of BamHl sites at both 5' and 3' ends, under the conditions as 
described in Methods 2.2.1. The PCR product was digested with BamHl, purified and 
ligated with BamHl digested psvCAT. After transformation, resulting colonies were 
screened by restriction digestion and verified by DNA sequencing. Clones containing 
inserts in either orientation were obtained and used for subsequent analysis. The 
sequences of the NRE in the forward orientation (NRE-F) and the NRE in reverse 
orientation (NRE-R) are shown in Figure 4.13 
Plasmids pNRE-F, psvCAT and psv212 were separately transfected into BHK cells 
and celllysates were obtained after 16 h. CAT assays revealed that the NRE-F insert 
regulated the activation of CAT gene expression. The activation was variable and 
averaged 27 ± 19 CAT units (Figure 4.14). This variability may have been due to the 
presence of ATG's within the sequence, as shown in red in Figure 4.13. The NRE 
sequence inserted in the forward orientation enhanced CAT expression, thus the insert 
did not act as a negative regulator in this context. If this non-HSV -1 sequence 
enhanced the expression of CAT in this assay could it confer a response to ICP27 
during HSV-l infection? Interestingly, the NRE-R insert gave a lesser effect resulting 
in only 3 ± 1 CAT units, a value very close to that seen when the plasmid contained 
no insert (Figure 4.14). 
BHK mono layers were transfected with the NRE-F plasmid and after 6 h cells were 
infected with wt HSV-l. CAT assays carried out on celllysates revealed that NRE-F 
did respond to HSV -1 infection, albeit to a low level, with values reaching only 70 
CAM units (Figure 4.15). To test whether this response was due to the presence of 
ICP27, cells were transfected with NRE-F and further infected with 27LacZ, d4-5 or 
M15 viruses. CAT levels during 27LacZ and d4-5 infections revealed less 
enhancement of CAT activity, reaching only some 36 CAM units when the ~'RE 
.' d" (F' 4 15) However this activity sequence was Inserted In the forwar onentatlOn Igure.. , 
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GCTAAACGCAAAAAACGTAAGCTGTAAGTATTGTATGTATGTTGAATT,-\GTGTTGT 
TTGTTGTGTATATGTTTGTA TGTTGA TCCGTCGAGA TTTTCAGGAGCT,-\..-\GG,-\ ,-\GCT 
AAAATG 
NRE-R: 
ACATACAAACATATACACAACAAACAACACTAATTCAACATACATACAATACTTAC 
AGCTTACGTTTTTTGCGTTTAGCTGATCCGTCGAGATTTTCAGGAGCTAAGGAAGCT 
AAAATG 
Figure 4.13: The NRE sequences in forward (F) or reverse (R) orientations \\'as 
inserted into the psvCA T vector. The presence of A TGs are highlighted in red and 
the final ATG is the CAT start codon.The sequence shown in blue is plasmid 
sequence. 
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was greater than values seen with mock infection. During infection with MI5, CAT 
activity levels were similar to those seen during mock infection. It was interesting to 
note that the NRE-F CAT plasmid responded poorly to HSV-I infection and 
displayed little difference in CAT activity when ICP27 was absent during 27LacZ 
infection. When the pNRE-R plasmid was transfected into BHK cells and CAT 
activity analysed, the CAT levels did not increase significantly above the level seen 
when there was no sequence present, i.e. psvCAT, reaching only levels of 3 CAM 
units/!J-I cell lysate (Figure 4.15). The expression of CAT via the NRE-R control 
sequence gave no significant elevation in CAT activation when cells were infected 
with wt HSV-l, 27LacZ, d4-5 or M15 viruses. 
CAT gene expression during wt HSV -1 infection was regulated via the sequence 
inserted in to the 5'UTR of the plasmid, however, the effect was shown here not to be 
entirely specific for HSV -1 sequences as a control sequence of HPV origin also 
enhanced CAT gene expression during wt HSV -1 infection, as compared to a plasmid 
with no insert sequence, albeit to low levels of activation. This effect was shown in 
part to be due to the presence of ICP27 indicating that a possible interaction of ICP27 
with insert is possibly not HSV -1 specific. Interestingly, insertion of the NRE in the 
reverse orientation gave little to no increase in CAT activity during infection therefore 
the sequences were inspected in the hope of revealing possible requirements involved 
in ICP27 regulation of their expression and also for the increase in ICP27 independent 
CAT activity. 
The G content of the NRE-R sequence is very low on the non-coding strand (5%), 
whereas the NRE-F control non-coding sequence has a considerably higher (24%) 
content and contains a GU rich region. Analysis of the HSV -1 sequences investigated 
in this study revealed that there are regions within each sequence that are rich in G 
residues. If this were a possible factor in enhancing gene expression in this assay then 
inserting a small sequence containing G residues might also give this effect. 
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4.11 Transfection of plasmid containing poly(G) 
elicited enhanced CAT gene expression during wt 
HSV -1 infection. 
RNA binding assays using recombinant protein and RNA homopolymers immobilized 
on agarose beads have been used extensively for RNA-protein binding studies by 
many investigators (Brown et at., 1998; Datar et at., 1993; Fabre et at., 1994; 
Fackelmayer and Richter, 1994; Qhno et at., 1994; Siomi et aI., 1993b). For example, 
Datar et at. described the RNA binding properties of the fragile X mental retardation 
protein (FMRP) using this method. Fragile X Syndrome is caused by a triple repeat or 
a point mutation in the non-coding region of the FMR1 gene mutation leading to the 
loss of function of the FMRP protein (De Boulle et at., 1993; Pieretti et at., 1991; 
Verkerk et at., 1991). The FMRP protein is an interesting example as it contains many 
of the same functional domains as ICP27. Both proteins contain an ROO box and KH 
domains, which function in RNA-binding. They both also contain NLS and NBS 
sequences and are known to shuttle in and out of the nucleus (Abrams et aI., 1999; 
Bardoni et at., 1997; Eberhart et at., 1996; Fridell et at., 1996; Lewis et at., 1999; 
Pollard et at., 1996). RNA binding assays carried out using FMRP protein revealed 
strong binding to poly(G) and weaker yet significant binding to poly(U) RNA 
homopolymers that was later shown to be a specific intrinsic property of the FMRP 
protein (Gunter et at., 1998). Strikingly, Mears and Rice, using the same method, 
described the ability of recombinant ICP27 protein to bind moderately to poly(O) and 
weakly to poly(U) RNA homopolymers (Mears and Rice, 1996a). Thus various 
homopolymers inserted into the 5'UTR of the psvCAT plasmid could identify a 
nucleotide requirement for the regulation of CAT gene expression during wt HSV-1 
infection. 
Oligonucleotides consisting of ten A, C, G or Ts were synthesised with a BamHI site 
introduced at each 5'end. The appropriate oligonucleotides were annealed and inserted 
into the psvCAT vector. Upon sequencing each construct it was possible to identify 
plasmids containing a run of ten A, C, G or Ts. Initial experiments were carried out to 
. . .. fi t· E ch plasmid was transfected analyse CAT gene express10n wIthout VIruS III ec 1On. a 
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into BHK cells and CAT activation was quantified by perfonning CAT assays on each 
cell lysate. The levels of CAT gene expression were significantly' d d Increase ,compare 
with psvCAT, when the poly(G) homopolymer was present (10 ± 1 CAM units), 
albeit reduced compared to psv212 (20 ± 7 CAM units) (Figure 4.16). Analysis of 
transfections with poly (A), (C) or (T) inserts revealed limited levels of CAT activity 
(0.6-2 CAM units) almost comparable to plasmid containing no insert (0.4 ± 0.6 CAM 
units). In these experiments there was an uncharacteristically low level of expression 
of CAT, possibly due to the quality of the BHK cells used, however the relative 
amounts of activity from psvCAT and psv212 plasmids were very similar, in all 
experiments from this point, thus allowing a comparison of the homopolymer 
plasmids with them. 
There was a significant increase in CAT activation with the poly(G) insert in the 
absence of viral factors and it was therefore of interest to study the effect of these 
sequences on CAT activation in the presence of virus. The plasmids were transfected 
and cells infected with wt HSV-1 or 27LacZ and CAT assays carried out on lysates 
obtained. CAT gene expression levels were dramatically enhanced to 136 CAM units 
with the poly(G) insert and wt HSV-1 infection whereas levels only reached 12 CAM 
units with 27LacZ infection (Figure 4.17). Plasmids with the other homopolymer 
inserts gave only slightly elevated levels of CAT expression, ranging from 2-10 CAM 
units, in response to infection with wt HSV-1 and also a slightly reduced level of 
expression, ranging from 1.8-3 CAM units, following 27LacZ infection. 
The data demonstrate that gene expression was increased when poly(G) 
homopolymers, but not poly(A), (C) or (T), are present. This indicates that the G 
content of the sequences used in this study was essentially responsible for the 
enhanced activation observed when ICP27 was present during infection. This 
enhancement was severely reduced when either ICP27 was not present or carried a 
mutation, or the insert sequence contained few or no G nucleotides. Furthermore, it is 
interesting to note that there was significant ICP27-independent CAT activation when 
poly(G) nucleotides were present in the 5'UTR of the CAT plasmid. Again this 
indicates an involvement of cellular factors in the activation of CAT gene expreSSIOn 
when this sequence is present. 
90 
:0. 
.. 
40 
35 
30 
25 
~ 20 
.. 
I) 
e 
~ 15 
U 
oi-
10 
5 
o 
·5 
r-~ l·~ h ·, 
~i~~, 
t~~'~ 
~~ ~} 
....L I >.~:':? 
pavCAT pav212 
I C Mock Infect ion 
I 
.1 
1 
I 
rTl r+l l ~ 
pavA pavC pavG ps vT 
1 
tran sfec t ed plas m id 
Figure 4.16: psvCAT plasmids containing a 10 mer homopolymer sequence 
of A, C, G or Ts were transfected and analysed for CAT expression levels 
(n=3) . 
160 (J Moc k i nfec t ed 
. Wt H SV · 1 i n fec ti on 
140 
120 
:0. 100 
.. 
"> ; 
I) 
e 
l-
e 
u 
oi-
80 
60 
40 
20 
0 
ps vCAT psv212 psvA psvC 
ps vG ps vT 
tran s fec t ed p lasmid 
Figure 4.17: Activities obtained when ho~opolymer-contammg plasm id 
DNAs were transfected then cells infected wlth wt HSV -lor 27LacZ and 
lysates analyzed for CAT activity. 
Analysis of RNAs that bound to the FMRP protein revealed that they fonned a 
complex tertiary structure termed a G-quartet i e a complex t I I 
. . s em oop e ement that 
folds back on itself to form a non-canonical base base t tu (B 
- s ruc re rown et at., 2001) 
and furthermore, the FMRP RGG box was shown to be required for binding of this 
RNA G-quartet structure (Darnell et at., 2001; Ramos et at., 2003). As ICP27 protein 
behaved very like the FMRP protein described above it was of interest to find out if 
any of the RNAs under investigation were capable of fonning G-quartet structures. 
Unpublished preliminary work carried out by Andres Ramos (National Institute for 
Medical Research, London) revealed that the #212 RNA analysed by NMR does not 
form a G-quartet type structure. 
4.12 Discussion 
ICP27 is an RNA binding protein that shuttles in and out of the nucleus. RNAs that 
bind to the ICP27 protein have been isolated, however, little is known of the 
specificity of these RNAs with regards to the function of ICP27 in the regulation of 
viral genes. In this study, ICP27 was shown to be involved in the positive regulation 
of CAT gene expression during wt HSV-l infection. The involvement of ICP27 was 
confinned by the observation that CAT activation was not enhanced in its absence, as 
illustrated by infection with 27LacZ. During M15 infection, the mutation in the ICP27 
protein and the subsequent defects caused by such a mutation seem to be possible 
factors in the lack of enhanced CAT gene expression. Furthermore, cells infected with 
both 27LacZ and M15 mutant viruses do not enter host cell shut off. The presence of 
ICP27 RNA binding sequences within the 5' UTR of the CAT reporter gene during 
transfection and wt HSV-l infection of BHK cells resulted in an increase of CAT 
activity but the enhancement was lower than that reached when no inserted sequences 
were present, indicating a certain level of inhibition of expression when these 
sequences were present. Even though there seems to be reduced activation of CAT, 
when these HSV -1 sequences were present, the absolute CAT enzyme levels reached 
were much higher than when no insert sequences were present. Thus enhanced 
expression as determined by CAT activity was demonstrated when ICP27 binding 
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sequences were present during wt HSV-1 infection An h· . 
. y c ange III sequence SIze, 
sequence composition etc of the insert consistently gave a d t·· . 
, re uc IOn III expreSSIOn 
levels. Furthennore, expression levels reached when no ICP27 b· d· 
- III Illg sequences 
were present were at levels, which were very difficult to detect. This problem could 
skew the activation levels, leading to inaccuracies in the extent of increases directed 
by HSV -1 infection. Taking all these factors into consideration, it is possible, that 
during transfection and wt infection when insert sequences were present, there could 
be levels of CAT approaching a maximum level of expression. 
Experiments using bacterially expressed ICP27 showed direct binding to RNA 
(Ingram et at., 1996). However, this binding was not specific for a target RNA as 
ICP27 bound equally efficiently to RNA fragments from early and late HSV -1 genes, 
fragments from exon-1 of a late HSV -1 gene and also to two RNA fragments from an 
adenovirus late gene, where one contained a splice site (Ingram et al., 1996). 
Further investigations using bacterially expressed ICP27 also showed that ICP27 did 
not bind to target RNAs specifically and identified that the RIG rich region of ICP27 
was responsible for RNA binding (Brown et al., 1995). Furthermore, RNA was found 
to bind the RGG box alone of ICP27 (Mears and Rice, 1996a). The ICP27-RNA 
interaction was confinued by the observation that RNA binding was abolished when 
using the d4-5 deletion mutant (Mears and Rice, 1996a). This interaction was not 
specific for an RNA target sequence as full length ICP27 and the RGG box region 
alone both bound to two control probes i.e. an SV 40 RNA, previously shown not to 
bind full length ICP27 (Brown et aI., 1995) and the IFN-~ antisense RNA. Therefore, 
bacterially expressed ICP27 and RGG box bind to non-specific RNA transcripts via 
the RGG box. However, using a eukaryotic system, ICP27 bound RNA transcripts 
specifically. Sandri-Goldin was able to UV cross-link HSV -1 infected cells and 
showed that ICP27 bound to a selected group of intronless RNAs e.g. ICP27, ICP4, 
TK, ICP8, and not to intron-containing RNAs e.g. ICPO and UL15. This in vivo UV 
cross-linking study shows the specificity of ICP27 binding to intronless HSV-1 RNA, 
albeit only eight transcripts were analysed (Sandri-Goldin, 1998a). Furthermore, 
ICP27 transcribed and translated in vitro in rabbit reticulocyte cell lysates binds to 
poly (G) and poly (U) RNA homopolymers but not to poly (A) and poly (C) 
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homopolymers (Mears and Rice, 1996a). Therefore, eukaryotically expressed ICP27 
showed some binding specificity to target RNAs. 
In the study described here, a lack of enhancement of CAT activation was also seen 
with ICP27 mutants lacking an RGG box irrespective of whether or not HSV-l 
sequences were present in the CAT reporter plasmid. The CAT expression levels 
observed during the d4-5 infection provide possible evidence for a direct role for 
ICP27 in enhancing CAT gene expression during wt HSV -1 infection. That is, high 
CAT activation levels are reached when ICP27 is present during wt HSV -1 infection 
and these high levels are severely reduced when ICP27 is mutated to prevent RNA 
binding. Given that ICP27 is present during the d4-5 infection, and that viral 
replication and growth proceeds, the prevention of enhanced CAT gene expression 
suggests an essential role for ICP27 in the expression of this reporter gene. 
Furthermore, as infection progresses with the d4-5 virus, the cells enter into host-cell 
shut-off, thus this event did not influence the enhanced CAT gene expression seen 
during wt HSV -1 infection. 
Transfection of plasmid without any HSV -1 sequences (psvCAT) gave an increase in 
CAT expression during wt HSV-1 infection suggesting that viral factors can cause an 
increase in gene expression in the absence of viral sequences. Taking this into 
account, alongside the orientation independent effect of the sequences, offers the 
possibility that the HSV -1 enhancement of expression could be the product of two 
separate non-specific effects. That is, an increase in CAT expression due to the 
presence of cloned sequence, or the global increase in gene expression caused by viral 
trans-acting factors. However, the cloned sequences, in the forward orientation, are 
known to bind ICP27 and not to mutant ICP27 (Y3-H) and, alongside the activation 
data here, this would strongly suggest that ICP27 is responsible, at least in part, for 
enhancing gene expression during wt HSV -1 infection. 
In an attempt to identify a minimal sequence requirement the #212 sequence was 
truncated. One truncation almost abolishes enhanced CAT gene expression when no 
viral proteins were present. EMBOSS (European Molecular Biology Open Software 
Suite) was used to analyse the frequency with which these small sequences existed 
within the HSV -1 genome. It was evident that each sequence appeared only once 
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within the genome. Upon analysis of the two #212 truncat d . e sequences It was not 
evident what the activating sequence was except that they HSV 1 were - sequences. 
The insertion of a non-HSV-1 sequence into the psvCAT 1 ·d .gh h C P asml ml t t erelore 
indicate whether this enhanced gene regulation was specific to HSV -1 sequences or 
not. This experiment needs to be extended to analyse the effect observed during HSV-
1 infections with and without ICP27, and also to include a more detailed analysis of 
sequence length requirements. 
Further indication of sequence requirements for CAT activation were gained by using 
the NRE-R control sequence which failed to enhance CAT activity either in the 
absence of presence of virus. The most obvious difference between this sequence and 
the activating ones is the difference in the content of the G-residues. The enhanced 
activation of CAT gene expression was not detected during wt HSV-1 infection when 
the inserted sequence contained only four randomly spaced G nucleotides, leading to 
the idea that multiple runs of G nucleotides are important for the enhanced activation 
of gene expression when ICP27 is present. 
RNA homopolymer assays have been a useful tool in identifying binding efficiencies, 
and to some extent specificities, of RNA binding proteins. Indeed, the classification of 
the hnRNP protein RNA-binding properties was originally based on their ability to 
bind RNA homopolymers e.g. hnRNP C is a poly(U) binding protein and hnRNP K 
and J are poly(C) binding proteins, whereas hnRNP E, F and M are poly(G) binding 
proteins. Interestingly, hnRNP A bound all four ribonucleotide homopolymers and 
furthermore, hnRNP P bound well to both poly(A) and (G). That is, both hnRNP A 
and P proteins are not absolutely base-specific binding proteins (Swanson and 
Dreyfuss, 1988) yet a degree of binding specificity is retained to the particular 
homopolymers mentioned above. 
The RNA-dependent RNA polymerase encoded by the hepatitis C virus NS5B gene 
was shown to bind strongly, but not exclusively to poly(G) RNA homopolymers 
(Johnson et aI., 2000; Lohmann et aI., 1997). The vaccinia virus processivity factor 
VP39 was shown to bind avidly to poly(A) and poly(U) homopolymers, however 
weak binding was also observed with poly(C) and (G) (Johnson and Gershon, 1999). 
The pseudorabies virus UL54 (which has an interesting 41 % homology to ICP27) 
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expresses an early protein that contains an RIG-rich region at the N-tenninus. This 
protein binds poly(G) RNA homopolymers, however, no other nucleotides were tested 
to identify binding efficiencies or specificities (Huang and Wu, 2004). The FMRP 
protein, previously described here, binds efficiently to poly(G) and weakly to poly(U) 
indicating that the FMRP protein has binding affinities to GIU-rich sequences (Siomi 
et al., 1993b). 
Iep27 binds preferentially, albeit moderately, to poly(G) RNA homopolymers and 
weakly to poly(U), however absolutely no binding was observed to poly(A) or (e). 
The RGG box of Iep27 was required but not absolutely essential for efficient poly(G) 
binding (Mears and Rice, 1996a). It is evident from the analysis of RNA binding 
assays described above that very few RNA binding proteins exhibit specific binding 
of a particular ribonucleotide, making the infonnation gained from these assays very 
difficult to interpret in terms of absolute specificity. Many RNA binding proteins 
show a preference for certain homopolymer ribonucleotides and ICP27 is no 
exception. In this investigation, the function of ICP27, with regard to the presence of 
homopolymer sequences inserted into the 5'UTR of a CAT gene was analysed to 
observe any nucleotide specificity. The Iep27 activation data obtained here, together 
with the reports demonstrating preferential direct binding with poly(G) RNA to 
Iep27, and to Iep27 RGG box alone (Mears and Rice, 1996), strongly indicate that 
Iep27 possesses specific RNA binding efficiencies to G-rich sequences and that an 
interaction between Iep27 and these G-rich sequences leads to an increase in gene 
expression. Interestingly, the 68% GC-rich HSV -1 genome has 1,103 runs of 5 G 
residues or more. Furthermore, the CAT gene has no runs of 5 Gs or more. 
The previously identified HSV -1 RNA sequences seemed not to carry any obvious 
specific sequence motifs responsible for the binding to ICP27 (Sokolowski et al., 
2003), except for the specific requirement of a G-rich sequence. The ICP27 RGG box 
alone binds RNA, however this binding was also not specific as this domain was also 
shown to interact with two control RNAs, that were previously shown not to bind full 
length Iep27 (Brown et ai., 1995). Non-specific binding to ribonucleotides has also 
been reported for a domain within the RNA-binding protein nucleolin (Ghisolfi et at., 
1992a; Ghisolfi et ai., 1992b; Ginisty et ai., 1999). Nucleolin is involved in the early 
. h 1 1 Nucleoll·n contains an RGG stages of ribosome assembly withm t e nuc eo us. 
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domain at the C-terminus of the protein that was shown to bind different RNA 
homopolymers with similar affinities. Nucleolin also contains a central domain knO\vn 
to bind specifically to the 5' external transcribed spacer of the pre-rRNA. The RGG 
domain of nucleolin was also shown to bind this region non-specifically. Further 
analysis of this non-specific binding was carried out using circular dichroism 
spectroscopy, a method that gives a measurement representing the structural 
behaviour of RNA within an RNA-protein complex. Interestingly, this investigation 
revealed that a change within the RNA occurs during the binding of the RGG domain 
to it. The changes in behaviour indicated an un stacking of bases and an unfolding of 
secondary RNA structures, possibly revealing the ability of nucleolin to bind and 
unwind RNA. It was therefore postulated that this efficient non-specific binding of the 
RGG domain of nucleolin allowed the RNA to be unstacked and unfolded thus 
allowing the specific binding of the central domain of the nucleolin protein to the 
unwound RNA (Ghisolfi et al., 1992a; Ghisolfi et ai., 1992b; Ginisty et al., 1999). 
Nucleolin is a multifunctional protein that exhibits properties similar to ICP27 
including RNA-binding, transcription repression and shuttling between nucleus and 
cytoplasm. In addition, both proteins are phosphorlylated by CKII. Furthermore, the 
proteins' structural similarities include an acidic domain, an NLS and an RGG box. 
Obviously, there are many differences in the roles of the proteins, however, taking 
these similarities above into consideration alongside the binding properties of the 
RGG box and the functional data gained here, it is feasible that the RGG box of 
ICP27 could behave similarly to the RGG domain of the nucleolin protein. That is, 
allowing non-specific binding of RNA transcripts leading to the specific binding of 
the RNA to a different domain of the protein. Further investigation into these matters 
is required. 
The enhancement of gene expression could be due to any of the known functions of 
ICP27. ICP27 can transactivate the transcription of certain HSV-1 genes (Rice and 
Knipe, 1988) possibly through an effect on initiation (Jean et al., 2001) or by the 
phosphorylation of viral and/or cellular proteins involved in, and thus promoting, 
transcription (Xia et al., 1996). Furthermore, ICP27 is known to associate with RNA 
polymerase II complexes (Jenkins and Spencer, 2001; Zhou and Knipe, 2002). ICP27 
increases RNA 3' processing at inherently weak poly (A) sites by increasing 
. .. l 1996b) d furthermore it stabilises R.,,\A processmg effiCIencIes (McGregor et a ., an , ' 
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by binding to the AU-rich elements found within the 3'UTR of labile Rc'\As (Brown et 
al., 1995). ICP27 protein contains an NBS and an NLS thus allowing the protein to 
shuttle in and out of the nucleus, and both are necessary for its role in RNA nuclear 
export. It is possible; therefore, that ICP27 regulates some viral gene expression via 
transcriptional processes, while regulating others by post-transcriptional mechanisms. 
Most of the functions mentioned above could be responsible for the increase in gene 
expression observed in this investigation. ICP27 enhances the expression ofUL24 (an 
HSV-1 leaky late gene) (Pearson et al., 2004) and VP16 (an HSV-1 tegument protein) 
(Ellison et al., 2005). During ICP27-null virus infection the protein levels ofUL24 are 
reduced by 70-fold. This was shown to be due to a decrease in cytoplasmic 
accumulation of UL24 mRNA, not a decrease in total mRNA, suggesting a post-
transcriptional regulation of gene expression at the level of nuclear export (Pearson et 
al., 2004). Furthermore, in the absence of ICP27, most cytoplasmic VP16 mRNA 
molecules do not associate with actively translating ribosomes but co-sediment with 
the 40S ribosomal subunit, suggesting a defect at the level of initiation of translation 
resulting in a 9-80 fold decrease in protein yield (Ellison et a/., 2005). Therefore, 
ICP27 has been shown to stimulate gene expression post-transcriptionally at two 
distinct levels; enhancing the export of UL24, and the interaction of VP 16-specific 
mRNA with polysomes thus leading to the stimulation of their translation. 
ICP27 associates with components of the cellular initiation translation machinery 
including eIF3 and eIF4G (see below) and also with the poly (A) binding protein 
(P ABP) indicating a possible role in the stimulation, or the repression, of translation at 
the initiation level (Fontaine-Rodriguez et al., 2004). This association with the 
translation machinery was confirmed when ICP27 was shown to co-sediment with 
polyribosomes, (as did P ABP) and was present in the 80S ribosome and polyribosome 
fraction (Larralde et al., 2006). A more direct indication of ICP27's ability to affect 
gene expression at the level of translation was investigated using a tethered function 
assay. Here, ICP27 was shown to directly stimulate the translation of mRNAs that 
bound to it in the absence of any other viral protein (Larralde et al., 2006). 
An increase in translation could also be possible without the influence of ICP2 c. The 
5'UTR can influence the translation of downstream ORF's and represents a level of 
. .' fl d b I ments of the 5'UTR usually 
control of gene expreSSIOn. RegulatIOn III uence Y e e 
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occurs at the level of translation initiation Briefly the 43S pre' 't' t' I' 
" -mIla lOn comp ex IS 
composed of the 40S ribosomal subunit bound to eUkaryotic initiation factors (eIFs), 
(including eIF3) and a ternary complex comprising tRNA and eIF2 that is coupled to 
GTP. This 43S pre-initiation complex is thought to bind RNA via the 5' cap-binding 
complex, eIF4F. Components of the eIF4F complex are eIF4E, that binds to the 5' cap 
structure, and the eIF4G, a scaffold protein that binds many initiation factors 
including eIF4E and eIF3. Thus, a competent scanning initiation complex is formed. 
Another possible reason for an increase in translation during wt HSV -1 infection 
could be due to the presence of the viral protein ICP34.5. This protein prevents host 
shutoff by ensuring the dephosphorylation of eIF2 and therefore allowing protein 
synthesis to continue. However, the expression of ICP34.5 should be analysed during 
27LacZ, M15 and d4-5 virus infections as these viruses do not progress into host 
shutoff and enhanced CAT gene expression is not observed during these infections. 
Control elements that determine translation efficiency that are located in the 5'UTR 
include internal ribosomal entry sites (IRESs), upstream AUGs (uAUGs) and 
upstream open reading frames (uORFs), 5'UTR sequence length, secondary structures 
and also binding sites for regulatory proteins. (Gray and Wickens, 1998; Mignone et 
ai., 2002). 
The IRES is a secondary structure found within the 5'UTR and is most commonly 
associated with picornavirus translations (Jackson and Kaminski, 1995). Most 
initiation factors, including eIF4F, are required for IRES-mediated translation 
(Jackson and Kaminski, 1995) along with other trans-acting factors such as 
polypyrimidine tract-binding protein (Hellen et ai., 1993; Kaminski et ai., 1995) and 
the La autoantigen (Meerovitch et ai., 1993; Svitkin et ai., 1994a). These trans-acting 
factors are possibly required to hold the IRES in position (Svitkin et ai., 1994b). 
uORFs and uAUGs in the 5'UTR can regulate the translation of the main ORF. The 
first AUG scanned by the ribosome is selected as the site of initiation (Kozak, 1983; 
Kozak, 1987), whereas uORF can function together to regulate translation 
(Hinnebusch, 1996). Both types of interruptions to the reading of the main ORF leads 
. H ORF can also directly proyide a 
to the repression of translatlOn. owever, u 
. h 11 'a degree of secondary initiation 
termination site before the mam ORF t us a owmb a 
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from the main ORF, that is less inhibitory than the uAUGs (Kozak 1984' L' I 
, ,IU et a ., 
1984). 
Long 5'UTRs allow for the fonnation of stable secondary structures that lead to 
repression of translation initiation by hindering the scanning ribosome, a process that 
is dependent on the stability of the RNA structure. A transcript containing a 5'UTR of 
870nt (TGF -~ 1) leads to an increase in translation efficiencies when compared to a 
larger 5'UTR of 1.1kb (TGF-~3) i.e. two of the three transcripts of the TGF-~ proteins 
differ in their abilities to regulate translation due to the variable lengths of the 5'UTR. 
Interestingly, all of these 5'UTRs are GC rich. The distance of the secondary structure 
from the 5' cap is also a detenninant of translational regulation as the closer the 
secondary RNA structure is to the 5' cap the more likely the 43S pre-initiation 
complexes will not bind to the RNA thus translation initiation is inhibited. Hairpin 
structures that are located further away from the cap can also inhibit translation as 
these structures can be particularly stable rendering the helicase component (eIF4A) 
of the initiation complex unable to unwind the RNA in the 5'UTR thus preventing the 
43S complex from binding to the AUG codon. 
Interestingly, many mRNAs that contain highly structured 5'UTRs are implicated in 
cell death or cell growth suggesting that their translation is tightly controlled by 
5'UTR elements. An over-expression of the initiation factors (e.g. eIF4E) involved 
here results in the loss of translational repression and can ultimately lead to 
tumorigenesis (De Benedetti, et ai., 1994). A severe reduction in 5'UTR length (less 
than 12nt) impairs translation initiation, and moderately increasing the length 
increases translation efficiency possibly by increasing the number of interactions of 
the 43S pre-initiation complexes (Kozak, 1991a; Kozak, 1991b). As the length of the 
5' leader sequence increases translation initiation is enhanced, however, as the 
sequence increases further in length and secondary structures are formed there is a 
decrease in the efficiency of translation initiation. 
An example of a small structural element within the 5'UTR (not an IRES) is the iron 
response element (IRE), a stem loop structure of approximately 30nt in length. The 
. . 1 RNA th t tal'n an IRE in response to iron Iron regulatory proteIns (IRP) regu ate s a con , 
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levels in the cell. Under conditions of iron deprivation the IRP binds to the IRE thus 
blocking the binding of the 43S pre-initiation complex. When iron is plentiful in the 
cell the IRP proteins are either inactivated or degraded (Tong and Rouault, 2000). The 
regulatory function of the IRPs are also determined by the distance of the IRE to the 5' 
cap resulting in the inhibition of initiation factors that bind the 40S ribosomal subunit 
which increases when the IRE is proximal to the 5' cap. However, as the IRE moved 
distally to the cap another inhibitory function occurs i.e. inhibiting the scanning of the 
40S ribosomal unit. The positioning of these binding sites reflects an ability of the 
regulatory protein to either down or up regulate translation rather than to switch it on 
or off (Gray and Hentze, 1994). 
Overall, the diversity with which the 5'UTR can regulate translation is evident leading 
to roles in enhancing, reducing or even eliminating an element(s) of the translational 
regulatory machinery depending on the sequence length, position or structure. These 
aspects of translation control should be taken into consideration in this investigation 
as alternative pathways of enhancing gene expression. The HSV -1 sequences studied 
in this investigation have been inserted into the 5'UTR of the CAT reporter gene and 
this range of possible routes of translational control makes it difficult to determine a 
possible effect of these sequences with regards to their position within the 5'UTR. The 
increase in length could be a possible factor for the increase in CAT gene activation as 
this is a common factor between all of the constructs containing HSV -1 sequences. 
However, the exception here is that a sequence of similar length that was inserted into 
the 5'UTR of the CAT gene as a non-HSV-1 control sequence failed to activate CAT 
gene expression. Analysis of this RNA did not reveal an inhibitory structure and there 
was no change in sequence length, however the nucleotide content was severely 
deficient in G residues. 
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CHAPTER 5: Enhanced CAT gene expression~ 
during HSV -1 infection, is at the level of 
translation. 
5.1 Introduction 
ICP27 is known to act at both transcriptional and post-transcriptional levels (as 
previously discussed). When ICP27-binding sequences were present, CAT 
production, from a transiently transfected reporter construct was enhanced during wt 
HSV -1 infection and was not enhanced during HSV -1 ICP27 mutant infections. 
During M15 mutant VIruS infection there is a disruption of the transcriptional 
transactivational properties of ICP27 and also a decrease in the expression of several 
L-2 genes e.g. gC. The lack of enhanced CAT production, as observed during the 
investigation presented here, may be due to a disturbance in this transactivational role 
of ICP27. However, the ability of M15 ICP27 to shuttle in and out of the nucleus is 
also abolished and this may have an additional affect on gene expression in this assay. 
Therefore, it is possible that the altered expression of CAT in M15 infections could be 
either transcriptional or post-transcriptional. 
The RGG box deletion within ICP27 (d4-5) severely reduces the binding of RNA 
transcripts with the Y3-H assay. The disruption of the ability of ICP27 to bind RNA 
may be the reason no enhancement of the CAT gene expression was observed during 
the d4-5 infections investigated here. Furthermore, the transcriptional activity of this 
mutant protein has not been investigated. 
To identify whether enhanced gene expression occurred at the level of transcription 
RNA quantification and the comparison of RNA levels was undertaken. 
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During the prevIOus transfection/infection assays discussed in chapter 5, 
transfections/infections were performed in duplicate in d t . 1 . or er 0 ISO ate RNA usmg the 
TRIZOL method of extraction. Each RNA sample was DNase treated and the amount 
of total RNA was quantified. RNA was added to the Omm' . t . d scnp mastermlX an 
reverse transcription was carried out (2.2.2.7) to generate cDNA. It is in this state that 
the amounts of eAT transcripts were compared using real time quantitative peR 
(2.2.2.8). 
5.2 Introduction to Real-Time Quantitative peR 
Real-time peR allows the detection and therefore the monitoring of the progress of 
the peR as it occurs. Measuring the kinetics throughout the peR process allows the 
reactions to be characterised, specifically during the early phase of the reaction i.e. the 
time-point during amplification when the target is first detected. The point at which 
the target DNA is first detected is during the exponential phase. During this phase 
there is an exact doubling of the product DNA at every cycle, thus, the reaction is 
specific and precise making the exponential phase the optimal point for analysing 
data. 
In order to quantify the peR product during this phase the peR is carried out in the 
presence of SYBR Green I dye, a highly specific, double-stranded DNA binding dye. 
When SYBR Green I dye is added to the peR reaction it immediately binds to all 
double-stranded DNA and the intensity of the fluorescent emissions increases. As the 
reaction proceeds the SYBR Green I dye binds to each new copy of double-stranded 
DNA sequence, thus, as progression through the exponential phase of the peR is 
made, an increase in the fluorescence intensity will be proportional to the amount of 
product produced. 
A major problem using the SYBR Green I dye is that it binds to all double-stranded 
(ds) DNA. The dye could bind to an unwanted dsDNA product and proceed to give a 
high intensity of fluorescence and therefore a false reading of the intensity of the dye 
bound to the desired DNA product. To ensure this problem is overcome it is important 
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Figure 5.2: Number of cycles reached when the cDNA of 
sample 212CAT was serially diluted and Q-PCR perfo mled. 
to make certain only one product is synthesised. Initial experiments to identify the 
products being synthesised, and therefore quantified, were performed. RT was carried 
out on 4 different RNA extraction samples, plus a control sample (dH20), and 1 ~l was 
added to a peR reaction. After cycling ended, each cDNA sample was run on an 
agarose gel alongside a DNA marker. Each sample collected after Q-RT -PCR indeed 
had only one product of the correct size (104bp). 
PCR was then carried out on serial dilutions of each cDNA sample. The dilutions 
were: neat, 1:10, 1:100 and 1:1000. The Q-RT-PCR, performed in triplicate, gave an 
approximately linear response to each dilution indicating the synthesis of only one 
product, and that pipetting techniques were accurate. During Q-RT-PCR with the 
control sample (no cDNA) , no product was observed until cycles 30-40, strongly 
indicating that no primer-dimers are formed and furthermore there was no 
contamination between samples. 
In summary, these control/preliminary experiments confirmed the specificity of the 
primers giving no by products, no primer-dimer and resulting in a product of the 
target gene area of the correct size. 
5.3 During infection with HSV-l wt and ICP27 
mutant virus total CAT RNA levels remain similar. 
During wt HSV-l infection CAT expression was enhanced, however, during ICP27 
mutant virus infections this enhancement was not observed. It was possible that this 
may be reflected in the different levels of CAT RNA in the two cases. 
BHK cells were transfected with psvCAT, psv212, psv247 or psv82 and subsequently 
infected with wt HSV -1, d4-5 or M15 virus, cells were harvested and RNA extracted. 
Using a 1:100 dilution of RNA, real time-RT-PCR was performed, in triplicate, to 
determine RNA levels of each sample. No significant differences were found in CAT 
specific RNA levels between cells infected with wt HSV-l, d4-5 or M15 (Figure 5.3). 
Unfortunately, cycle numbers reached during this assay were too low to give an 
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Figure 5.4: RNA levels analysis after Q-RT-PCR using IU, A 
extracted from the nucleus and the cytoplasm of psv212 transfected 
cells with or without wt HSV-l infection (n=3) . 
accurate interpretation of these results. That is d· . . 
, accor mg to the prelImmary data 
using the serial dilution, cycles of around 25 should h b ave een reached. Any sample 
giving less than 20 cycles during the exponential phase st I· d· rong y m lcates the ~,\A 
sample is too concentrated. This suggests a flew techno 1 bl h lca pro ems s ould be 
addressed. To ensure dilution is accurate, future work should include three dilutions 
of each sample, e.g. 1: 1 0 1: 1 00 1·1000 To ensure tran C t· fIi· . , ,.. Slec IOn e ClenCles are 
similar between wells a further reporter plasmid, e.g. y-actin, should be co-transfected 
into BHK cells with psvCAT plasmid DNA. Thus, the y-actin RNA can be quantified 
during the PCR assay and used as an internal control to ensure transfection 
efficiencies are similar. If efficiencies are not similar original RNA stocks can be 
adjusted to take any differences into account. 
5.4 Q-PCR analysis of nuclear and cytoplasmic 
extracted RNA fractions 
ICP27 is known to act at the post-transcriptional level leading to an increase in gene 
expression by mechanisms including RNA stability and export, and has been linked to 
a role in translation. Quantifying RNA levels in both nuclear and cytoplasmic 
fractions would give an indication whether ICP27 acts transcriptionally or post-
transcriptionally. 
Due to time restrictions only preliminary experiments were performed. BHK cells 
were transfected with plasmid psv212 and later mock or HSV-1 infected before 
nuclear and cytoplasmic RNA fractions were isolated. Real time-RT -PCR was 
performed for each sample and RNA levels analysed. There was little difference 
observed in the levels of nuclear CAT RNA, extracted from cells transfected with 
psv212, whether wt HSV-1 infection had occurred or not (Figure 5.4). The 2 cycle 
increase in nuclear RNA levels does not account for the 9-fold increase in CAT 
expression when psv212 was transfected and infected with wt HSV-1, as compared to 
no infection. 
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There was a 2 cycle decrease in cytoplasmic RNA I I fr . 
eve s om psv212 transfectIOns 
during HSV -1 infection, as compared to no infection Th 1 1 f . ~ 
. e eve s 0 cytoplasmIc R.'\A 
remained relatively constant regardless of wheth '. . 
er an mcrease m gene expreSSIOn had 
occurred, indicating again that RNA stability is not af'.C: t d d . lec e unng wt HSV-1 
infection. Again, these results could not be accurately analysed th 1 b 
,as e cyc e num ers 
reached was less than 20, thus indicating too much RNA' th " 1 
m e on gIna sample. 
Future experiments would include the use of PCR standards to allow RNA 
quantification. This would be highly beneficial as it would oi t l' b~ ve an accura e ana YSIS 
of amounts of CAT RNA transcribed. Also, co-transfection of the psvCAT constructs 
with a reporter plasmid into BHK cells would ensure transfection efficiencies were 
similar. 
5.5 Discussion 
The ability of ICP27 to transactivate transcription is well documented where rCP27 
has been shown to transactivate viral promoters including gB, rCP5 and gC, albeit 
most cases required the co-expression of ICP4 and rcpo (Everett, 1986; Rice and 
Knipe, 1988; Rice and Lam, 1994; Rice et al., 1993; Sekulovich et al., 1988). rCP27, 
however, was shown to have the ability to transactivate the gB promoter on its own 
(Rice and Knipe, 1990). Deletion analysis of ICP27 revealed that the C-terminal 
domain (between amino acids 406 and 512) of the ICP27 protein was involved in the 
transactivation (Rice et a!., 1989). The ICP27 mutant plasmid M15 has a two amino 
acid mutation within this activation domain (PG465,466LE). Co-transfection of the 
MI5 plasmid with the gBCAT plasmid (as used in the Rice, 1990, investigation) did 
not stimulate the expression of CAT, indicating a disruption in the transactivation 
activity of ICP27. The MI5 virus was constructed and during infection it was 
observed that the gC L-2 protein was not produced. Upon further inspection it was 
revealed that the inability to express gC was at the mRNA level, as demonstrated by 
northern blot analysis. However this was only shown for RNA levels detected from 
the cytoplasmic fraction of MI5 infected cells thus the requirement of ICP27 for the 
transactivation of transcription of gC was only postulated (Smith et aI., 1992). Other 
investigations have described the need for ICP27 during late gene expression and 
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showed a decrease or lack of mRNA of certain vir lIt d . 
a a e genes unng ICP27 mutant 
virus infections (Soliman et aI., 1997). However, the effect of ICP27 on viral DNA 
synthesis, during these infections, was shown to play a key r 1 . th d . . 
oem e re uctlOn m 
transcription (McCarthy et al., 1989· Smith et al 1992) 0 ICP27 . 
, .,. ne mutant VIruS 
with a deletion at the C-terminal domain n504 was sh t h f'C 
, , own 0 ave an elect on late 
gene expression yet DNA replication levels remained normal (Rice and Knipe, 1990). 
This virus was later shown to promote the transcription of two L-2 genes, gC and 
UL47, as established by in vivo RNA labelling assays (Jean et al., 2001). 
To attempt to determine if ICP27 affects the rates of transcription, when ICP27-
binding sequences are present, real time-R T -PCR experiments were performed to 
establish the RNA levels within the cell during infections with wt HSV -1 or ICP27 
mutant viruses. 
After transfecting psvCAT plasmids into BHK cells, total RNA levels did not alter 
significantly when the cells were infected with wt HSV-l, d4-5 or M15 viruses. 
However, the analysis was inaccurate as the concentration of RNA in the original 
samples was too high. Thus during real time PCR, the samples were overloaded and 
cycles numbers reached were too low. This was unfortunate as a further dilution of the 
samples would most likely have given at least some preliminary data. If further 
dilution of these RNA samples (by 1: 10,1: 100 and 1: 1000), revealed no difference in 
RNA levels it would strongly indicate that transcription is not affected during the psv 
transfection assays. This would lead to a hypothesis for a post-transcriptional role for 
ICP27 in the assays conducted. 
ICP27 has been reported to regulate gene expression post-transcriptionally by acting 
at various levels including splicing, polyadenylation, export and translation. Further 
real time-RT-PCR analysis was carried out to determine the levels of RNA within the 
nucleus or cytoplasm of non-infected and infected cells, to give an indication of the 
level ICP27 is acting at. Due to technical difficulties, these results could not be 
successfully analysed. However, if RNA levels did not change between samples this 
would indicate that the changes in CAT gene expression during mock and wt HSV-1 
infection was not due to an effect at the level of export, and is therefore unlikely to be 
at the level of splicing and polyadenylation. This would lead to a hypothesis that 
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ICP27 is acting at the level of translation. Conversely ICP27 ld b fu . . 
, cou e nctlOrung at 
the level of RNA export and would be identified by a change in levels of R.,\A 
between nuclear and cytoplasmic fractions ICP27 l'S a 1m h l' '. 
. own s utt mg protem wIth a 
role in RNA export, aiding in the increase of viral gene expression, thus this 
hypothesis could be valid. 
Unfortunately, due to time restriction, nuclear and cytoplasmic extracts were not 
isolated for cells that were infected with the ICP27 mutant viruses and these 
experiments should be performed to include the transfection of all the psvCAT clones 
and infections should also include d4-5 and M15 to further determine whether ICP27 
has a role in export in these assays. These technical problems make it very difficult to 
link ICP27 to an effect on translation here; however, it has previously been linked to a 
role in translation. ICP27 associates with polysomes during infection and furthermore 
the protein has been shown to directly enhance mRNA, using a tethered function 
assay in Xenopus oocytes. Briefly, this assay involves injecting oocytes with two 
different RNA transcripts, one containing a luciferase reporter gene, binding sites for 
the bacteriophage MS2 coat protein, and the other a MS2/ICP27 fusion. Interaction of 
the MS2 coat protein with its binding site would therefore bring Iep27 into close 
proximity to the RNA and gene expression was analysed by carrying out luciferase 
assays on celllysates. MS2/ICP27 was shown to increase luciferase gene expression, 
whereas, MS21M15 or MS2/d4-5 abolished this increase in gene expression. Thus wt 
ICP27 directly stimulated the translation of mRNAs to which it was bound (Larralde 
et al., 2006). ICP27 has also been implicated in regulating translation at the initiation 
step through its interaction with eIF3 and eIF4G (Fontaine-Rodriguez et al., 2004). In 
the study presented here, the change in CAT expression levels could be due to an 
ICP27 mediated effect on translation. To determine whether ICP27 has an effect on 
translation of the CAT gene during infection further work should be carried out. 
Previous work investigating the expression of the VP 16 gene, which is transcribed yet 
protein synthesis is severely reduced during an ICP27-null virus infection, revealed 
that the mRNA distribution changes from the actively translating large polyribosomal 
subunit during wt HSV -1 infection to the 40S ribosomal subunit during ICP2 7 -null 
virus infection. VP 16 expressed during a wt HSV -1 infection was shown to be 
associated with actively translating complexes by treating the infected cells with 
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puromycin, which causes ribosomes to disrupt, thus releasing the transcripts from the 
ribosome. Another method to confirm this association is to disrupt the ribosome using 
EDT A. A shift in wt HSV -1 VP 16 to the top of the sucrose gradient was shown using 
both ribosomal disruption methods (Ellison et at., 2005). This data provided strong 
evidence that ICP27 is required for translation ofVP16 mRNA and is of interest in the 
investigation presented here, as sequences #334 is located within VP16 gene. Further 
fractionation assays have shown that ICP27 associates with the 80S ribosome and 
polyribosome fraction and, furthermore, MIS ICP27 was found to be absent from the 
polyribosome fraction (Larralde et at., 2006). Both of the above investigations should 
be considered when furthering the investigation presented here. 
Future work would entail an investigation into the ribosomal distribution of the CAT 
transcripts during mock, wt HSV -lor ICP27 mutant virus infected cells. Polysomes 
would be fractionated into polyribosomes, monoribosomes and uncomplexed 
ribosomal subunits by sucrose gradients. RNA should be extracted from each fraction 
and then analysed on northern blots to determine the distribution of the CAT mRNA 
across the gradient. UV absorbance profiles would distinguish the position of the 
polysomes in each fraction would then be correlated with the northern blot results to 
determine where the CAT transcript is located during mock, wt HSV-l or ICP27 
mutant virus infections. A change in the distribution of the CAT transcript during wt 
HSV -1 of ICP27 mutant virus infection would strongly indicate a role for ICP27 in 
the translation of these transcripts. 
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Conclusion 
The results obtained in the study presented here are d· d· h 1 ISCusse In t e re evant chapters, 
therefore this section will summarise the main findl·ngs f th· .. 
o e InVestIgatIOns. 
ICP27 is an RNA binding protein that has the ability to shuttle in and out of the 
nucleus thus a hypothesis was born suggesting that these two properties of ICP27 
were responsible for an increase in viral gene expression. This is believed to be the 
property of ICP27 that contributes to the switch from early gene to late gene 
expression during a wt HSV -1 infection. However, with recent reports connecting 
ICP27 to the translation machinery it was postulated that ICP27 might playa further 
role to promote this 'switch'. With these reports it became fundamentally important to 
investigate RNAs that bind to ICP27, to identify any functional properties of these 
sequences when ICP27 is present, which would further the understanding of this 
multifunctional protein. 
Presented here are the results of the first investigations and analyses into the 
properties of ICP27 -binding HSV -1 sequences and ICP27's role in gene expression 
when these sequences are present. A CAT assay was developed which enabled 
measurement of activity in cells transfected with a CAT reporter plasmid when an 
ICP27-binding sequence was inserted into the 5'UTR. This system was used to 
demonstrate that CAT activity increased when these sequences were present, in an 
orientation independent manner. Sequence analysis did not identify a consensus 
'activation code' or RNA structure that could be responsible for this increase in 
expression. It was also of interest to note that no viral proteins were present in this 
assay, which indicated cellular proteins were possibly responsible for this increase in 
CAT expression when ICP27-binding sequences were present. It would be of interest 
to identify these cellular proteins and investigate any possible similarities they have to 
ICP27. 
CAT activity was further enhanced following wt HSV-l infection. This was shown to 
be ICP27 -dependent as there was little to no enhanced CAT activation upon infection 
with ICP27 -null or mutant viruses. However, ICP27 alone was insufficient to enhance 
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CAT activation, strongly indicating ICP27's requirement for other viral proteins. This 
is most likely, as ICP27 has, on many occasions, been reported to require both Iepo 
and ICP4 for its transcriptional function. Further investigations to identify the viral 
protein( s) in this reaction should be pursued. 
The introduction of a non HSV -1 sequence in the reverse orientation into the 5'UTR 
of the CAT reporter plasmid resulted in the identification of a possible sequence 
requirement for enhanced activation during wt HSV -1 infection. A sequence with a 
high G content was necessary to elicit enhanced activity and this was confirmed when 
using the CAT reporter plasmid with homopolymer sequences as 5'UTR inserts. 
Interestingly, ICP27 was previously known to bind poly (G) homoploymers 
suggesting that ICP27 binds to G-rich sequences and aids to increase their expression. 
HSV-l sequences are 68% GC-rich making an RNA-binding protein that binds to G-
rich sequences and enhances gene expression beneficial, if not crucial, to the virus. 
The level at which ICP27 aids gene expression was investigated by quantifying CAT 
RNA in the nucleus and cytoplasm of uninfected and wt HSV -1 infected cells. It is 
hypothesised that ICP27 binds HSV -1 G-rich sequences to aid in their translation. 
This is plausible, as it has been demonstrated that ICP27 can directly enhance 
translation and has also been shown to be present at active translation sites. 
Furthermore, ICP27 interacts with two translation initiation factors as well as P ABP. 
Further investigations into the involvement of this important viral protein at the level 
of translation should ultimately lead to the discovery of the mechanism(s) involved, 
possibly at the initiation stage, and it is this information that may lead to human 
intervention of the HSV -1 infection. 
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